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Abstract
During neonatal development, tendons undergo a well orchestrated process whereby extensive structural and
compositional changes occur in synchrony to produce a normal tissue. Conversely, during the repair response
to injury, structural and compositional changes occur, but in this case, a mechanically inferior tendon is
produced. An injured tendon that is mechanically inferior has compromised function and reruptures after
treatment are commonly observed clinically. As a result, the process of development has been postulated as a
potential paradigm through which improved adult tissue healing may occur. First, the role of CD44 in healing
was examined through a patellar tendon injury in a CD44 knockout mouse. A beneficial environment post
injury was shown to lead to improved function in the CD44 knockout tendons. Second, type XIV collagen
was examined in tendons during development and maturity through Col14a1-/-, Col14+/- and Col14+/+
flexor digitorum longus tendons. A lack of type XIV collagen during development was associated with
reduced mechanical parameters but had no effect in mature tendons. Third, compositional, structural and
mechanical properties were quantitatively characterized during multiple stages of neonatal Achilles tendon
development in a mouse. Mechanical parameters, collagen content, fibril diameter average and standard
deviation all increased with age. Biglycan expression decreased with age while decorin and angular deviation
did not change. Fourth, compositional, structural and mechanical parameters were quantified after injury
during two different stages of development, early and late. An accelerated healing process was demonstrated
during early development over late development. Lastly, regression analysis was used to determine which
compositional and structural parameters predicted mechanical parameters during early and late development
and healing. Applying these differentially regulated parameters to new treatments may help improve healing in
adult tendons. Importantly, this dissertation was conducted in a mouse model which is allows for future
mechanistic studies due to the availability of genetically modified mice and commercially available assays.
Over all, this dissertation introduces development as a new paradigm through which to study improved
function during healing and potential new therapeutic treatments.
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ABSTRACT 
DEVELOPMENT AS A NEW PARADIGM FOR IMPROVED TENDON HEALING: A 
CHARACTERIZATION OF NEONATAL TENDON DEVELOPMENT, HEALING DURING 
DEVELOPMENT AND AN INVESTIGATION INTO DIFFERENTIAL PARAMETERS DURING 
ACCELERATED HEALING 
Heather L. Ansorge 
Louis J. Soslowsky, Ph.D. 
During neonatal development, tendons undergo a well orchestrated process whereby extensive 
structural and compositional changes occur in synchrony to produce a normal tissue. Conversely, 
during the repair response to injury, structural and compositional changes occur, but in this case, 
a mechanically inferior tendon is produced.  An injured tendon that is mechanically inferior has 
compromised function and reruptures after treatment are commonly observed clinically. As a 
result, the process of development has been postulated as a potential paradigm through which 
improved adult tissue healing may occur.  First, the role of CD44 in healing was examined 
through a patellar tendon injury in a CD44 knockout mouse.  A beneficial environment post injury 
was shown to lead to improved function in the CD44 knockout tendons.  Second, type XIV 
collagen was examined in tendons during development and maturity through Col14a1-/-, Col14+/- 
and Col14+/+ flexor digitorum longus tendons.  A lack of type XIV collagen during development 
was associated with reduced mechanical parameters but had no effect in mature tendons.  Third, 
compositional, structural and mechanical properties were quantitatively characterized during 
multiple stages of neonatal Achilles tendon development in a mouse.  Mechanical parameters, 
collagen content, fibril diameter average and standard deviation all increased with age.  Biglycan 
expression decreased with age while decorin and angular deviation did not change.  Fourth, 
compositional, structural and mechanical parameters were quantified after injury during two 
different stages of development, early and late.  An accelerated healing process was 
demonstrated during early development over late development.  Lastly, regression analysis was 
vi 
used to determine which compositional and structural parameters predicted mechanical 
parameters during early and late development and healing. Applying these differentially regulated 
parameters to new treatments may help improve healing in adult tendons.  Importantly, this 
dissertation was conducted in a mouse model which is allows for future mechanistic studies due 
to the availability of genetically modified mice and commercially available assays. Over all, this 
dissertation introduces development as a new paradigm through which to study improved function 
during healing and potential new therapeutic treatments. 
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Chapter 1: Introduction 
 
1.1 Significance 
1.1.1 Prevalence of Tendon Injuries in the US 
 Tendon injuries affect a large number of individuals and account for enormous associated 
costs [1, 2].  These injuries account for 45% of the almost 33 million musculoskeletal injuries that 
occur in the United States each year[3].  The work place is a large source of these injuries.  In 
1996, approximately 44% of all injuries and illness that resulted in days away from work were 
sprains, strains and tears [4].  However, soft tissue injuries are also extremely common outside 
the work place.  Between the years 1991 and 1998, the number of sports related injuries in 
people 35-54 years of age increased 33% [5].  It was estimated that from the approximately 1 
million sports related injuries in 1998, the cost to the nation was more than $18.7 billion[5]. The 
number of tendon injuries will continue to increase in our aging and active population[6].  Tendon 
injuries that are especially common, requiring surgical repair, include the shoulder's rotator cuff 
tendons (51,000 per year), the Achilles tendon (44,000 per year), and the patellar tendon (42,000 
per year) [7] [8]. Tendon injuries are of particular concern because they heal slowly and rarely 
regain normal function. Surgery [9], rehabilitation [10], drugs [11] and tendon grafts [7] have all 
been employed to improve healing.  However, despite surgical advances, adhesion formation, 
reruptures and decreased function are still common problems.   
 
1.1.2 Scar Formation 
 Adult tendons heal through a reparative process [12, 13] and undergo a set of 
coordinated responses that include inflammation, extracellular matrix production and remodeling 
of the tissue [14] . During these processes, cellular and extracellular matrix components are 
quickly deposited by fibroblasts to fill the defect and restore function; however, the quality and the 
structure of the scar tissue are both altered from native uninjured tendon.  While in some cases 
this scar does return some function to the tendon, it is still mechanically impaired.  For instance, 
scar tissue from the tendon proper can attach to the tendon sheath preventing normal sliding of 
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the tendon through the sheath.  Reduced quality of tissue results in tendon reruptures and is of 
prominent concern. Therefore, it is imperative that new strategies are developed to quickly return 
tendon to normal function post-injury. 
 
1.1.3 Healing Parameters throughout Development 
 Unlike adult reparative healing, fetal tissue is well known to heal through a regenerative 
process [15].  While first demonstrated in skin, fetal healing also occurs in tendon [16, 17].  In 
general, fetal wound healing occurs at a fast rate and without scar formation [18].  The 
mechanism behind fetal healing is still unknown, but it is believed that the regenerative response 
is a property of the tissue and not the environment [17].  Some candidates with differential 
expression or roles during fetal healing versus adult healing include the presence or absence of 
cytokines, relative amounts and organization of extracellular matrix components and mechanical 
stresses on the tissue.  While fetal healing is an excellent model for scarless healing, it is possible 
extensive differences, including load and inflammation, between fetal and adult healing may have 
prevented major breakthroughs in improving adult healing.  It has been hypothesized that healing 
parameters change from the fetal stage, through development and into adulthood.  For example, 
neonatal developmental tendons may heal through scar formation but regain normal structure 
and function faster than adult tendons.  Few studies have been able to test this hypothesis due to 
the small size and fragile nature of developing tendons. One study, on the healing of subfailure 
ligament injury in immature and mature rat, showed that a 21 day old rat regained 95% of its 
strength by 7 days post injury whereas an 8 month old rat only regained 81% at 14 weeks [19].  
Understanding which parameters contribute most to improved healing will allow the identification 
of key factors to examine when developing new therapies for adult healing.  The hope of this 
dissertation is to develop new therapeutic strategies to improve the outcome of tendon injuries 
through basic science investigations into the mechanisms involved in development and injury at 
different stages of neonatal development. 
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Figure 1.1: Example of a normal tendon 
with aligned fibers stained with hemotoxylin 
and eosin.   
 
 Figure 1.2: 
Hierarchical 
structure of tendons 
from collagen 
molecule through the 
fascicle.  Inset 
demonstrates a 
hypothesized 
interaction of 
proteoglycans with 
the collagen fibrils 
(Derwin, 1998). 
 
1.2 Background 
 1.2.1 Tendon Composition and Structure 
 Tendon is a highly organized soft 
connective tissue composed mainly of parallel 
collagen fiber bundles surrounded by extracellular 
matrix and tendon fibroblasts (Figure 1.1).  The 
fiber bundle’s main constituent is type I collagen 
whereas the matrix that surrounds the fibers is 
composed mainly of water, minor collagens, 
proteoglycans, and glycosaminoglycans (GAGs).  
Water represents 60-80% of the wet weight of tendon while type I collagen represents 
approximately 65-80% of the dry weight. Proteoglycans, such as decorin and biglycan, are 
approximately 1-5% of the dry weight [20, 21].  Minor collagens, such as type XII and type XIV 
collagens, are present in varying, yet small, amounts throughout tendon development and 
maturation [22-24]. 
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Figure 1.3: Achilles tendon shown 
connecting the calcaneous to the 
gastrocnemius muscle. (Photo: 
http://www.eorthopod.com)  
 
Achilles Tendon
Calcaneous
Gastocnemius Muscle
  The development of tendon’s hierarchical structure is a complex process consisting of 
fibrillogenesis  and higher order organization.  Fibrillogenesis alone consists of three distinct 
phases [25-27] and each step is independently regulated by specific fibril-associated 
macromolecules including proteoglycans and minor collagens.  First, immature type I collagen 
molecules assemble extracellularly to form immature fibril intermediates.  Next, during linear fibril 
growth, pre-formed fibril intermediates assemble end-to-end to form longer fibril consistent with 
mature, mechanically functional fibrils.  Lastly, in lateral fibril growth, the fibrils associate laterally 
to generate larger diameter fibrils.  As tendons mature, this lateral association of fibrils creates a 
wide range of fibril diameter sizes [2, 27-29].  For example, a fibril range from 40 to 400nm is 
seen in a three month old mouse[27]. The fully formed fibrils are then organized into fibers which 
are primarily parallel and aligned with the long axis of the tendon (Figure 1.2).  These fibers, 
along with the spindle-shaped tendon fibroblasts, are organized into fascicles.  Lastly, sheaths 
called endotenon bind fascicles together to form tendon which are in 
turn surrounded by epitenon. The formation of this 
hierarchy is a highly regulated, multistep process on 
which the mechanical integrity and function of tendon 
is dependent. 
 
1.2.2 Tendon Mechanics 
 Tendon is primarily a uniaxial tissue which 
transfers load from muscle to bone and stabilizes the 
joint (Figure 1.3). Whereas the primary function of 
collagen in tendon is to withstand tensile strength, 
the non-collagenous components are thought to 
serve mainly as resistance to compressive forces. 
Tendons have the highest tensile strength of any connective tissue in the body, a characteristic 
that is likely due to the high collagen content of the tendon fibers and their densely packed, 
parallel alignment along the direction of force.  For example, direct in vivo measurements of 
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Figure 1.4: Typical stress vs strain curve 
from a constant ramp to failure tensile 
test of tendon.  The toe, linear, yield and 
failure regions are indicated. 
 
forces during various activities revealed loading in the Achilles tendon as high as 9 kN during 
running in humans, which is up to 12.5 times body weight [30].   
 In vivo, tendons most often experience uniaxial tensile forces.  Mechanically testing a 
tendon ex vivo in similar conditions produces a nonlinear curve.  Stress-strain curves can be 
calculated from load-displacement uniaxial tensile 
testing and the cross-sectional area  of the tendon 
(Figure 1.4).  There are three distinct regions of 
the tendon stress-strain curve produced during 
tensile testing [31].  Initially the curve is 
characterized by a low modulus (toe) region at low 
strains.  The toe region is thought to be a result of 
the gradual recruitment and uncrimping of fibers 
as the tendon is elongated.  During this period 
there is extensive deformation with little increase 
in load.  After the toe region, the stress-strain curve is characterized by a high modulus (linear) 
region during which the tendon demonstrates linear elastic behavior.  It is believed that at these 
strains all of the fibers are engaged and bear load. The yield point, where the modulus gradually 
decreases, is thought to be the point where collagen fibers begin to break, slide past each other 
and eventually fail.   
 Structural properties, which do not account for differences in size and structure, can be 
obtained from the load-displacement curve.  Toe region properties are calculated from a bilinear 
fit where the inflection point is identified.  Subsequently the toe region stiffness is calculated as 
the slope of the curve up to the inflection point and the load and deformation can be determined 
at the inflection point.  Parameters obtained from the linear region include the maximum load (the 
highest load reached) and stiffness (the slope of the curve in the linear region).  These structural 
parameters describe the behavior of the tendon as a whole.  On the other hand, material 
properties are intrinsic measures of the quality of the tissue substance.  Material properties 
including, toe region modulus, inflection point stress and strain, maximum stress and linear region 
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Figure 1.5: Representative schematic for a 
tendon during a stress-relaxation test. 
 
modulus, can be calculated in a similar fashion as the structural properties but from the stress-
strain curve.   
 Tendons possess time and history 
dependant properties that can be observed 
through stress relaxation (Figure 1.5) and 
creep mechanical tests.   Stress relaxation 
tests involve stretching the tendon to a 
constant length (strain) and allowing the stress 
to vary over time.  Subsequently, percent 
relaxation can be calculated from peak stress, 
the (highest stress after initial strain) and equilibrium stress (the stress reached after relaxation 
has occurred).  A creep test involves subjecting tissue to a constant force and allowing the length 
to vary with time.  Viscoelastic parameters are dependant on time and rate of loading of the 
tendon.  Proteoglycans and water, along with the inherent viscoelasticity of the collagen itself, are 
thought to be primarily responsible for viscoelastic behavior [32, 33].  Structural, material and 
viscoelastic parameters characterize the functional behavior of tendons; however, one instance 
when all these parameters are markedly changed from normal mature tendon values is after 
tendon injury. 
  
1.2.3 Reparative Tendon Healing 
 Adult tendons heal through a reparative process [12, 13] and undergo a set of 
coordinated responses that include inflammation, extracellular matrix production and remodeling 
of the tissue [14] . During the inflammatory phase, accumulating leukocytes perform extensive 
phagocytosis of necrotic tissue and release pro-inflammatory cytokines [34].  Subsequent to 
fibroblast proliferation, increased extracellular matrix production then alters the composition of the 
tendon from its uninjured state.  For example, biglycan levels increase and decorin levels 
decrease [35, 36], the cellular receptor CD44 is highly expressed[16] and type XIV collagen is 
upregulated [37].  At this stage, not only is the composition altered but also the structure.  For 
Stress Relaxation
t
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instance, the fibril diameter size distribution is narrowed and consists mainly of small diameter 
fibrils [38-40].  Extracellular matrix is also laid down in a disorganized fashion, altering the parallel 
alignment of the fibers[41].   During remodeling, the final stage, collagen fibrils begin to coalesce 
laterally and fibers reorganize along the long axis of the tendon.  However, even after remodeling, 
the overall result of reparative healing is a fibrotic scar with structure, composition and 
mechanical properties that are inferior to normal tendon.  
 Tendon properties improve over time after injury, but they rarely return to normal levels 
[42, 43].  For example, the repair tissue in the patellar tendon 1.5 months post-injury only 
achieved 20% of normal maximum stress and at 6 months was still only 22% of normal [43]. 
Similarly, 21 months after a central third defect the patellar tendon only regained 34% of the 
uninjured ultimate stress [44].  Numerous studies have tried to improve the reparative healing 
response through the application of cytokines and growth factors, mechanical stimulation or 
deprivation and gene therapy to name a few.  While some studies demonstrate improved 
mechanical properties of one treatment versus another, even in the best cases, mechanical 
properties remain only a fraction of native tissue.  Therefore, it is imperative that new strategies 
are developed that promote an efficient return to normal function post-injury. 
 
1.2.4 Current Strategies for Tendon Repair 
         As previously stated, tendon injuries are still a major area of scientific study due the 
inability of most tendons to fully heal on their own.  Clinical management of tendon injury currently 
follows two basic routes: conservative (rehabilitation, rest and pain relief) or surgical.  However, 
treatment choices between and within each of these disciplines can be complicated.  For 
example, in the biceps tendon, nonoperative treatments (rest, activity modification, ice, non-
steroidal anti-inflammatories, immobilization) are employed for older patients while younger 
patients receive acute repair[45].  Many factors affect outcome including the specific tendon 
injured (flexor, intrasynovial, extrasynovial, other), age of the patient and the type of injury 
(chronic, acute), not to mention obesity, diabetes and other health complications[46].  The most 
conventional surgical treatment, suturing the torn tendon back to itself or to bone, is commonly 
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Cytokine Function
bFGF Stimulates angiogensis, cellular migration and proliferatoin
BMP-12 Stimulates cellular differentiation
IL1b Intiaties multiple pro-inflammatory cascades
IL-10 Anti-inflammatory
PDGFB Influences extracellular matrix remodeling and DNA synthesis
TGFb1 Plays a role in the initial inflammatory response and throught to increase fibrosis
TGFb3 Involved in inflammation and is increased in scarless healing
VEGF Plays a role in angiogensis
Table 1.1: Example of several key growth factors and cytokines 
involved in tendon healing. 
 
used to repair rotator cuff tears.  However, despite a greater understanding of tendon healing and 
advances in surgical treatment, rotator cuff failure after surgery remains common[47]. Reruptures 
have been correlated with tear size, tear chronicity, and patient satisfaction[48].  Tendon grafts 
are an alternative to tissue repair and are commonly used; however, they can insight 
inflammatory reactions and can also mechanically fail [49].  It is clear that despite recent surgical 
and rehabilitative advances extensive improvement in the treatment of injured tendon is still 
necessary. 
 New methods to help advance tendon healing are being explored to improve upon 
current clinical outcomes.  Specific cytokines play a role in wound healing include transforming 
growth factor-beta, platelet-derived growth factor, basic fibroblast growth factor and interleukin-1 
beta [50] (Table 1.1). While many in vivo animal studies observed promising results for cytokine 
application[14], there are still many complications to be overcome before wide clinical application.  
For instance, not all cytokines have a monotonic effect.  One study found that bFGF promoted the 
formation of repair tissue; however, while a high dose was not detrimental, it delayed later 
maturation of the tissue [51].  Even when appropriate doses are determined in animal models it is 
difficult to scale these doses for clinical application. Animal studies have also shown that growth 
factors work well in combination, but again, the appropriate ratios and concentrations are difficult 
to determine clinically.  Clinical application of a single growth factor has been successful in 
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Figure 1.6: Maximum stress after injury in tendons injected with either saline, empty vector or IL-10 
vector.  The asterisk (*) indicates a significant difference (p<0.05)  and the pound sign (#) denotes a trend 
(p<0..1) when comparing between treatment groups within a postinjury time point. (RIcchetti, 2008).  
 
orthopaedic tissues but can be accompanied by unforeseen complications..  Therefore, while 
promising, the application of cytokines and growth factors still pose many clinical concerns. 
 One solution to the issues posed by cytokine application is the use of autologous growth 
factors, particularly those obtained through platelet-rich plasma (PRP).  PRP is being widely used 
clinically for both surgical and non-surgical treatments in sports orthopaedics. Platelets contain 
many biologically active factors, including proteins responsible for haemostasis, synthesis of new 
connective tissue and revascularisation [52].  It is thought that PRP can stimulate a physiological 
release of growth factors to jumpstart healing in chronic injuries, or speed up an acute injury 
repair process [53-55]. However, few studies have shown a direct effect from PRP on soft tissue 
healing and very few randomized controlled trials have been performed.  Even fewer trials are 
adequately powered, use appropriate outcome measures or have decent follow-ups[56]. In 
general, the results of treating tendon injuries with PRP are unknown.   
 An alternative method for the delivery of specific growth factors or cytokines is gene 
therapy.  Genes can be transfected into cells ex vivo or in vivo through retro-viruses, and thereby 
increase the expression of a protein or suppress protein synthesis in targeted cells. With this 
technology, it might be possible to deliver multiple genes of specific cytokines to cells, and to 
regulate the extent and timing of their expression.  Adenoviral-mediated gene transfer has been 
successfully used in numerous soft tissue wound healing animal models [57]. Similarly,  Richetti 
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et al demonstrated successful gene transfer of IL-10 into healing adult murine patellar tendon 
using a lentiviral vector[58] and showed improved mechanics relative to controls  (Figure 1.6).  
While viruses can be amplified easily, they can also elicit an immune response. The use of viral 
vectors also places constraints upon the size of the gene being transferred, and can require that 
the target cells be actively dividing which posses a complication with tendon fibroblasts.  While 
gene therapy is a promising new area, there are still many complicated issues that need to be 
unraveled before it is widely used. 
 Tendon grafts, in conjunction with cell based therapies, are also being used to improve 
tendon healing.  Autologous cells are removed, expanded in vitro, possibly treated and placed 
back in vivo with a carrier device (graft).  This consists of removing autologous cells, expanding 
them in culture, possibly treating them in vitro, and placing them back in vivo with a carrier device.  
Potential cell sources include mesenchymal stem cells (MSCs) or cells from the native tissue, 
tendon fibroblasts. Numerous in vitro studies have been done to improve cell/graft constructs 
prior to implantation.  Some of the methods include application of growth factors and mechanical 
stimulation[59, 60].  These methods have been shown to stimulate extracellular matrix 
production, cell proliferation and improved mechanical properties.  In vivo studies showed that 
implantation of MSCs into injured rabbit Achilles tendons significantly improved their structural 
properties [61, 62].  Despite these advances cell based therapies have their limitations.  
Specifically, using autologous cells requires two surgeries with the possibility of donor site 
morbidity.  In addition, cell/graft constructs have yet to recapitulate the mechanical strength of 
native tissue and could possibly rupture after implantation.   
 One can easily see from the previous paragraphs that while great advances have been 
made in the field of tendon healing, there is still significant room for improvement.  By gaining a 
greater understanding of the natural development of tendons and their mechanical strength, 
these processes may be recapitulated during healing.  
 
1.2.6  Regenerative Tendon Healing 
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 Extensive experimental evidence suggests that early  and mid-gestation fetal tissue 
responds to injury in a fundamentally different way than adult tissue.  While first observed in skin, 
regenerative healing also occurs in fetal tendon [16] (Figure 1.7). Identifying key factors in fetal 
healing has been previously used as a strategy with which to improve adult healing.  One main 
difference between fetal and adult healing is that fetal healing occurs with almost no inflammatory 
response and anti-inflammatory cytokines are elevated. Some authors believe that this differential 
response plays a key role in scarless healing; therefore, numerous studies were conducted that 
decreased inflammation in adult tissue.  For example, hyaluronic acid (HA) is a 
glycosaminoglycan that is abundant in tendons and is associated with embryogenesis, and 
healing [63-65].  It is believed that high molecular weight HA is anti-inflammatory while low 
molecular weight in pro-inflammatory.  During adult tendon healing, CD44 (a cellular receptor for 
hyaluronic acid, HA) and HA levels were both elevated [17, 34]. However, during scarless 
Figure 1.7: Adult and fetal tendon response to healing.  H&E stained tendon: 1) 
adult normal, 2) adult wounded showing significant fiber disruption, 3) fetal normal, 
4) fetal wounded with completely reconstituted collagen architecture (Beredjiklian, 
2003). 
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Figure 1.8: CD44 expression in adult and fetal healing.  CD44 increased markedly in the 
wounded adult tendons but only slightly or not at all in the fetal (black indicates wound, brown 
represents immunostaining). (A) Adult, original magnification 100; (B) 1 week fetal, original 
magnification 200 (Beredjiklian 2003). 
 
 
regenerative fetal healing, CD44 expression is down regulated [17] (Figure 1.8) and HA levels 
surpass those of healing adult tendons [15, 66].  Studies attempting to recreate regenerative 
wound environments have demonstrated that increased levels of HA are indeed beneficial, 
possibly through an anti-inflammatory pathway [67, 68].  Therefore, since HA is degraded 
primarily through CD44, strategies to decrease CD44 expression or activation may reduce scar 
formation 
 The regenerative response of fetal tendon offers a model for the study of scarless healing 
mechanisms. Current investigations however have yet to produce profound effects on adult 
healing.  However,  it is interesting to note that while fetal wounds looked healed histologically, 
they still had significantly decreased mechanical parameters post injury [16].  This could be one 
reason why current investigations using knowledge gained from fetal studies have yet to produce 
profound effects on adult healing.  Additional limitations of the fetal healing model system are the 
numerous and drastic differences between fetal and adult healing. Specifically, fetal healing 
occurs in a relatively unloaded environment which could be the cause of reduced mechanics 
despite histological healing.  A lack of inflammatory response in fetal healing also presents an 
issue when trying to apply fetal healing mechanisms to adult healing.  Therefore, while fetal 
healing may be an appropriate paradigm for studying reduction in scar, it is not an ideal model for 
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Figure 1.9: Linear regression plots for strength  
versus collagen cross sectional area fraction.  Solid 
line is data from adult mice only (R2=0.61), dashed 
line includes data from Robinson et al of 3wk old 
mice (R2=0.69) (Goh, 2008).   
 
 
improved function and mechanical strength.  A new model system that employs improved healing 
but also incorporates improved function needs to be explored.    
 
1.2.7  Structure-Function Relationships 
It has long been hypothesized that the structure and composition of tendons are a result 
of the specific function tendons perform.  Previous studies have provided insight into the complex 
interplay of a tendon’s constituents which is critical to formalizing structure-function relationships 
[29, 69-71]. Importantly, some studies have performed statistical correlations between structure 
or composition and mechanics.  For example, age-related declines in tissue strength have been 
positively correlated with a 
decrease in fibril diameter 
distribution and size.  Similarly, 
collagen fibril cross-sectional area 
fraction explained more than half 
of the changes in mechanical 
properties of mature to aged 
tendons through linear regression 
[72] (Figure 1.9).   Interestingly, 
the addition of data from younger 
tendons to this study improved the 
regression model, thereby supporting the need for further structure-function analyses of younger, 
developing tendons.   
 While many studies have demonstrated that fibril diameter size is correlated with tendon 
mechanics in normal tendons, similar relationships have not been shown in healing tendons. A 
study in the healing MCL of rabbits demonstrated that while the injured ligament increased in 
mechanical strength to 2/3 the control tendon at 40 weeks, the mean fibril diameter remained 
smaller than controls and did not increase over the same time period [73].  An extended study in 
the same model showed that the mean fibril diameter did not change up to 104 weeks post injury; 
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Figure 1.10: Tendon fibrillogenesis. (A) Molecular 
assembly of type I collagen generates the fibril 
intermediate. (B) In the linear growth step, the 
intermediates in (A) grow by end-to-end growth to 
generate longer fibrils. (C) In the lateral growth 
step, there is a lateral association and growth of 
the developing fibrils (Zhang, 2005). 
 
however, it was noted that there was an increased proportion of very small fibrils along with large 
fibrils, creating an increased spread in fibril diameter size [42].  This indicates that fibril diameter 
spread may be a more appropriate collagen fibril parameter to correlate with mechanics than 
mean fibril diameter size.    
 These studies begin to distinguish the relationships between structure, composition and 
mechanics; however several limitations should be noted.  First, few studies used quantitative 
correlations.  Second, few studies have systematically quantified tissue structure, composition 
and mechanical properties simultaneously.  Further investigation into these relationships, 
specifically during development and healing could identify key factors necessary for the 
production of functional tendon.  
 
1.2.8   Tendon Development  
 Tendon development is initiated 
in utero and continues through neonatal 
development until maturity. Numerous 
studies have investigated the 
composition and structure of tendon 
throughout growth and have found them 
intimately connected.  The development 
of tendon’s hierarchical structure 
through fibrillogenesis is a multistep 
process with at least three phases [25-
27] (Figure 1.10).   First, collagen 
molecules assemble extracellularly to 
form immature fibril intermediates.  
Next, during linear fibril growth, fibril 
intermediates assemble end-to-end.  
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Figure 1.11: Collagen fibril structure during development in mouse tendons. Transmission 
electron micrographs of transverse sections from mouse flexor tendons and the diameter 
distributions at each developmental stage from normal mice (a-d). Bar 300nm (Ezura, 2000). 
 
 
Lastly, in lateral fi  bril growth, the fibrils associate laterally to generate larger diameter fibrils.  
Each step of fibrillogenesis is independently regulated by specific fibril-associated 
macromolecules, including minor collagens, type XII and XIV, and the proteoglycans, biglycan 
and decorin.  Type XIV collagen is believed to play a role in linear growth of the fibrils.  Biglycan 
is believed to promote fibril diameter growth, where as decorin is believed to control lateral fusion 
of the fibrils and increase fibril stability.  During early development, biglycan and type XIV 
collagen are highly expressed while decorin is relatively low; however, as growth progresses 
biglycan and type XIV collagen are down regulated and decorin is upregulated [2, 74-76].  Due to 
their role in fibrillogenesis, it has been hypothesized that their temporal expression during 
development plays a crucial role in the mechanical formation of tendons.  In support of this, in 
vivo studies of decorin and biglycan deficient mice showed unregulated lateral growth, structurally 
abnormal tendon fibrillogenesis and altered mechanics [77, 78]. Therefore, it has been 
hypothesized that type XIV collagen, biglycan and decorin not only play a role in the structure of 
tendons but also in the function. 
 Another parameter that changes throughout development is the distribution of fibril 
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Figure 1.12: Mechanical changes during 
chick development from prehatchling day 43 
to 2 day old hatchling.  These stress strain 
curves demonstrate an increase in 
mechanical strength during development 
(McBride, 1988). 
 
 
diameter sizes [28, 71, 79, 80] (Figure 1.11). Early in development, the distribution is narrow, 
consisting of mainly small diameter fibrils.  As growth progresses, the distribution increases as 
fibrils coalesce to form larger diameters while some remain unaltered.   Often this change begins 
at the onset of locomotion; therefore, it has been hypothesized that the large diameter fibrils have 
higher tensile stress than small diameter fibrils [29, 71]. The small size and fragile nature of 
neonatal tendons has made it difficult to obtain mechanical data to test this hypothesis during 
development when the largest changes in fibril diameter are occuring.  However, one study 
showed a rapid increase in ligament mechanical strength throughout development but the 
youngest age studied was only 1.5 months old in a r  at [81]. An additional study done in chick 
tendons examined composition, structure and mechanics from post-fertilization through hatchling 
[82] (Figure #).  While this model does provide mechanical data of tendon development, the chick 
is not the ideal model system due to lack of genetically modified animals and available assays.  
An ideal model system would allow for the detailed study of the mechanisms behind structural, 
compositional and mechanical changes during 
development.   
  As previously mentioned tendons 
undergo drastic compositional and structural 
changes during both development and healing.  
Many of these changes parallel each other. In 
both development and healing collagen content 
increases and the fibril diameters increase.  
Minor matrix molecules, like Collagen XIV and 
biglycan, are present during development and 
healing but are very sparse in mature 
tendon[83]. However, there are also 
differences in these two events.  In particular, 
during development decorin is initially low and 
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increases with age, and biglycan is initially high and decreases [2].  Alternatively healing, both 
decorin and biglycan are elevated and most notably, biglycan maintains higher levels for an 
extended period of time.  The most striking difference, despite the numerous similarities, is that 
during development a mechanically functional tendon is formed whereas during healing a tendon 
with inferior mechanics results.  Therefore, there must be inherent difference between 
development and healing. It has been postulated that development could serve as a paradigm 
through which improved adult healing may occur. By comparing and contrasting neonatal 
development and healing, key parameters can be identified through which adult healing can be 
improved.  
 
1.3 Specific Aims and Hypotheses 
 The overall aim of this bioengineering study is to investigate parameters that affect 
tendon mechanics within neonatal development and healing.  The overall objective is to use 
neonatal development as a paradigm through which to study healing, specifically by studying 
compositional and structural parameters during healing and neonatal development and relate 
them to the mechanical strength of the tendon.  The specific aims and hypotheses are as follows: 
Specific Aim 1: To investigate the effect of CD44 in the healing of the adult patellar tendon.   
Hypothesis 1: CD44 knockout mice will have decreased material properties and increased 
organization of the healing patellar tendon. 
 This hypothesis is based on previous studies that showed a delay in skin wound closure 
in the CD44 knockout mouse [84]  CD44 was chosen to be investigated in tendon healing based 
on previous studies that demonstrated a lack of CD44 in scarless healing. To assess the healing 
parameters of tendon in the CD44 knockout mouse a mouse patellar tendon injury model will be 
used.   
Specific Aim 2: To determine the functional role(s) of type XIV collagen in the development of 
tissue-specific mechanical properties.   
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Hypothesis 2a:  The significant role type XIV collagen plays in the regulation of fibrillogenesis 
would lead to alterations in the mechanics of developing Col14a1 null tendons but not mature null 
tendons.  
Hypothesis 2b: Prolonged presence of type XIV collagen in skin versus tendon would lead to 
altered mechanics in Col14a1 null mature skin but not mature null tendon. 
 This hypothesis is based on previous work that demonstrates the role of type XIV 
collagen in linear fibril growth and in regulating lateral fibril fusion.  A knockout mouse model, 
Col14a1-/-, along with the heterozygote, Col14a1-/+ and wildtype counterparts will be employed.  
The flexor digitorum longus tendon was chosen to be investigated during neonatal development 
and in maturity.  In addition, skin mechanics will be investigated in mature animals to determine 
the tissue specific role of type XIV collagen.   
Specific Aim 3: To characterize the structure, composition and biomechanics of the developing 
tendon. 
Hypothesis 3a: The collagen fiber alignment of the developing tendon will not change during 
development. The collagen content and fibril diameter spread will increase throughout 
development. 
Hypothesis 3b: Biglycan will decrease and decorin will increase throughout development. 
Hypothesis 3c:  The maximum stress and modulus of the developing tendon will decrease 
during early development and then increase, whereas the percent relaxation will increase and 
then remain constant. 
 These hypotheses are based on previous compositional and structural studies in the 
mouse and one previous mechanical study conducted in the chick.  An Achilles tendon mouse 
model of neonatal development will be used to create a quantitative model that can make use of 
numerous genetically modified mice and commercially available assays.  The availability of these 
tools will allow for study of the specific mechanisms involved during development. 
Specific Aim 4:  To determine the differential affect of developmental age on the healing 
response. Specifically, characterize the structure, composition and biomechanics of the healing 
tendon at two stages of development. 
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Hypothesis 4a:  Maximum stress, modulus and decorin levels will be significantly higher in early 
developmental injury when compared to late developmental injury (injured tendon normalized by 
contralateral uninjured tendon). 
Hypothesis 4b:  Collagen content, fibril diameter spread and percent relaxation will be 
significantly higher at late stages of healing in early developmental injury when compared to late 
developmental injury (injured tendon normalized by contralateral uninjured tendon). 
Hypothesis 4c:  Collagen content, angular deviation and biglycan levels will significantly increase 
over time in late developmental injury (injured tendon normalized by contralateral uninjured 
tendon).   
Hypothesis 4d:  When normalized, maximum stress, modulus and percent relaxation will 
significantly increase over time in early development injury but will remain low in late development 
injury. 
 These hypotheses are based on previous studies of tendon healing.  The mouse model 
of neonatal tendon development created in specific aim 3 will be used to determine two distinct 
stages of tendon development through which to study healing.  A full thickness, partial width 
injury will be created in one Achilles tendon of each neonatal mouse while the controlateral leg 
will serve as the uninjured control. 
Specific Aim 5:  To determine the differential roles of structure and composition on 
biomechanical properties during development and healing using a predictive statistical 
model based on experimentally measured inputs.   
Hypothesis 5a:  Collagen content will be a significant predictor in all groups for all mechanical 
parameters. 
Hypothesis 5b:  Fibril diameter spread will be a significant predictor for maximum stress and 
modulus in late development and late stages of healing; however, it will be a stronger predictor in 
injury during early development than in injury during late development. 
Hypothesis 5c: Biglycan and decorin will both be significant predictors of maximum stress and 
modulus; however biglycan will predict decreased mechanics and decorin will predict increased 
mechanics. 
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 Previous studies have attempted to determine which compositional and structural 
parameters are involved in the development of mechanical strength with limited success.  This 
aim will use the data collected in specific aim 4 and implement it in a linear, backwards stepwise 
regression model.  This study will lend significant insight into the structure-function relationships 
in tendons. Key factors identified in this study will provide design parameters for both new 
therapeutic treatments and tissue engineered constructs.   
 
1.4 Chapter Overviews 
 This thesis consists of 7 chapters and an Appendix.  Chapter 1 is an introduction and 
provides the necessary framework for the studies described in the subsequent chapters. This 
includes a summary of basic tendon composition, structure and mechanics.  In addition, the 
typical response of adult tendon to injury along with current strategies for treatment is included. It 
also provides background on the processes that are currently known to occur during 
development, both fetal and neonatal, that serve as a foundation for the work that follows.   
 Chapter 2 addresses Aim 1 of this dissertation by evaluating the effect of an absence of 
the cellular receptor CD44 on adult tendon healing.  To accomplish this a CD44 knockout mouse 
was used along with a mouse patellar tendon injury model to evaluate healing at multiple time 
points post injury.  CD44 was investigated in this study due to its lack of expression in scarless 
fetal healing but high expression in adult tendon healing.  Tendon mechanics, structure and gene 
expression of specific cytokines and growth factors were examined.   
 Type XIV collagen has been shown to be highly expressed during neonatal development 
but not in mature tendons.  Chapter 3 addresses Aim 2 by evaluating the affect of an absence of 
type XIV collagen on skin mechanics and neonatal and mature tendon mechanics.  This was 
accomplished by utilizing the Col14a1-/-. Col14a1-/+ and wildtype mice at 7 and 60 days old.  
Background on type XIV collagen and the Col14a-/- mouse is provided in Chapter 3.  Due to the 
small size and fragile nature of neonatal tendons they have not previously been mechanically 
evaluated.  Details on the development of a new method to mechanically test these tendons are 
also provided in Chapter 3. 
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 The establishment of a method to mechanically test neonatal tendons led directly to the 
characterization of the mechanical, compositional and structural parameters during neonatal 
tendon development as described in Chapter 4 (Aim 3).  Of particular importance was developing 
a quantitative method to measure all parameters investigated.  In addition, a mouse model was 
chosen due to the availability of genetically modified mice and commercially available assays.  
After the establishment of basic knowledge of normal development, the specific mechanisms of 
mechanical development can be ascertained through these available tools. 
 Chapter 4 clearly described specific stages of development in the neonatal mouse 
Achilles tendon.  It has been previously hypothesized that composition and structure play a 
significant role in healing.  Therefore, Chapter 5 (Aim 4) evaluates the differential affect of healing 
at two distinct stages of development.  A full thickness, partial width (~50%) injury without need 
for suture repair was created in the neonatal mouse Achilles tendon with a biopsy punch that 
created a full thickness, partial width (~50%) injury without need for suture repair.  Only one 
Achilles tendon per neonatal mouse was injured so the uninjured controlateral leg could serve as 
an internal control. 
 Rigorous statistical tests have previously been used to determine which parameters play 
a significant role in tendon mechanics.  The data from Chapter 5 was used in a backwards 
stepwise regression in Chapter 6 (Aim 5) to determine which compositional and structural 
parameters had a significant effect on neonatal development and healing.  The ability to use 
rigorous statistical methods in this manor was the motivation behind developing quantitative 
assays in Aims 3 and 4.  Finally, Chapter 7 draws overall conclusions from the studies described 
in Chapters 2-6 and discusses potential future directions in which this research might advance. 
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Chapter 2: CD44 deficiency improves healing tendon mechanics and increases matrix and 
cytokine expression in a mouse patellar tendon injury model 
 
2.1. Introduction 
2.1.1 Significance  
Tendon injuries affect a large number of individuals and account for enormous associated 
costs[1]. The number of tendon injuries will continue to increase as our population continues to 
age and remain active.  A complex cascade of events occurs during healing which results in a 
fibrotic scar. Scar tissue is characterized by altered structure and composition and decreased 
tendon function.  Despite advances in surgical techniques and postoperative rehabilitation 
protocols, adhesion formation[2], reruptures and decreased function due to scaring are still 
common problems; therefore, decreasing the formation of the fibrotic scar may lead to improved 
healing properties.   
 
2.1.2 CD44 and Hyaluronic Acid  
CD44, a polymorphic type I 
transmembrane glycoprotein, is a key 
mediator during fibrotic healing (Figure 2.1). 
CD44 is involved in cell-cell and cell-matrix 
interactions, leukocyte homing and activation, 
cellular migration, extracellular matrix 
assembly and cytokine binding and 
activation[3, 4].  However, its main role is 
mediating the uptake and clearance of 
hyaluronic acid (HA)[5]. HA is a high 
molecular-weight (HMW) 
glycosaminoglycan that is abundant in 
Figure 2.1: Schematic of the cellular receptor 
CD44 (Photo: http://www.cancer-
therapy.org/CT2A/html/25.%20Coradini%20et
%20al,%20201-21%20copy.html). 
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soft connective tissue[6].  Degradation and turnover of hyaluronic acid is associated with multiple 
processes including embryogenesis[7], healing [7, 8], and inflammation[3]. However, HMW-HA 
and LMW-HA have differential roles. LMW-HA has demonstrated numerous proinflammatory 
effects[8], where as HMW-HA blocks proinflammatory effects[9-11].  Therefore, in some 
environments increased levels of HMW-HA are beneficial but LMW-HA is detrimental.   
The increased presence of CD44 and LMW-HA in the adult wound environment plays a 
role in inflammation and cellular activities [12, 13]. For example, HA suppresses the expression of 
IL-1B [14]and PDGF-BB induced cellular migration[15].  The CD44-mediated clearing of LMW-HA 
is thought to contribute to the resolution of the inflammatory response.  These data suggest that 
CD44 plays a crucial role during inflammation and healing during adult healing. Unlike adult 
wounds, fetal wounds are known to heal through a regenerative process characterized by 
decreased inflammation, early deposition of extracellular matrix and lack of scar [13, 17, 18].  
During regenerative fetal healing, CD44 expression is down regulated [13] and HA levels surpass 
those of healing adult tendons [19, 20].  Studies attempting to recreate regenerative wound 
environments have demonstrated that increased levels of HA are indeed beneficial[16] [17] in 
animal models, but similar results clinically have been unsuccessful[18].  Therefore, since HA is 
degraded primarily through CD44, strategies to decrease CD44 expression or activation may 
reduce scar formation.  
One strategy to decrease the interaction between CD44 and HA is the use of anti-CD44 
blocking antibodies.  Multiple antibodies have been employed with different modes of action, 
including CD44 receptor blocking and receptor shedding [22-25].  In vivo studies have shown 
decreased migration of cells [19, 20]and decreased tissue damage[21]. These studies have 
demonstrated a role of CD44 in inflammatory disease; however interpretation of the results 
warrant some caution due to poor understanding of the exact action of the antibodies.   
A CD44 knockout mouse was created to study the effects of a complete absence of CD44 [26, 
27]. These mice had decreased macrophage recruitment and decreased expression of 
proinflammatory cytokines at the site of lung injury[22].   When examining inflammatory disease, 
CD44 knockout mice had greater HA accumulation when compared to their wild type 
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counterparts[23];  however, increased signaling through RHAMM, another HA receptor, may have 
exacerbated inflammation in this disease model[24].  Lastly, the absence of CD44 in skin wounds 
delayed early wound closure[25].  These studies collectively demonstrate that CD44 plays a 
crucial role in wound healing and inflammation; however, to date, the role of CD44 in tendon 
healing has not been evaluated.    
 
2.1.3 Objective and Hypotheses 
  The purpose of this study was to investigate the effect of CD44 in the healing of the 
patellar tendon.  We hypothesize that CD44 knockout mice[26] will have decreased material 
properties and increased organization of the healing patellar tendon. In addition, we hypothesize 
that proinflammatory cytokines will be down regulated and extracellular matrix proteins will be up 
regulated during early stages of 
healing. 
 
2.2 Methods 
2.2.1 Specimens 
  This study was 
approved by the University of 
Pennsylvania IACUC. Forty-two 
male mice from both C57Bl/6 
wild type (WT) and CD44 
knockout (KO) in a C57Bl/6 
background were included in 
this study. Thirty two mice from 
each group underwent surgery 
at 12 weeks of age using an established tendon injury model in our laboratory as previously 
described[27] (Figure 2.2).  Briefly, mice were prepared under normal sterile conditions and both 
Figure 2.2: Photos that depict the partial transection created 
in the mouse patellar tendon. A plastic coated backing is 
placed underneath the tendon (Fig. 1(1)), and a circular 
biopsy punch is used to create a full thickness partial 
transection (Fig. 1(2)). A distinct and reproducible injury is 
left (Figs. 1(3) and (4)). 
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hind limbs were shaved. Following a skin incision, two cuts parallel to the tendon were made in 
the retinaculum on each side, and a plastic coated blade was then placed underneath the patellar 
tendon. With the coated blade serving as support, a 0.75mm diameter biopsy punch (Shoney 
Scientific, Waukesha, WI) was used to create a full thickness partial transection in the patellar 
tendon (Figure 2.2). Marginal fibers were left intact, circumventing the need for suture repair.  An 
injury was created in both  legs.  Skin wounds were closed with suture and the mice were allowed 
to resume normal cage activity until they were sacrificed at 1 day (n=4), 3 days (n=4), 7 days 
(n=4), 3 weeks (n=10), and 6 weeks (n=10) post surgery. An additional ten mice per genotype 
were sacrificed without injury to serve as controls. 
 
2.2.2 Biomechanical Analysis    
  To determine the mechanical properties of the healing patellar tendon, one patellar 
tendon from each of twenty-six mice of each genotype was used. Ten mice were sacrificed at 
both 3 and 6 weeks post injury while six uninjured mice 
were sacrificed to serve as controls. As described 
previously[27], the patellar tendons were dissected and 
cleaned, leaving only the patella, patellar tendon, and tibia 
as one unit. Tendon width and thickness were then 
quantified, and cross-sectional area was measured using 
a custom built device consisting of LVDTs, a CCD laser, 
and translation stages[28].  Each tendon was dumbbell 
stamped to remove the uninjured fibers on either side of 
the injury.  The cross-sectional area was then measured 
again for material property calculations.  Stain lines were placed 1mm apart in the midsubstance 
to track strain optically.  The tibia was then embedded in polymethylmethacrylate in a custom-
designed fixture. The patella was held in place with a custom-designed cone-shaped fixture 
(Figure 2.3). Each tendon specimen underwent the following protocol while immersed in a 37oC 
saline bath—preloaded to 0.02 N, preconditioned for 10 cycles from 0.02 to 0.04N at a rate of 
Figure 2.3:  Example of the set up 
for tensile testing of mouse patella 
tendon. 
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0.1%/s (0.003 mm/s), and held for 300 s. Immediately following, a stress relaxation experiment 
was performed by elongating the tendon to a strain of 5% (0.15 mm) at a rate of 5%/s (0.15 
mm/s), followed by a relaxation for 600s. The tendon was returned to pre-stress relaxation 
elongation (-0.15mm) for 60s and finally, a ramp to failure was applied at a rate of 0.1%/s (0.003 
mm/s). Local tissue strain was measured optically as described previously[29]. From these tests, 
maximum stress and failure strain were determined, modulus was calculated using linear 
regression from the near-linear region of the stress–strain curve and strain energy density was 
calculated as the area under the stress-strain curve until failure.  Failure strain was defined as the 
strain at the point of maximum stress.  
 
2.2.3 Histological Analysis   
  To determine the organization of the healing patellar tendon, the contralateral legs used 
in the biomechanical analysis were evaluated using a quantitative polarized light microscopy 
method as described previously[30]. Briefly, the hind limb was disarticulated, the skin dissected 
off, and processed with standard histological techniques. 7 mm sagittal sections were cut parallel 
to the tendon fibers, stained with hematoxylin and eosin, and analyzed using a quantitative 
polarized light microscopy method. Using circular statistics (Oriana, Kovach Computing Services, 
Wales, UK), the angular deviation, a measure of collagen fiber orientation, was determined.  
 
2.2.4 Gene Expression    
  To determine the expression of matrix components and cytokines (Table 2.1), one 
patellar tendon from each of sixteen mice of each genotype was used. Four mice were sacrificed 
at each of 1, 3 and 7 days post injury while four uninjured mice were sacrificed to serve as 
controls. Individual patellar tendons were mechanically homogenized with a mortar and pestle 
under liquid nitrogen and RNase-free conditions. RNA was extracted using the TRIZOL isolation 
system (Invitrogen, Carlsbad, CA) and RNeasy Mini Kit (Qiagene Inc., Valencia, CA) as 
described by the manufacturers. cDNA was produced by reverse transcription-polymerase chain 
reaction (RT-PCR) from 100 ng of total RNA using the Superscript first-strand synthesis system 
34 
Cytokine involved in inflammation and is 
increased in scarless healing
TGFb3
Fibrillar collagen that is the main component of 
tendon
COL1A2
Fibrillar collagen involved in development and 
healing
COL3A1
Proteoglycan that regulates lateral fusion of fibrilsDEC
Proteoglycan that promotes fibril diameter growthBIG
Main synthase of hyaluronic acidHAS2
Housekeeping geneGAPDH
Cytokine  that plays a role in the initial 
inflammatory response and thought to increase 
fibrosis
TGFb1
Cytokine that influences extracellular matrix 
remodeling and DNA synthesis
PDGFB
Cytokine that initiates multiple proinflammatory 
cascades
IL1b
Cytokine that stimulates angiogenesis, cellular 
migration and proliferation
bFGF
FunctionCytokine
for RT-PCR as described by the manufacturer (Invitrogen).  1 mL aliquots of the cDNA were 
amplified by real time quantitative polymerase chain reaction (Q-PCR) in a 25 mL reaction volume 
in a ABI Prism 7300 Sequence Detection System (Perkin-Elmer; Applied Biosystems, Warrington, 
UK) with a SYBR Green PCR Master Mix (Applied Biosystems).  Mouse specific primers were 
used for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), collagen type I (COL1A2), 
collagen type III (COL3A1), decorin (DEC), biglycan (BIG), hyaluronan synthase 2 (HAS2), 
interleukin-1 beta (IL1btransforming growth factor beta 1 (TGFb1), transforming growth factor 
beta 3 (TGFb3), platelet derived growth factor B (PDGFB) and basic fibroblast growth factor 
(bFGF) (Table 2.2).  Each replicate was performed in triplicate. CT values will be determined for 
each gene during the linear phase of the CT verses amplification plots.  The relative quantity and 
Table 2.1: Brief description of the growth factors and matrix components  
examined 
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65TTGGGCACCCGCAAGAGTCCTCAGTGGAGAAAAATGGAATGFb3
70GAGCCTTAGTTTGGACAGGATCTGTCGACATGGAGCTGGTGAAA TGFb1
104CGAATGGTCACCCGAGCTTCGCCTGCAAGTGTGAGACAATPDGFB
54TGGACAGCCCAGGTCAAAGTTGACGGACCCCAAAAGATGIL1b
166AAGACCCTATGGTTGGAGGTGTTCATTCCCAGAGG ACC GCT TATHAS2
66GTGACCAGGCGCCCAATACTCGTCCCGRAGACAAAATGGGAPDH
139TTGCCGCCCAGTTCTATGACGCTGCGGAAATCCGACTTCDEC
142CTCCAGGTGCACCAGAATCACCCTGGTCCACAAGGATTACACOL3A1
137ATGCACATCAATGTGGAGGAAGGCTGACACGAACTGAGGTCOL1A2
68GCAACCACTGCCTCTACTTCTTATAACCTTCCGCTGCGTTACTGA BIG
103CGTCCATCTTCCTTCATAGCAAAGCGACCCACACGTCAAACTbFGF
BPReverse PrimerForward PrimerGene
range of mRNA for each gene of interest was computed using the comparative 2-DDCT method 
(ABI; Sequence Detection System User Bulletin #2) relative first to GAPDH within each specimen 
and then to the uninjured tendons within each genotype.   
 
2.2.5 Statistical Analysis  
  Prior to initiating the study, a power analysis was performed to ensure sufficient power for 
the experiments proposed (80% power, with p<0.05).  All material, structural and organizational 
parameters were statistically analyzed by 2-way ANOVA across time post injury and genotype.  
An LSD post-hoc test was used to evaluate differences across time and between genotypes. 
Statistical significance was set at p ≤0.05; and a trend was defined at p ≤ 0.1. 
 
2.3 Results 
2.3.1 Biomechanical Analysis    
  There were no differences among groups based on gross inspection at any time point 
post surgery. In addition, no significant difference in cross-sectional area was found across 
genotype in the uninjured tendons (Figure 2.4). However, the cross-sectional area of the CD44 
knockout tendons was significantly reduced at 3 (p = 0.008) and 6 weeks (p = 0.05) post injury 
when compared to wild type. Similarly, no significant differences across genotype were seen in 
maximum stress, failure strain or strain energy density in the uninjured tendons (Figure 2.5); 
Table 2.2: Q-PCR Primers: Forward and Reverse Primers and the Base Pair (BP) Length of the 
Amplicon Used in Q-PCR 
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however, the maximum stress in the knockout animals was significantly greater than in the wild 
type at 3 (p = 0.003) and 6 (p = 0.02) weeks post injury. The strain energy density was also 
significantly increased at 3 (p = 0.02) and 6 (p = 0.03) weeks post injury.  The knockout animals 
demonstrated a trend toward increased failure strain at both 3 (p = 0.1) and 6 (p = 0.09) weeks 
post injury.  No differences across genotype were observed for modulus.  See Appendix # for 
complete data set. 
 
2.3.2 Histological Analysis 
  Qualitative observations 
of hematoxylin and eosin stained 
sections showed no differences 
across genotype at any time 
point. Injured tendons in both 
genotypes and at both time 
points post injury had increased 
cellularity and an obvious injury 
site when compared to uninjured 
tendons.  No difference in 
angular deviation between CD44 knockout and wild type tendons was seen at any time point 
when comparing across genotype. When examining across time, in contrast to comparing 
knockout to wild type, angular deviation showed an appreciable difference. The wild type tendons 
remained disorganized up to 6 weeks post injury; however, the knockout tendons approached 
uninjured values at 6 weeks post injury (Figure 2.6).  Figure 2.7 is representative images from 
each time point post injury and uninjured samples to qualitatively demonstrate changes observed.   
2.3.3 Gene Expression    
  The relative quantity of TGFb3, bFGF and DCN was increased at least two fold at 1, 3 
and 7 days post injury in the CD44 knockout when compared to wild type (Figure 2.7).  Similarly, 
the relative expression of COL3A1 and PDGFB was increased at least two fold at 1 and 3 days 
Figure 2.4: Cross-sectional area was significantly reduced 
in knockouts (KO) compared to wild-types (WT) at both 3 
and 6 weeks postinjury. 
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Figure 2.5: Maximum stress and strain energy density were significantly increased in 
knockouts (KO) compared to wild-type (WT) at both 3 and 6 weeks postinjury. Similarly, 
knockout animals demonstrated a trend toward greater failure strain compared to wild-type. 
No significant changes were seen across genotype in modulus. *:p < 0.05; #:p < 0.1. 
0
75
150
225
300
375
450
Uninjured 3 weeks 6 weeks
Weeks Post Injury
M
od
ul
us
 (M
Pa
)
WT
KO
25
6 weeks
*
0
5
10
15
20
Uninjured
Weeks Post Injury
M
ax
im
um
 S
tr
es
s 
(M
Pa
)
3 weeks
*
WT
KO
Weeks Post Injury
St
ra
in
 E
ne
rg
y 
D
en
si
ty
 (m
J/
m
m
3 )
Uninjured 3 weeks 6 weeks
0
25
50
75
100
125
150
*
*
0
6
12
18
24
30
# #
6 weeksUninjured
Weeks Post Injury
3 weeks
Fa
ilu
re
 S
tr
ai
n 
(m
m
/m
m
)
WT
KO
WT
KO
M
od
ul
us
 (M
Pa
)
M
ax
im
um
 S
tr
es
s 
(M
Pa
)
St
ra
in
 E
ne
rg
y 
D
en
si
ty
 (m
J/
m
m
3 )
Fa
ilu
re
 S
tr
ai
n 
(m
m
/m
m
)
Fa
ilu
re
 S
tr
ai
n 
(m
m
/m
m
)
post injury.  Relative expression was also increased at least two fold for BGN at 1 day post injury 
and for TGFb1 at 3 days post injury in the CD44 knockout.  HAS2 was initially decreased at 1 day 
post injury in knockout animals but by 3 days was increased to at least 2 fold.  There were no 
appreciable differences in COL1A2 and IL1b. 
2.4 Discussion 
2.4.1 Interpretation of Results 
  This study demonstrated that the absence of CD44 led to improved healing in a patellar 
tendon injury.  Alternative to our hypothesis, the material properties of the healing CD44 knockout 
patellar tendon were superior when compared to wild type tendons at both 3 and 6 weeks post 
injury.  It was initially hypothesized that CD44 knockout mice would have decreased material 
properties based on delayed wound healing in skin[25].  However, in the current study, it was 
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Figure 2.6: Appreciable differences were seen in 
angular deviation in the knockout (KO) tendons across 
time. While the wild-type (WT) tendons remained 
disorganized, the KO tendons approached uninjured 
values at 6 weeks post injury. *:p < 0.05; #:p < 0.1. 
demonstrated that extracellular matrix components were upregulated while some of the 
proinflammatory cytokines showed little change. The gene expression data indicates that matrix 
components and cytokines that are beneficial to superior healing were up regulated in CD44 
knockout tendons. These findings 
are in agreement with previous 
studies that showed improved 
healing through decreased 
inflammation and an accumulation 
of HA in the absence of CD44[28, 
29].  Therefore, the current study 
demonstrated that the absence of 
CD44 in tendon healing leads to 
improved material properties and 
reduced cross-sectional area 
through superior extracellular 
matrix expression.   
CD44 and HA are important mediators in healing and numerous studies have shown 
beneficial effects from decreased CD44 expression and elevated levels of HA.   It has previously 
been shown, by our laboratory and others, that this environment occurs naturally during fetal 
wound healing [13, 20]. Unlike reparative healing in adult tissue, fetal tissue is well known to heal 
through a scarless regenerative process [20, 36].  It is believed that recapitulating a regenerative 
environment during adult healing will reduce adhesion formation and the rate of reruptures[13].  In 
the current study HAS2 expression, the main HA synthase, was elevated in concurrence with a 
previous CD44 knockout study[22].  Interestingly, in an a prior in vitro study, HA-treated cells 
stimulated type III collagen and TGFβ3 expression[31], both of which are indicative of 
regenerative healing. TGFβ1, which is indicative of fibrotic healing, was also increased by HA; 
however, this effect was no longer present when cells were pretreated with CD44 silencing RNA. 
Similarly, the previous study also showed an increase in type I collagen expression only when low 
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Figure 2.7: Representative histological images for each genotype and time point.  Injury is clear 
in both genotype at 3 and 6 weeks post injury; however, in the knockout tendons the fibers are 
more aligned. 
molecular weight HA was added but not with high molecular weight or native HA.  Conversely, 
type III collagen expression was increased with all three forms of HA.  Even more importantly is 
that the increased type I expression by low molecular weight HA was reversed with the 
application of CD44 silencing RNA.  Therefore, in agreement with the previous study, in the 
current study increased HAS2, an increased expression of TGFβ3 and type III collagen with only                                         
a mild up regulation in TGFβ1 and no changes in type I collagen were demonstrated.  These 
factors combined indicate that the absence of CD44 created an environment that is conducive to 
regenerative healing.   
The absence of CD44 in this study altered the expression of multiple extracellular matrix 
components and cytokines.  The effects of cytokines and matrix components on cells are 
interdependent.  Cytokines stimulate extracellular matrix production; however, the interaction 
between extracellular matrix molecules and cellular receptors, like CD44, lead to the upregulation 
of certain cytokines.  For example, administration of bFGF to injured tendon increased expression 
of type III collagen[32].  Similarly, application of TGFb3 to skin wounds reduced scar 
formation[33]. Conversely, decorin is closely 
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Figure 2.8: Gene expression in a patellar tendon injury in wildtype (WT) and CD44 
knockout (KO) represented as relative quantity fold changes (2-DDCT) with error bars 
representing (2-DDCT-s), where s is the standard deviation of the DDCT value. All postinjury 
time points are normalized to uninjured tendons (day 0), which is represented by a value 
of 1. 
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related to both collagen metabolism and TGFb activity [34]. Similar results were demonstrated in 
the current study, indicating that these synergistic effects helped create an improved tendon 
healing environment.   
Previous studies showed that CD44 was over expressed in fibrotic healing[35] yet had 
decreased expression in scarless healing.  This suggests that CD44 is detrimental to healing and 
subsequently led to methods that decreased CD44 expression or activation.  One strategy was 
the application of anti-CD44 blocking antibodies in a healing environment.  Blocking antibodies 
decreased cellular migration[19] and  tissue damage[21], but interpretation of these results 
warrant some caution due to poor understanding of the exact function of the antibodies. Studies 
have also previously been conducted in the CD44 knockout mouse model.  While most CD44 
knockout studies examined inflammatory disease[30], one group demonstrated a delay in skin 
wound closure at 1 and 3 days post injury which recovered by 7 days[25]. Unlike the previous 
study, in the current study tendon injury was examined through multiple parameters of healing at 
both early and late stages of healing.  While healing was not directly measured during early 
stages,  improved extracellular matrix gene expression was demonstrated.  An improved 
environment early in healing resulted in improved material properties during late stages.  
Therefore, the current study offers a more complete understanding of how the absence of CD44 
affects wound healing at both early and late stages of healing.    
There is currently extensive knowledge on the role of CD44 during fetal development and 
healing and during adult healing.  However, little information is available about the role of CD44 in 
neonatal development and healing.  During neonatal development, structural and compositional 
changes occur that are similar to those seen during adult healing; however, unlike adult healing a 
functional tendon results.  An advantage to studying neonatal development verses fetal 
development is that environmental and mechanical factor are more similar between neonates and 
adults; therefore the influence of other factors can more easily be elucidated in neonates than in 
fetal tissue.  It is known from the current study that a lack of CD44 in adult healing improves 
tendon function. In addition, that neonatal tendons express more HA than adult tendons and 
therefore can hypothesize that neonatal healing would show superior healing over adult healing is 
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also known.  By examining first, the role of CD44 and HA in normal neonatal tendon development 
and second, the effect of an absence of CD44 in neonatal development and healing, a greater 
understanding of CD44 and HA can be obtained.  Future studies will include developing a mouse 
model of tendon development and developmental healing which includes mechanical analysis.  
Then the CD44 knockout mouse can be used to determine the mechanisms behind CD44’s role 
in development, healing and mechanical strength. 
  
2.4.2 Limitations 
  This study has several limitations.  First, mRNA expression may not completely mirror the 
protein levels since there is post-transcriptional regulation of protein synthesis.  Nevertheless, our 
findings are consistent with those reported by other investigators.  Second, only male mice were 
examined in this study.  It was recently demonstrated that collagen synthesis in human females is 
significantly less than in males[36]; therefore, the results of this study may not be translatable to 
female mice.  However, since there was no change in type I collagen expression, the overall 
conclusions are likely still applicable to both sexes.  Third, all the uninjured control tendons were 
harvested at 12 weeks of age, even though they were compared to injured mice as up to 18 
weeks of age.  Somerville et al [37]demonstrated that most material and mechanical properties of 
cortical bone had reached their maximum value around 3 months of age.  Therefore, it is unlikely 
that an additional 6 weeks would have significantly affected results on the material properties of 
the tendons due to growth. Fourth, as with all knockout studies, there is a possibility of 
compensation by other molecules. The most likely candidate is RHAMM, another HA receptor.  
Expression of RHAMM was not increased in the CD44 knockout under normal or arthritic 
conditions in a previous study [30].  However, prolonged RHAMM signaling was seen and could 
be attributed to the accumulation of HA. Finally, the inflammatory response or RHAMM 
expression and signaling was not directly examined.  Nevertheless, expression of IL1b, a main 
down stream effecter of RHAMM, was not increased in this study; therefore, it is unlikely that 
RHAMM signaling increased in this study.   
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2.4.3 Summary 
In summary, it was demonstrated that the absence of CD44 in a mouse patellar tendon 
injury creates an environment that is conducive to regenerative healing through altered gene 
expression, resulting in superior material properties and reduced cross-sectional area.  It was 
also shown that cytokines and matrix molecules that are characteristic of regenerative healing are 
elevated in the CD44 knockout animals during healing.  The application of these and similar 
cytokines to improve tendon healing is commonly studied; however, varying concentrations and 
time courses of application make the results difficult to interpret and implement in a clinical 
setting.  In this study, it was demonstrated that the elimination of CD44 during wound healing 
gave rise to beneficial changes in cytokines and extracellular matrix gene expression.  Therefore, 
by altering the activities of this single cellular receptor, multiple advantageous downstream effects 
are initiated that lead to superior tendon healing.  This study indicates that limiting the role of 
CD44 may improve healing parameters in adult tendon injury.   
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Chapter 3: Temporal and tissue specific dysfunction in the absence of type XIV collagen : 
in a mouse model 
 
3.1 Introduction 
3.1.1 Tendon Development and Fibril Associated Macromolecules 
  Connective tissues, such as tendons and skin, have tissue-specific structure and 
function. The collagen fibril is the major structural element in these tissues and is assembled from 
fibril-forming collagens, specifically types I, II, III, V and XI[1]. The development of the 
extracellular matrix is dependent on the organization of fibrils into higher ordered structures, e.g., 
fibers and lamellae. The assembly of collagen fibrils is a multi-step process that is highly 
regulated. Specific developmental periods are associated with distinct stages in collagen fibril 
assembly and growth[2, 3]. Early development is a pregrowth phase that is characterized by 
short, small-diameter fibril intermediates. Sequentially, an end to end linear growth occurs 
followed by lateral growth of the preformed intermediates. Each step is independently regulated 
by specific fibril-associated macromolecules. These molecules associate with fibrils and modify 
fibrillar properties. There are two major groups of fibril-associated molecules. The first group is 
the small leucine-rich repeat proteoglycans and glycoproteins, which includes decorin, biglycan, 
lumican and fibromodulin. Previous studies found that these proteoglycans associate with 
collagen fibrils and regulate lateral growth during tendon development[4]. A deficiency of these 
macromolecules in vivo resulted in unregulated lateral growth and therefore structurally abnormal 
tendon fibrillogenesis[5-7]. The second group of fibril-associated molecules is the fibril-associated 
collagen with interrupted triple helices (FACIT). Members of this group include type IX, XII, XIV, 
XVI, XIX, XX, XXI, XXII and XXVI collagen[8]. The focus of the current work, type XIV collagen, is 
present in developing tendon[9, 10] and is localized to the surface of tendon fibrils[11, 12].  
 
3.1.2. Type XIV collagen 
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Figure 3.1: Model of type XIV collagen in fibril assembly. (a): Type XIV collagen has 
multiple functional domains. These domains interact with different components of the 
extracellular matrix (ECM). (b): Type XIV is localized periodically to the surface of the 
striated collagen fibrils.  (c): Fibrillogenesis can be divided into distinct phases beginning 
with the formation of short, immature fibril segments, then a period of linear growth, 
followed by a rapid lateral growth characterized by an increase in fibril diameter and 
length (Young, 2000).  
a
b
c
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Figure 3.2: Type XIV collagen expression in normal 
neonatal developing mouse tendons. Type XIV collagen 
mRNA expression (between P4-P90) was analyzed by real 
time quantitative RT-PCR (a) and semi-quantitative RT-PCR 
(b). (c) Semi-quantitative immuno-blotting analysis. All results 
demonstrate a clear decrease in type XIV collagen in 
neonatal development. 
  
 Type XIV collagen decorates the surface of collagen fibrils and its large non-collagenous 
domain (NC3) projects into the inter-fibrillar space (Figure 3.1a)[11, 12]. This domain has been  
implicated in the regulation of fibril packing[13, 14] and these interactions would be expected to 
inhibit lateral fibril growth; therefore, decreased expression of type XIV collagen would be 
associated with the beginning of lateral fibril growth (Figure 3.1c). The controlled replacement of 
type XIV collagen with other fibril-associated molecules such as type XII collagen or leucine-rich 
proteoglycans would allow continued regulation of the growth steps.  
 Studies of type XIV collagen in chicken[12, 15], bovine [15] and human [16] tissues 
showed that type XIV collagen is prevalent in skin, tendon, cornea and articular cartilage. In 
addition, type XIV collagen is often found specifically in areas of high mechanical stress[10, 17, 
18]. Localization to these areas indicates that collagen XIV may affect the mechanical properties 
of a tissue. Evidence in support of this is that type XIV collagen plays a role in corneal stromal 
compaction[19]  and promotes 
collagen gel contraction in 
vitro [18]. In addition, in vivo 
studies of chicken tendon 
during embryogenesis and 
early post-hatching stages 
showed that type XIV collagen 
expression is high during 
development, but decreases 
during tissue 
maturation[12].   
 
3.1.3 Type XIV Collagen in Neonatal Tendon Development 
 The regulatory role(s) of type XIV collagen in fibrillogenesis have been analyzed in 
developing tendons. Expression of Col14a1 mRNA in mouse flexor digitorum longus (FDL) 
tendons at post-natal days 4, 10, 30, and 90 (P4, P10, P30 and P90) were analyzed using semi-
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quantitative and quantitative reverse transcription polymerase chain reaction (RT-PCR) [17]. 
Quantitative PCR demonstrated the highest amount of Col14a1 mRNA at P4 that then decreased 
sharply between P4 and P10. A very low level of expression was reached by P30 and this was 
maintained in the mature (P90) tendon (Figure 3.2a). Semi-quantitative PCR confirmed these 
results (Figure 3.2b). Expression of type  XIV collagen was also analyzed using immuno-blot 
analyses. Protein immuno-blot results were consistent with the mRNA analyses (Figure 3.2c). 
Tendons at P4 demonstrated the highest amount of type XIV collagen with a sharp reduction by 
P10. Virtually no type XIV collagen was present in extracts from P30 and P90 tendons. 
 The temporal and spatial expression patterns of type XIV collagen in the tendon were 
investigated utilizing immunofluorescence microscopy (Figure 3.3). These findings demonstrate 
homogeneous type XIV collagen expression throughout the tendon at P4 and P10. However, by 
P30 and maintained at P90, reactivity against type XIV collagen was undetectable. Consistent 
with the immuno-blot and QPCR analyses, a reduction in type XIV collagen reactivity was 
observed between P4 and P10. The temporal and spatial expression patterns indicate a role(s) 
for type XIV collagen in regulation of the early stages in tendon fibrillogenesis. 
 
3.1.3 Type XIV Collagen Knockout Mouse 
 Our collaborators created a Col14a1 knockout mouse in a C57BL/6 background and 
confirmed its genotype by southern blot, semi-quantitative PCR, immunolocalization (Figure 3.4a) 
and immunoblot (Figure 3.4b) in the skin [17]. These mice did not show any gross phenotypic 
differences when compared to wild type counterparts.  However, ultrastructural differences were 
observed when examining the fibril diameters in the FDL tendon.  At early stages of development 
between 1 and 5 days old, tendon architecture was disorganized in the Col14a1-/- compared to 
wild type tendons. This was seen as altered organization of fibrils into fibers with a disruption of 
the associated fibroblast compartmentalization in the null tendons. This suggests a role for type 
XIV collagen in mediating inter-fibrillar interactions involved in packing into fibers. Absence of 
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Figure 3.3: Type XIV Collagen expression patterns in mouse tendon neonatal development. 
Localization of type XIV collagen or type I collagen by immunofluorescence microscopy with 
nuclear localization using DAPI (blue). There was a dramatic decrease in reactivity against 
type XIV collagen between P10 and P30.  
                     
these interactions may also suggest a role in altered biomechanical properties. However, in the 
mature type XIV collagen-deficient tendons, general fiber and fibroblast organization was 
comparable to that observed in the wild type tendons. 
 The P4 null and wild type tendons both had a normal circular cross-sectional fibril profile.  
However, the collagen fibrils in the null tendons were larger and less uniform in size than fibrils 
53 
a. Immunoflourescence
 
Figure 3.4: Absence of type XIV collagen in Col14a1 null mouse skin. 
(a). Immunofluorecence staining of Col14a1 knockout mouse skin using 
anti-type XIV collagen antibody was completely negative in Col14a1 
null mice skin. DAPI staining shows skin structure (blue nuclear). (b). 
Western blotting of protein samples extracted from mouse skin showed 
complete absence of type XIV collagen in Col14a1 null mice and 
reduced synthesis in heterozygous mice. 
from wild-type tendons (Figure 3.5a). In addition, the P60 type XIV collagen-deficient tendons 
contained fibrils with larger cross sectional profiles compared to fibrils from wild type controls.  
The increase in fibril diameter seen at all stages of development, suggests that type XIV collagen 
functions to regulate entry into the lateral fibril growth phase during development.   
 The fibril diameter distributions for both P4 and P60 tendons were also analyzed (Figure 
3.5b). At P4 the fibril diameter distribution of wild type and Col14a1-/- tendons were both 
unimodal, however 
there was a 
broadening of the 
distribution and 
shift toward larger 
diameter fibrils in 
the Col14a1-/- 
tendons. This 
observation was 
consistent with a 
premature entry 
into the fibril 
growth phase in 
tendon development. In contrast, at P60, the fibril diameter distributions in  
both Col14a1-/- and wild type tendons were multimodal with a comparable range of diameters. 
However, the fibrils in Col14a1-/- tendons had a prominent subpopulation of large diameter fibrils 
in the 150-190nm range that was not present in the wild type tendons. This subpopulation  is 
consistent with the progression of fibril growth of the fibrils seen at P4 in the null tendons[12] 
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Figure 3.5: Altered collagen fibril formation in Col14a1-/- tendons. Transmission electron 
micrographs of FDL tendon at P4 and P60 from (a) Col14a1+/+ and (b) Col14a1-/- mice.  
In the Col14a1-/- tendon, there are fewer smaller fibrils and more fibrils of larger diameter 
as compared to the wild type control. Bar = 100 nm. (c) Histograms representing fibril 
diameter measurements of tendons at P4 and P60.  
 
 
suggesting that type XIV collagen could stabilize immature fibrils, preventing lateral association  
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Figure 3.6: Proteoglycan expression in 
the FDLs of Col14a1-/- tendon. (a) No 
significant difference was found in 
expression at either P4 or P30 for type 
XII collagen, biglycan, decorin, lumican, 
or fibromodulin.  
and therefore, lateral growth in tendon. In addition, immature fibrils undergo significant linear 
growth during the period where type XIV collagen expression is down regulated[3, 20]. Therefore, 
while type XIV collagen may not play an active role during lateral growth, the current data indicate 
that it regulates the fibril’s entry into the lateral growth phase. 
 Lastly, the expression of leucine rich proteoglycans and type XII collagen at P4 and P30 
was determined to investigate the possibility of 
compensation in the FDLs of null mouse at P4 and 
P30 (Figure 3.6).  Type XIV collagen, type XII 
collagen,  biglycan, decorin, lumican, and 
fibromodulin protein expression were analyzed by 
semi-quantitative immunoblot. Relative expression 
levels of proteoglycans and type XII collagen 
showed that the core protein expression in the wild 
type compared with null mice was comparable for 
all four proteoglycans and type XII collagen at both 
developmental stages..Therefore, if any 
biomechanical alterations are observed in  
Col14a1-/- mice , these data would indicate a direct 
relationship between the absence of type XIV 
collagen and the structural and functional changes 
observed in the tendon. 
 
3.1.4 Objective and Hypotheses 
 The purpose of this study was to determine the functional role(s) of type XIV collagen in 
the development of tissue-specific mechanical properties. Mechanical analysis was conducted on 
skin and at multiple stages of tendon growth, including neonatal development and maturity, to 
elucidate the role(s) of type XIV collagen in regulation of mechanical properties. It was 
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Figure 3.7: Dumbbell stamped skin 
sample.  Skin samples were dumbbell 
stamped for mechanical testing.  Stain 
lines were placed at 10mm for grip to 
grip gauge length placement and 5mm 
apart for optical strain measures. 
 
hypothesized that the significant role type XIV collagen plays in the regulation of fibrillogenesis 
would lead to alterations in the mechanics of developing soft tissues.  
 
3.2 Methods 
3.2.1. Mechanical Analysis of Skin 
 For analyses of skin, samples were dissected at 60 days old (P60) from the back of 6 
wild type and 7 Col14a1-/- littermates. The hair was shaved and two dumbbell-shaped skin 
specimens per mouse, oriented normal to the sagittal plane, were prepared (Figure 3.7). The right 
side of each sample was marked to ensure consistency of direction. Cross-sectional area of the 
skin was calculated from measurements of the width and thickness[21]. Skin samples were glued 
(cyanoacylate) to sand paper 10mm apart and stain lines were placed 5mm apart within the mid-
substance to track strain optically[22]. Samples were clamped in custom test fixtures. Standard 
mechanical testing protocols were used, including preload to 0.03N and loading to failure at 
0.33mm/s (1.67%/s)[21]. Both skin samples for each mouse were tested and parameters were 
averaged within each animal. For all tests, samples 
were immersed in a 37ºC saline bath and tested with 
an Instron 5543 (Instron Corp., Canton, MA).  
Maximum stress was determined and modulus was 
calculated using linear regression from the near-
linear region of the stress-strain curve.  
 
3.2.2. Mechanical Analysis of Neonatal Developmental FDL Tendons  
 For analyses of P7 FDLs, 6 wild type, 13 Col14a-/- and 12 Col14a1+/- littermates were 
utilized. Cross-sectional area of the P7 FDL was measured using a custom built device consisting 
of LVDTs, a CCD laser, and translation stages. Briefly, the specimen was translated beneath the 
laser while displacement data was simultaneously acquired in two directions from two LVDTs, as 
well as thickness data from a CCD laser displacement sensor[23]. Due to their extremely small 
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Figure 3.8: Custom designed fixture for P7 FDL mechanical 
testing.  The tendon (as shown with bold arrow) is secured in grips.  
The holding fixture, which is attached to the clamps through pins, 
ensures that the tendon is in a relaxed position until the fixture is 
secured in the Instron.   
 
size and fragile nature, P7 mouse tendons have not been mechanically tested previously. Each 
end of the P7 tendon was glued (cyanoacylate) to sand paper 4mm apart. Stain lines were placed 
2mm apart within the mid-substance to track strain optically[22]. Tendons were placed in custom 
grips and a 
custom holding 
fixture was 
secured to the 
grips (Figure 3.8). 
Importantly, the 
holding fixture 
was designed to 
ensure that the 
tendons 
remained 
unloaded prior to 
testing. The 
tendons were 
preloaded to 
0.005N and held for 5 minutes. The load was returned to 0N and held for 1 minute. The tendons 
were then loaded at a constant ramp to failure at 0.004mm/s (0.1%/s). Both the right and the left 
FDL were tested and parameters were averaged within each animal. Maximum load and stiffness 
were determined, and maximum stress was calculated from the maximum load and cross-
sectional area, and modulus was calculated from the slope of the linear region. 
 
3.2.3. Mechanical Analysis of Mature FDL Tendons                                                             
 For analyses of P60 FDLs, 8 wild type, 12 Col14a1-/- and 8 Col14a1+/- littermates were 
analyzed. Cross-sectional area of the P60 tendon was calculated from measurements of the 
width and thickness as described previously [24]. P60 tendons were glued (cyanoacylate) to sand 
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Figure 3.9: Skin mechanics in P60 wildtype and null 
mice.  No significant differences were found in the 
cross-sectional area of the P60 skin.  The maximum 
stress was significantly decreased in the skin of the 
col14 a1 null mice compared to that of wild-type.  
Additionally, the modulus showed a trend toward lower 
modulus when compared to wild type mice. *:p<0.05; #: 
p<0.1. 
 
paper 5mm apart and stain lines were placed 2.5mm apart within the mid-substance to track 
strain optically[22]. Samples were clamped in custom test fixtures and standard mechanical 
testing protocols were used including pre-conditioning, stress-relaxation and ramp to failure as 
described[25]. Samples were immersed in a 37ºC PBS bath and tested with an Instron 5543 
(Instron Corp., Canton, MA). Maximum load and stiffness were determined, and maximum stress 
and modulus were calculated as 
described above.  
 
3.2.4. Statistical Analyses 
 T-tests were performed 
on skin cross-sectional area, 
maximum stress, and elastic 
modulus across genotype 
(significance at p≤0.05, trend at 
p≤0.1). One way ANOVAs were 
performed on tendon cross-
sectional area, maximum load, maximum stress, stiffness, and elastic modulus comparing across 
genotype within each age group (significance at p≤0.05, trend at p≤0.1). 
 
3.3 Results 
3.3.1. Skin Biomechanics 
 To ascertain the functional consequences of a type XIV collagen-deficient dermis, skin 
from wild type and Col14a1-/- mice was subjected to biomechanical analyses. No significant 
difference was seen in the cross-sectional area (Figure 3.9). However, significant alterations were 
present in biomechanical properties associated with the type XIV collagen-deficient skin at P60. 
The maximum stress was significantly decreased (p = 0.05) in the skin of the Col14a1-/- mice 
compared to that of wild type controls. Additionally, the deficient mice showed a trend toward 
decreased modulus when compared to wild type mice (p = 0.07).  
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Figure 3.10: FDL cross-sectional area at P7 and P60.   No significant 
differences were observed in cross-sectional area at P7 or P60 between 
wildtype, heterozygotes or null FDLs at either stage of development.   
 
3.3.2. Tendon Biomechanics 
 Biomechanical studies of wild type, Col14a1+/- and Col14a1-/- tendons were conducted 
for developing (P7) and mature (P60) tendons. Cross-sectional area as well as maximum load, 
maximum stress, stiffness and modulus were measured. At both developmental stages the cross-
sectional areas were comparable in all genotypes (Figure 3.10). The develo ping Col14a1-/- 
tendons (P7) demonstrated a significant reduction in maximum load (p = 0.005), stiffness 
(p<0.001) and modulus (p=0.008) when compared to wild type tendons (Figure 3.11a). In 
addition, FDLs from the developing Col14a1-/- mice showed significantly decreased maximum 
load (p=0.02) and a trend towards decreased maximum stress (p=0.09) and stiffness (p=0.06) 
when compared to the heterozygote mice. FDLs from heterozygous mice had significantly 
decreased stiffness (p=0.02) compared with wild type mice. In contrast, the mature tendons 
demonstrated no significant differences between the wild type, Col14a1+/- or Col14a1-/- tendons 
(Figure 3.11b).  
 
3.4 Discussion 
 3.4.1 Interpretation of Results 
 The assembly and final properties of the collagenous fibrillar matrix are not only 
dependent on the main constituents of the fibrils, but also fibril associated molecules that 
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participate in fibrillogenesis. In this study, type XIV collagen played a significant role in the 
biomechanics of the neonatal developing mouse FDL tendon. Maximum load, stiffness and 
modulus were all significantly reduced when comparing the Col14a1-/- with wild type tendons. 
However, by P60 the differences seen at P7 were absent.  Interestingly, there were no 
differences seen in the cross-sectional area of any genotypes at either age. Therefore the 
decrease in mechanics is not due simply to a decrease in type I collagen but most likely due to 
the changes in structure of the collagen fibrils/fibers or the matrix that surrounds the fibers.  
These results support the hypothesis that type XIV collagen plays a significant role in 
fibrillogenesis during neonatal development.  
 Type XIV collagen has previously been implicated in playing a role in soft tissue 
mechanics[10, 16, 20]. It was shown to aid in the compaction of collagen gels in vitro[18] and is 
up-regulated during the compaction stage of the corneal stroma[19]. A previous study examined 
type XIV collagen expression in chick tendon and demonstrated high expression during pre-
hatchling phases of development but almost no expression post-hatchling [12].  Interestingly, 
chick tendons have a marked increase in strength during the period when type XIV collagen 
expression was decreasing [26].  It is also interesting to note that the heterozygote FDL tendons 
had mechanical properties intermediate to those of the wild type and null tendons. This implies 
that type XIV collagen has a dose dependent effect on the mechanics of neonatal developing  
tendon. The current study, along with others, indicates that type XIV collagen  
has a significant role in establishing the mechanical properties in developing tendons.  
 In the current study mechanical differences were not seen in mature null tendons but the 
mechanics in the mature Col14a1-/- skin were inferior to wild type skin. Most notably, the null skin 
aand a reduced maximum stress and modulus. Regional and temporal differences of the 
presence of type XIV collagen in skin and tendon could help explain the tissue-specific 
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Figure 3.11: FDL mechanics at P7 and P60.  (a) The P7 FDL deficient tendons demonstrated 
a significant reduction in maximum load, stiffness and modulus when compared to wild type 
tendons. In addition, FDLs from the developing deficient mice showed significantly decreased 
maximum load and a trend towards decreased maximum stress and stiffness when compared 
to the heterozygote mice. FDLs from heterozygote mice also had significantly decreased 
stiffness when compared to wild type mice.  (b): In contrast, the mature tendons demonstrated 
no significant differences between the control, deficient or heterozygote tendons. *:p<0.05; #: 
p<0.1 
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differences  observed in the null mouse[16]. Type XIV collagen was highly expressed early in 
mouse FDL development. Furthermore, type XIV collagen expression rapidly decreases as the 
tendon matures becoming virtually absent by P30. On the other hand, skin from P60 wild type 
mice still contained type XIV collagen, even though it was greatly reduced from neonatal 
development. These findings are consistent with previous studies that demonstrated expression 
of type XIV collagen is maintained longer in skin than in tendon [16].  
 While skin and tendon are both connective tissues consisting mainly of collagen fibrils 
organized as fibers, they have important differences.  Most notably, the skin has a decreased 
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Figure 3.12: Type XIV collagen expression after tendon injury. The panel on the 
left is a normal P90 tendon and the one on the right is a tendon 1 week post injury, 
both were stained with anti-col14a1 antibody.  No type XIV is present in the 
uninjured tendon whereas protein expression is visible one week post injury. 
 
fibril content compared to the tendons and the collagen fibers are loosely packed, small and non-
aligned.  In contrast, tendons are composed of densely packed, large and well aligned fibers. 
Another important feature of connective tissues is the type of stresses they see in vivo. The skin 
experiences multi-axial stresses whereas the tendon sees mainly tensile stresses.  Each of these 
tissues gives a unique view into how these components work together in a functioning tissue.   
Therefore, while the basic fundamentals of fibrillogenesis are the same in these two tissues, it is 
not surprising that we see a differential effect of the absence of type XIV collagen.   
 After tendon injury, many structural and compositional changes occur including a 
decrease in fibril diameter and an increase in type XIV collagen (Figure 3.12, unpublished data 
from Dr. Birk).  Type XIV collagen has been hypothesized to play a role in the linear growth of 
fibrils, but not the lateral growth [12].  After injury, fibril diameters are markedly decreased and 
uniform unlike normal mature fibril diameters [27].  Therefore, the increased expression of type 
XIV collagen could play a role in the fibrillogenesis and linear growth of fibrils during repair. In 
addition, its expression could prevent the lateral growth of collagen fibrils during injury [28] 
helping to explain the extended presence of small diameter fibrils.  Except for these few 
observations, the specific role of type XIV collagen during tendon healing is unknown.  
Understanding the role of type XIV collagen during healing would lend great insight into the 
mechanism of tendon healing and mechanics.  Future studies will include investigating type XIV 
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collagen during injury and injury in the absence of type XIV collagen.  In addition, the 
mechanisms behind mechanical development and growth can be elucidated by examining 
healing at distinct stages of neonatal development with and without the presence of type XIV 
collagen.   
 
3.4.2 Limitations 
 It was first proposed that fibril diameter parameters may predict mechanics by Parry et al 
in a large, multiple species study[29].  Several groups, including ours, have since examined the 
relationship between mechanics and fibril parameters including: mean fibril diameter size, fibril 
cross-sectional area fraction and fibril distribution variation[30-32].  While some of these studies 
have found significant correlations between fibril parameters and mechanics, they were usually 
accompanied by a low correlation coefficient.  A low correlation coefficient indicates that there are 
other parameters that also play a significant role in tendon mechanics.  For example, Robinson et 
al. demonstrated that proteoglycans and fibril area fraction were both significant predictors of 
mechanical parameters[32].  Therefore, while there are differences in fibril diameter distribution in 
both the P4 and P60 tendons, it is very likely that at P60 another parameter, such as 
proteoglycan or collagen content, is significantly affecting the mechanics. 
 Discrepancy between neonatal and mature tendons could be attributed to compensation 
by other molecules in the mature null tendon or could simply mean type XIV collagen plays a 
more significant role in mechanical development.  Four proteoglycans, decorin, biglycan, lumican, 
fibromodulin,  and type XII collagen are the main candidates for compensation. Types XIV and XII 
collagen are closely related members of the FACIT collagen class [8]. Type XII collagen is more 
widely expressed throughout development, maturation and aging in most connective tissues [1, 
33, 34]. It is possible that type XII collagen replaces type XIV collagen, both structurally and 
functionally at later stages of tendon development. Therefore, compensation in the null mouse is 
possible, however, compensation by type XII collagen was not observed in the developing 
tendon.  The four proteoglycans have previously been shown to play multiple roles during 
fibrillogenesis, making them candidates for compensation.  These proteoglycans were also not 
64 
shown to be upregulated in the current study;  therefore, it can be hypothesized that the 
discrepancy seen between neonatal development and maturity in the Col14a1-/- tendon is due to 
type XIV collagen. Work on other closely related fibril-associated molecules, the leucine-rich 
proteoglycans, supports this suggestion. Both decorin/biglycan and fibromodulin/lumican have 
been shown to be important regulators of collagen structure and mechanical function[5, 6, 35, 
36]. However due to high similarity of these proteoglycans, they may share redundant function(s). 
For example, in the fibromodulin-deficient mouse, lumican was increased[7] and in the decorin 
deficient mouse, biglycan was increased [37]. Therefore, compensation occurs only when the 
proteoglycan expressed throughout development, maturation and aging was deleted, i.e. decorin 
or fibromodulin.  If a similar interaction between types XII and XIV collagen exists, then a 
compensation with up-regulation of type XIV collagen in the absence of type XII collagen would 
be predicted and not the reverse. Future analyses of type XII collagen-null and compound type 
XII/XIV collagen null mouse lines will provide insight into this and other possible interactions.   
 3.4.3 Summary 
 Overall, the data suggests a tissue-specific role of type XIV collagen in the structure-
function relationship of connective tissues.  Differences in fibril and fiber architecture in 
developing tendon, but not mature tendon may account for mechanical differences. Interestingly, 
mechanical differences are seen in mature skin that could be due to longer temporal expression 
of type XIV collagen in the skin as compared to the tendon. 
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Chapter 4: Mechanical, Compositional and Structural Properties of the Neonatal Mouse 
Achilles Tendon 
 
4.1 Introduction 
4.1.1 Significance 
 During neonatal development, tendons undergo a well orchestrated process whereby 
extensive structural and compositional changes occur in synchrony to produce a normal tissue [1, 
2].  Conversely, during the repair response to injury, structural and compositional changes occur, 
but in this case, a mechanically inferior tendon is produced.  Tendon injuries affect large numbers 
of individuals and account for enormous associated costs.  While the development of new 
surgical techniques and postoperative rehabilitation protocols have led to improved results, 
postsurgical scarring and restoration of the normal tendon mechanics following injury remain 
problematic in tendon repair.  An injured tendon that is mechanically inferior has compromised 
function and reruptures after treatment are commonly observed clinically.   As a result, the 
process of development has been postulated as a potential paradigm through which improved 
adult tissue healing may occur.  Of particular importance is a thorough understanding of the 
progression of mechanical strength and function during development.  In depth knowledge of the 
changes and processes during development could lead to new therapeutic treatments to improve 
functional outcomes in adult tendon healing.  
 
4.1.2 Tendon Development 
 Whereas embryonic growth has been thoroughly examined, less quantitative information 
is available on changes in tendon mechanics, structure and composition during neonatal growth. 
It is however well established that type I collagen is the most abundant constituent in tendon 
during development and collagen content increases throughout development into maturity [3, 4].  
The collagen hierarchy is established through fibrillogenesis, a multistep process that is 
independently regulated by specific fibril-associated macromolecules, two of which include the 
proteoglycans biglycan and decorin.  Biglycan is believed to promote fibril diameter growth, where 
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as decorin is believed to control lateral fusion of the fibrils and increase fibril stability.  During 
early development, biglycan is highly expressed while decorin is relatively low; however, as 
growth progresses biglycan is down regulated and decorin is up regulated [5-8].  It has been 
hypothesized that the temporal expression during development plays a crucial role in the 
mechanical development of tendons.  In support of this, in vivo studies of decorin and biglycan 
deficient mice showed unregulated lateral growth, structurally abnormal tendon fibrillogenesis and 
altered mechanics [9, 10].  
 Similarly, due to the preponderance of collagen and its hierarchical organization, many 
have hypothesized that collagen is the main effecter of mechanical strength in tendon.  Initially 
during development, collagen fibril diameters are small and have a narrow distribution.  As 
tendons mature, the fibril diameter increases, as does the fibril diameter distribution [1, 2, 11].  It 
is during this shift in collagen fibril diameter size and distribution that tendons gain significant 
mechanical strength[12].  Collagen fibril diameter average has often been used to determine the 
extent of mechanical contribution of collagen fibrils but has not always been a significant predictor 
for mechanical parameters[13-15]. Therefore, other tendon parameters must also be affecting the 
mechanical strength.   
 
4.1.3 Animal Model 
 Neonatal development is characterized by a multitude of compositional, structural and 
mechanical changes, including the ones outlined above and more.  While there is currently a 
basic knowledge of compositional and structural changes, there is sparse information on the 
mechanical development of neonatal tendons.  Previous studies have examined tendon 
development in the mouse, rat, rabbit, chick and horse.  Each of these animal models presents its 
own set of benefits and deterrents when choosing an appropriate animal model to study tendon 
development.  The rabbit and horse’s larger size make tendons easy to be mechanically 
manipulated, but handling the neonates is difficult and housing for these animals is expensive; 
therefore only small sample sizes are feasible.  The chick is beneficial because different stages of 
growth, including pre-hatchling through hatchling, can be easily examined.  One study did 
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mechanically test post-fertilization, and hatchling chick tendons along with fibril diameter and 
collagen content[12].  However, healing cannot be easily examined in prehatchling chick tendons.  
Rats are easy to handle and house but there are limited commercial assays and few genetically 
modified rats available to study specific mechanisms.  Mice on the other hand, are easy to 
handle, associated with low husbandry costs, and have similar tendon anatomy to humans.  The 
wide range of genetically modified mice and commercially available assays allow for rigorous 
mechanistic studies to be conducted in mice. Due to the fragile nature and small size of neonatal 
tendons most studies that have examined neonatal development have not mechanically tested 
the youngest specimen[10], or simply started the study at later stages of development, when the 
tendons are larger and easier to handle [4, 16]. .  However, compositional and structural studies 
have demonstrated that the most significant changes occur at very early stages of development, 
including fetal and neonatal.  In addition, it is during early neonatal growth that compositional and 
structural changes are most similar to changes observed during healing.  Therefore, the 
establishment of a mouse model of tendon development that includes quantitative measures for 
composition, structure and mechanics will be an enormously useful tool to determine the specific 
mechanisms of tendon development.    
 The current study will use the mouse Achilles tendon (AT) as a model of tendon 
development.   The mouse was chosen due to the reasons outlined above.  The Achilles tendon 
was chosen due to homologous anatomy to the human Achilles tendon, manageable size during 
development and accessibility for surgical injury (discussed in Chapter 5). 
  
4.1.4 Objective and Hypotheses 
 The purpose of this study is to develop a quantitative model of neonatal development in the 
mouse Achilles tendon.  Collagen content, biglycan and decorin expression, collagen fiber 
alignment, collagen fibril parameters, and elastic and viscoelastic mechanical properties will be 
quantified.  It is hypothesized that tendon mechanical properties, fibril parameters, and collagen 
content will increase throughout neonatal development.  In addition, it is hypothesized that 
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decorin and biglycan will be temporally regulated and the collagen fibers will be well aligned 
throughout development. 
 
4.2 Methods 
4.2.1 Animals 
 This study was approved by the University of Pennsylvania IACUC. Neonatal mice in a 
C57BL/6 background were bred in house.  All litters were weaned at birth to 6 pups to reduce 
variance from litter size [17].  Mice were weaned at 21 days old and sexes were separated at this 
time.  Both males and females were used in this study.  AT were harvested from neonatal mice at 
4, 7, 10, 14, 21 and 28 days old.  Care was taken to ensure that AT from the same mouse or from 
the same litter was not used in the same assay. 
 
4.2.2 Mechanical Analysis 
  To determine the mechanical properties of the developing neonatal mouse AT, one AT 
from each of forty-eight mice (8/age) was carefully dissected under a dissection microscope.  The 
tendons were cleaned of excess tissue leaving only the calcaneous.  Tendon width and thickness 
were then quantified, and cross-sectional area was measured using a custom built device 
consisting of LVDTs, a CCD laser, and translation stages[18].  Stain lines were placed to 
measure strain optically.  Sand paper was then glued to the calcaneous and myotendinous end of 
the AT.  Grip to grip and stain line to stain line gauge lengths were as follows (grip:stain): 4 and 7 
days old (2mm:1mm), 10 and 14 days old (3mm:1.5mm), 21 and 28 days old (4mm:2mm).  While 
gauge lengths varied with age due to increased AT size, the ratio of grip to stain line gauge length 
remained constant.  Due to the fragile nature of neonatal mouse AT, custom fixtures were 
designed to ensure the AT was unharmed during test preparation.  Custom designed grips were 
placed in a grip-boat to eliminate unwanted motion of the grips while the tendon was being 
secured in the grips (Figure 4.1A).  Once the tendon was secured, a custom grip-holder was 
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Figure 4.2: Example of the testing protocol for neonatal AT.  Protocol includes a preload, 
precycle, stress relaxation and constant ramp to failure. 
Figure 4.1: A: Custom designed grip-boat with grips and an AT tendon. B: Custom 
designed grip-holder, indicated by the arrow, with a tendon loaded between the grips, 
indicated with the circle.  The grip-holder ensured that the tendon remained unloaded 
during manipulation and mounting prior to testing. 
 
attached to both grips (Figure 4.1B).  Importantly, this fixture ensured that the tendons remain 
unloaded during handling and mounting for mechanical testing (Instron 5543, Instron Corp., 
Canton, MA). Each AT underwent the following protocol while immersed in a 37oC PBS bath—
preloaded to a nominal load, preconditioned for 10 cycles (0.005N-0.008N for 4 to 7 days old, 
0.01N-0.02N for 10 to 17 days old, 0.02N-0.04N for 21 to 28 days old) at a rate of 0.1%/s, and 
held for 300s. Immediately following, a stress relaxation experiment was performed by elongating 
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the tendon to a strain of 5% at a rate of 5%/s, followed by a relaxation for 600s. The tendon was 
returned to pre-stress relaxation elongation for 60s and finally, a ramp to failure was applied at a 
rate of 0.1%/s (Figure 4.2). Local tissue strain was measured optically as described 
previously[19]. From these tests, percent relaxation, toe region stiffness and modulus, the load, 
stress and strain at the transition point from toe to linear regions (from a bilinear fit), and linear 
region stiffness and modulus were determined.  
  A pilot study was conducted to ensure that the stress-relaxation test did not mechanically 
injure the neonatal tendons.  Eight neonatal mice at 7 days old were utilized.  One AT was 
mechanically tested through stress-relaxation at 5% strain followed by a ramp to failure while the 
contralateral tendon underwent only ramp to failure. Elastic parameters maximum load, maximum 
stress, stiffness and modulus were then compared with paired t-tests to determine if damage had 
decreased the elastic parameters.  No significant differences were seen between stress 
relaxation plus ramp to failure versus just ramp to failure (Table 4.1).  Therefore, the stress- 
relaxation ramp did not cause damage to the tendon and it is acceptable to conduct a stress-
relaxation test followed by ramp to failure on neonatal Achilles tendons. 
Table 4.1 : Comparison of elastic parameters in pilot study in 7 days old neonatal tendons (mean +/- st dev)
Elastic Parameter MaxLoad Max Stress Stiffness Modulus
(N) (MPa) (N/mm) (MPa)
Ramp to failure only 0.45 ± 0.12 16.45 ± 5.33 6.63 ± 4.45 168.23 ± 89.68
Stress-relaxation plus ramp to failure 0.40 ± 0.07 17.59 ± 2.46 6.05 ± 4.21 167.91 ± 81.48
p value 0.3 0.1 0.3 0.5  
 
4.2.3 Hydroxyproline Analysis 
 For analysis of total collagen content, a total of twenty-four AT (4/age) were cleanly 
dissected and the length of tendon corresponding to the grip to grip gauge length was isolated.  
Wet weights were obtained and subsequently AT were dried at 65°C for 24 hours. Dry weights 
were then obtained, followed by tissue digestion in 5mg/mL proteinase K solution at 65°C for 18 
hours.  For hydrolysis, samples were sealed in glass vials with 6N HCL and heated to 110C for 
16 hours.  Upon completion of hydrolysis, samples were neutralized by evaporating off HCL in a 
lyophilizer with NaOH and then resuspended in water.  o-Hydroxy-proline (OHP), a measure of 
75 
collagen content, was determined colorimetrically by reaction of the digest with p-
benzaminoaldehyde and chloramine-T. OHP content was converted to total collagen content, 
assuming hydroxyproline content is 14% of total collagen as previously reported[20].  
 
4.2.4 Gene Expression 
 To determine the mRNA expression of the proteoglycans biglycan and decorin, one AT 
from each of twenty-four mice (4/age) was used.  The AT was cleanly dissected and the length of 
tendon corresponding to the grip to grip gauge length was isolated. Individual AT were 
mechanically homogenized with a mortar and pestle in RNase-free conditions. RNA was 
extracted using the TRIZOL isolation system (Invitrogen, Carlsbad, CA) and RNeasy Mini Kit 
(Qiagene Inc., Valencia, CA) as described by the manufacturers. cDNA was produced by reverse 
transcription-polymerase chain reaction (RT-PCR) from 100ng of total RNA using the Superscript 
first-strand synthesis system for RT-PCR as described by the manufacturer (Invitrogen).  1 mL 
aliquots of the cDNA were amplified by real time quantitative polymerase chain reaction (Q-PCR) 
in a 25 mL reaction volume in a ABI Prism 7300 Sequence Detection System (Perkin-Elmer; 
Applied Biosystems, Warrington, UK) with a SYBR Green PCR Master Mix (Applied Biosystems).  
Mouse specific primers were used for glyceraldehyde-3-phosphate dehydrogenase (GAPDH; F - 
CTC GTC CCG TAG ACA AAA TGG; R - GTG ACC AGG CGC CCA ATA), decorin (DEC; F – 
GCTGCGGAAATCCGACTTC; R - TTGCCGCCCAGTTCTATGAC), biglycan (BIG; F – 
CCTTCCGCTGCGTTACTGA; R - GCAACCACTGCCTCTACTTCTTATAA).  Each replicate was 
performed in triplicate. The relative quantity of mRNA for each gene of interest was computed 
using the comparative 2-DCT method (ABI; Sequence Detection System User Bulletin #2) relative 
to GAPDH. Statistics were performed on the DCT value as is commonly done [7].  
 
4.2.5 Histological Analysis 
 To determine the organization of the developing AT, a total of 31 neonatal mice were 
euthanized (4-7/age).  AT were evaluated using a quantitative polarized light microscopy method 
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as described previously[21]. Briefly, the hind limb was disarticulated, the skin dissected off, and 
processed with standard histological techniques. During processing the foot was secured at a 90 
degree angle to the tibia[22].  7 mm sagittal sections were cut parallel to the tendon fibers and 
analyzed using a quantitative polarized light microscopy method. Using circular statistics (Oriana, 
Kovach Computing Services, Wales, UK), the angular deviation, a measure of collagen fiber 
orientation, was determined.  
  
4.2.6 Transmission Electron Microscopy 
 AT samples from twenty-four mice (4/age) were analyzed by transmission electron 
microscopy as previously described[23]. Briefly, the AT was dissected out with the calcaneous 
and muscle intact and fixed in 4% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M sodium 
cacodylate, pH 7.4, with 8.0 mM CaCl2, post-fixed with 1% osmium tetroxide. They were 
dehydrated in an ethanol series, followed by propylene oxide. The tissue samples were infiltrated 
and embedded in a mixture of EMbed 812, nadic methyl anhydride, dodecenyl succinic 
anhydride, and DMP-30 (Electron Microscopy Sciences, Hatfield, PA). Thin sections (80 nm) 
were cut using a Leica ultramicrotome and poststained with 2% aqueous uranyl acetate and 1% 
phosphotungstic acid, pH 3.2. The AT were examined at 80 kV using a JEOL 1400 transmission 
electron microscope equipped with an Orius widefield side mount CCD camera. 
  
4.2.7 Fibril Diameter Distribution  
 For each age, 4 AT were analyzed. Micrographs (4/AT) from non-overlapping regions of 
the central portion of the tendon were taken at 60,000x.  Micrographs were randomly chosen in a 
masked manner from the different ages and fibril diameters were measured using a RM 
Biometrics-Bioquant Image Analysis System (Nashville, TN). A region from a single micrograph, 
containing 27-214 fibrils/field, was measured.  Frequency of different diameter fibrils was 
analyzed in a total of 1514-2995 collagen fibrils/age.  All fibrils in the region of interest were 
measured; multiple regions of interest were used if necessary to collect at least 70 fibril diameter 
measurements per micrograph.  For each age, the total number of regions of interest and 
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minimum and maximum fibril measurements per region are as follows [age/# ROI (min-max)]:  
4/16 (146-233), 7/16 (108-168), 10/16 (111-152), 14/20 (52-126), 21/23 (43-127), 28/36 (27-54).  
For each AT the average and the standard deviation of the fibril diameters were determined and 
analyzed statistically.   
 
4.2.8. mRNA Comparison to Protein Expression 
 To determine whether mRNA expression mirrored protein expression, 6 mice were used 
for each age.  Both tendons were dissected (12/age), rinsed in PBS, and one AT was pooled for 
immunoblot analysis while the contralateral AT was pooled for mRNA analysis according to age.  
For immunoblot analysis, AT were homogenized in 10-20 fold excess (weight/volume) of 
extraction buffer (4M guanidine-HCL, 50nM sodium acetate, pH 5.8) with proteinase inhibitor 
(Roche).  Proteoglycans were extracted at 4 C for 48 h with stirring followed by clarification by 
centrifugation.  After dialysis against 150 mM Tris-HCl pH 7.3, 150 mM NaCl, the samples were 
digested with chondroitinase ABC for 24 h at 37 C.  Total protein content in the samples was 
determined using a BCA Protein Assay Kit (Pierce).  For semi-quantitative analysis of decorin and 
biglycan in neonatal developing tendons, 6-12 ug of total protein from neonatal developing 
tendons was loaded based on determination of optimal loading conditions.  Immuno-blotting was 
done as previously described [24].  Antibodies (from Dr. L. Fisher, NIH-NICDR) anti-decorin 
(LF#113) and antibiglycan (LF#159) were both used at 1:200.  Anti-actin antibodies (Millipore, 
MAB1501) were used at 1:100.  Donkey anti-rabbit and sheep anti-mouse IgG-horseradish 
peroxidase-linked secondary antibodies (GE Healthcare were used as 1:2500 (NA934V) and 
1:2000 (NA931V), respectively, with an ECL (Amersham) detection system. 
 For mRNA analysis, tendons underwent the same protocol outlined above with the same 
primer sets and were analyzed for DCT relative to actin. 
  
4.2.9 Statistical Analysis  
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Figure 4.3: Growth curve of the body weights of C57BL/6 mice during 
neonatal development. 
 
 Each parameter was quantitatively measured and the mean +/- the standard deviation 
was reported unless otherwise stated.  A one-way ANOVA with Tukey’s post hoc was performed 
across age for each measured parameter (significance set at p< 0.05, trend set at p<0.1). 
 
4.3 Results 
4.3.1 Animals  
  Extensive body weight growth was observed in neonatal mice between the ages of 4 and 
28 days old (Figure 4.3).  To determine if sex had an effect on the mechanical parameters 
measured in this study, individual t-tests were conducted at each age when possible.  Due to 
random assignment of mice, there were not enough female mice at 10 days of age for statistical 
analysis of a sex effect.  Table 4.2 demonstrates that sex did not have an effect on the 
mechanical parameters measured in this study, with one exception of males having a significantly 
larger transitional stress than females at 21 days of age.   
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Table 4.2: Mean +/- standard deviation and the significance for each mechanical parameter 
Figure 4.4: Typical 4 days old (A) and 28 days old 
(B) AT immediately after dissection.  Obvious size 
increases occur over the period of time 
investigated in this study. 
 
 
4.3.2 Mechanical Properties  
 There were obvious changes 
with age, specifically in size, upon 
dissection (Figure 4.4).  As expected, 
the cross-sectional area increased 
significantly with age (Figure 4.5).  21 
and 28 days old AT were significantly 
larger than all other ages studied, and 
28 days old AT were significantly larger 
than 21 days old AT. Most mechanical 
parameters increased throughout 
development as demonstrated by load 
vs displacement curves of the constant 
ramp to failure for representative 
samples at each age (Figure 4.6).   
Specifically, percent relaxation, a  
        viscoelastic property, was significantly 
lower in 4 days old AT when compared to 14, 21 and 28 days old AT (Table 4.3).  Significant 
differences were seen in toe region parameters that were obtained from a bi-linear fit.  The 
transitional strain (strain at the inflection point in the stress-strain curve) was significantly higher in 
Parameter
Age (days) Female Male p-value Female Male p-value Female Male p-value
4 51.7 ± 3.2 48.3 ± 4.7 0.3 3.18 ± 1.65 1.83 ± 0.86 0.2 102.2 ± 40.5 72.0 ± 31.7 0.3
7 55.5 ± 6.0 59.2 ± 6.6 0.5 7.27 ± 2.75 3.54 ± 2.15 0.08 238.8 ± 70.8 114.6 ± 77.7 0.09
14 61.2 ± 5.3 59.4 ± 5.1 0.7 9.08 ± 2.14 11.52 ± 4.00 0.4 373.7 ± 267.5 408.5 ± 58.2 0.8
21 63.6 ± 5.4 62.0 ± 3.9 0.7 19.74 ± 8.38 22.22 ± 12.18 0.8 469.2 ± 195.9 408.7 ± 141.1 0.7
28 58.2 ± 5.4 63.5 ± 6.3 0.2 38.84 ± 19.56 61.85 ± 38.03 0.3 566.7 ± 237.4 521.2 ± 278.4 0.8
Parameter
Age (days) Female Male p-value Female Male p-value Female Male p-value Female Male p-value
4 0.04 ± 0.03 0.03 ± 0.02 0.6 1.64 ± 1.50 1.27 ± 0.81 0.7 0.58 ± 0.18 0.53 ± 0.23 0.8 22.8 ± 10.3 26.1 ± 22.6 0.8
7 0.04 ± 0.02 0.04 ± 0.03 0.8 1.13 ± 0.82 1.76 ± 1.60 0.6 0.63 ± 0.23 0.48 ± 0.26 0.4 22.6 ± 10.0 15.2 ± 9.4 0.4
21 0.1 ± 0.02 0.06 ± 0.08 0.2 1.76 ± 0.60 0.47 ± 0.53 0.05 2.4 ± 1.14 1.65 ± 1.51 0.5 63.5 ± 44.1 27.8 ± 17.8 0.3
28 0.31 ± 0.3 0.2 ± 0.08 0.3 2.13 ± 1.63 0.76 ± 0.37 0.2 7.5 ± 4.79 5.27 ± 3.34 0.5 99.7 ± 52.5 45.0 ± 27.8 0.1
Transitional Load (N) Transitional Stress (MPa) Toe Stiffness (N/mm) Toe Modulus (MPa)
Percent Relaxation (%) Stiffness (N/mm) Modulus (MPa)
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4 and 7 days old AT when compared to 21 and 28 days old AT.  Transitional load (load at the 
inflection point) was significantly higher at 28 days old than at all other ages except at 21 days 
old.  Interestingly, transitional stress showed no significance at any age.  Toe stiffness and toe 
modulus, parameters obtained from the slope of the toe region, also showed significant increase 
with age.  Toe stiffness was significantly higher at 28 days old than at all other ages.  Toe 
modulus was significantly higher in 28 days old AT than at 7 and 14 days old AT.  Similarly, linear 
stiffness and modulus, parameters obtained from the linear portion of the curve increased with 
age (Figure 4.7). AT were significantly stiffer at 28 days old than at all other ages.  Linear 
modulus was significantly lower in 4 days old AT than at 10, 14, 21 and 28 days old AT and in 7 
days old AT than at 21 and 28 days old AT. 
Table 1: Mechanical, compositional and organization parameters throughoutneonatal development (mean± stdev)
Age   
(Days)
Cross-
sectional 
Area (mm2)
Percent 
Relax 
(%)
Trans 
Load     
(N)
Trans 
Stress 
(MPa)
Trans 
Strain   
(%)
Toe 
Stiffness 
(N/mm)
Toe 
Modulus 
(MPa)
Linear 
Stiffness 
(N/mm)
Linear 
Modulus 
(MPa)
Collagen
Content 
(%)
Ang
Dev   
(o)
4
0.015 ±
0.003ab
50.03 ±
4.14abc
0.036 ±
0.023a
1.43 ±
1.06
7.29 ±
4.28ab
0.55 ±
019a
24.6 ±
17.2
2.50 ±
1.42a
87.12 ±
37.3abcd
2.88 ±
1.04abc
9.0 ±
2.4
7
0.021 ±
0.006ab
56.86 ±
6.05
0.038 ±
0.025a
1.47 ±
1.14
7.73 ±
4.78ab
0.57 ±
0.24a
19.4 ±
9.7a
5.87 ±
3.06a
192.19 ±
93.4ab
6.38 ±
abc
6.7 ±
3.5
10 0.023 ±
0.008ab
56.26 ±
9.06 
0.047 ±
0.026a
1.71 ±
0.72
3.36 ±
1.45
1.26 ±
1.14a
62.0 ±
40.0
6.67 ±
2.33a
345.75 ±
150.4
10.85 ±
1.81ab
6.0 ±
1.0
14
0.041±
0.010ab
60.51 ±
4.92
0.035 ±
0.026a
0.80 ±
0.43
4.32 ±
1.95
0.61 ±
0.20a
21.7 ±
10.1a
9.99 ±
2.97a
386.75 ±
205.4
18.74 ±
2.92a
6.8 ±
1.5
21 0.098 ±
0.030a
62.58 ±
4.22
0.096 ±
0.065
1.12 ±
0.87
2.25 ±
1.39
2.03 ±
1.27a
45.7 ±
35.9
21.15 ±
9.97a
431.37 ±
152.7
27.17 ±
7.09
6.2 ±
3.3
28
0.166 ±
0.049 
60.85 ±
5.82
0.237 ±
0.199
1.45 ±
1.32
1.91 ±
0.93
6.39 ±
4.01
72.3 ±
48.7
50.35 ±
30.58 
544.00 ±
240.8
36.20 ±
9.76
6.2 ±
1.0
a: significantly different from 28 days; b: significantly different from 21 days; c: significantly different from 14 day;  
d: significantly different from 10 days.  Significance set at p ? 0.05.
0.8
± stdev)4.3: Mechanical, comp sitional and organ zation parameters throughout neonatal development (mean ± Stdev)
 
4.3.3 Collagen Content  
 Throughout neonatal development collagen content increased as expected (Table 4.3).  
Specifically, the percent of collagen (per dry weight) in AT was significantly larger 28 days old 
than at 4, 7, 10 and 14 days old.  21 days old AT also had significantly higher collagen content 
than at 4, 7 and 10 days old AT.  Lastly, 14 days old AT had significantly more collagen than at 4 
and 7 days old AT. 
  
4.3.4 Proteoglycan mRNA Expression  
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 The relative quantity of biglycan decreased with age (Figure 4.8).  4 days old AT had 
significantly higher biglycan content than all ages.  10 days old had significantly higher biglycan 
than at 21 and 28 days old AT and 14 days old AT had significantly higher biglycan than at 28 
days old.  No significant differences were seen in decorin content between any of the ages 
studied. 
 
4.3.5 Comparison of mRNA Expression to Protein Expression  
  Protein and mRNA expression are presented in Figure 4.9.  No error bars are 
represented for western blot analysis due to lack of experimental replicates (error bars for RT-
qPCR represent replicates of a  single 
experimental sample) and each bar 
represents only one pooled sample. As 
shown, there is a small range of expression 
across age for both decorin and biglycan in                               
                                                                                  
both mRNA and protein expression in this 
pilot experiment.  Unfortunately, due to the 
small range of expression values and lack of 
experimental replicates, no conclusive result 
can be stated. 
4.3.6 Fiber Organization  
 No differences were shown in angular deviation between any of the neonatal ages 
studied.  Qualitative observation of the hemotoxylin and eosin stained sections of the AT at each 
age confirmed that the fibers are well aligned throughout development (Figure 4.10). 
 
4.3.7 Fibril Diameter Parameters 
 Ultrastructural analyses demonstrated circular fibril profiles.  Fibril diameters were initially 
small and uniform as demonstrated in the 4 days old AT (Figure 4.11; Figure 4.12).  As the mice 
Figure 4.5: Increase in cross-sectional area 
throughout neonatal development; increases 
occurred at 21 and 28 days old. -: p<0.05. 
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developed, fibril diameters increased and the distribution of the diameters became spread out.  
By 28 days old the fibril distribution was extremely spread out and no one range of fibrils 
dominated the whole population.  These changes are demonstrated quantitatively by examining 
the average, and standard deviation (StDev) of the fibril diameters throughout development 
(Table 4.4).  All measured parameters demonstrated a significant increase with age during 
development.  Specifically,  both the average and standard deviation of the fibril diameters were 
significantly larger in 28 days old AT when compared to all other ages, 21 days old AT were 
significantly larger than 4, 7 and 10 days old AT and were significantly larger in 14 days old AT 
than in 4 and 7 days old.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.4 Discussion 
4.4.1 Interpretation of Results  
Figure 4.6: Representative load vs displacement curves from the constant ramp to failure for 
each neonatal developmental age.  
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Figure 4.7: Linear stiffness and modulus significantly increased with age in a neonatal AT 
(error bar represents st dev).  – : p< 0.05  
 The goal of this study was to quantify compositional, structural and mechanical changes 
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during neonatal development in a mouse Achilles tendon.  The results demonstrated an increase 
in mechanical strength throughout development.  These changes were accompanied by 
increased collagen content, decreased biglycan content, increased fibril diameter average and 
standard deviation and no changes to decorin content or fiber angle.  Known alterations in tendon 
composition and structure during development include increased fibril diameter means, area 
fraction and distributions, increased  collagen content, temporally regulated proteoglycan 
content[5, 7, 9, 10] and other minor constituents[3, 27], and increased mechanical strength[4, 12, 
28]. Previous studies have focused on the chick, rabbit, rat and horse due to either accessibility of 
embryonic tendons or the larger size of fetal and neonatal tendons.  In addition to what is 
currently known, the present study provides fundamental, quantitative knowledge of the 
development of neonatal tendons.  In addition, this new neonatal mouse AT model allows for 
study of the mechanisms behind not only compositional and structural parameters but also 
mechanical development during neonatal growth due to the availability of genetically modified 
mice and commercially available assays for mice.   
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Figure 4.8: Relative expression of biglycan and decorin relative to GAPDH.  Biglycan 
decreased significantly throughout development while no significant differences were seen 
in decorin mRNA expression.  1-way ANOVA was performed on dCT values, while 2-DCt is 
represented graphically.  – : p< 0.05 
 
Figure 4.9: Western blot and mRNA expression for 7, 14 and 
28 days old pooled AT.  Both sets of data were normalized to 
7 days old for easy comparison.  
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 It is widely hypothesized that mechanical strength is created through a combination of the 
compositional and structural elements present in tendon.  Despite the extensive work done to 
understand these interactions, there is still little knowledge about how composition and structure 
affect mechanical strength during development.  One exception is a study examining the 
mechanical strength of metatarsal tendons in chicks from post-fertilization day 14 through 2 days 
post hatchling [12].  Chick and mouse tendon development have previously been compared 
based on extensive work 
done in fibrillogenesis[7].  
Briefly, intermediate fibril 
assembly occurs at post-
fertilization day 14 and in 
neonatal mice at 4 days 
old, fibril growth begins at 
post-fertilization day 17 
and in 10 days old 
neonatal mice while rapid 
lateral growth into maturity 
Western Blot Results RT-qPCR Results
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begins in hatchlings and sometime between 10 days and 1 month old in mice.  Increased 
mechanical strength was demonstrated throughout all stages of both chick (previously 
demonstrated) and mouse development (current study).  In the current study all structural 
parameters increased with age, as expected considering the large increase in cross-sectional 
area during neonatal development.  Similarly, most material parameters increased with age in 
both the chick and the mouse.  However, in the current study, the transitional stress showed no 
increase with neonatal age even though changes were seen in transitional load.  It appears that 
the quality of tissue initially present during neonatal development is sufficient for stresses 
experienced within the toe region through out development.   
 Interestingly, transitional strain in the neonatal mouse decreased after 7 days of age and 
remained low whereas no change was demonstrated in the chick.   Previous studies have shown 
that by post-fertilization day 17, almost no fibril intermediates could be identified in the chick 
tendon[29], only mature fibrils. Full length fibrils would translate forces initially to uncrimp the 
collagen (toe region) and then along the length of the fibrils (linear region).  In the mouse, 
intermediate fibrils are still forming until about 10 days of age. Therefore, the toe region in 4 and 7 
days old mouse AT may not be an effect of collagen uncrimping alone but also collagen fibril 
sliding and shearing.  Further mechanical and histological studies need to be done to confirm this 
hypothesis.  In addition, it should be noted that significant differences in mechanical testing were 
employed in each study. Most notably, strain was measure optically in the current study versus 
grip to grip strain in the chick tendon study.  Optical strain is a better measure of the local strains 
experienced by the tissue; therefore, the grip to grip strains reported in the previous study may 
have masked changes in transitional strain. 
 The AT was chosen for this study due to the relatively large size during neonatal 
development and ease of accessibility.  In addition, the AT is surgically accessible allowing for the 
introduction of a developmental injury model in the future.  While some of the parameters studied 
were previously defined during development, it is imperative that these parameters were defined 
in the proposed  model due to differences in species [2, 14], between strains [30] and between 
specific tendons[31].  For instance, extensive fibril diameter measures have been examined in 
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Figure 4.10: Representative examples of H&E stained sections of the AT at 4, 7, 10, 
14, 21, and 28 days old.  Fibers were well aligned throughout development. 
 
4 days old 7 days old 10 days old
14 days old 21 days old 28 days old
mouse flexor tendons [31].  General trends observed in the current study are similar but the 
mouse flexor tendon has a larger fibril diameter mean and spread at all comparable ages.  In 
addition, the expression of decorin has previously been shown to decrease during neonatal 
development and remain at a moderate level[10] while in the current study a moderate level of 
decorin was seen throughout development.  Aside from differences between tendons, it has 
recently been shown that structural and compositional differences are present in the same 
tendon, at the same age in mice with different genetic backgrounds [30].  Therefore, not only is it 
important to clearly define quantitative parameters in a new model, but also to take into account 
the tendon, the species and strain studied when comparing and contrasting with previous studies.   
 Adult tendons heal through a reparative process [32, 33] and undergo a set of 
coordinated responses that include inflammation, extracellular matrix production and remodeling 
of the tissue [34]. Subsequent to fibroblast proliferation, increased extracellular matrix production 
alters the composition of the tendon from its uninjured state.  Specifically, collagen production 
increases during healing [35, 36] which is similar to increases seen during development.  In 
addition, during healing, biglycan levels increase [37] and decorin levels remain unaltered or 
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Figure 4.11:  Frequency of fibril diameters demonstrated increased fibril diameters and fibril 
diameter distributions through out mouse AT neonatal development. 
 
decrease[37]. These changes are similar to tendon development but levels of biglycan remain 
elevated in healing for an extended period of time, unlike development.  Not only is composition 
altered during healing but also structure.  For instance, the fibril diameter size distribution is 
narrowed and consists mainly of small diameter fibrils [38-40], similar to what is seen during the 
early stages of neonatal development.  However, this population does not mature into a 
population of large fibrils with a wide spread.  Instead fibrils remain fairly small and unimodel for 
an extended time post-injury. In addition, the extracellular matrix that is produced is disorganized 
during healing, altering the parallel alignment of the fibers[41].  The parallel alignment does return 
to an organized state throughout remodeling; however, this is in stark contrast to development 
where fibers are aligned throughout.  The current study starts to define the similarities and 
differences between development and healing.   
 Recently researchers have attempted to improve adult tendon healing through the 
application of cytokines and growth factors.  However, applying current knowledge of cytokines 
and growth factors in a clinical setting presents many complications including appropriate dosage, 
time of administration, synergistic effects with other cytokines, and length of exposure. Therefore, 
new strategies for improved healing need to be investigated.  A neonatal development model not 
only provides compositional and structural changes similar to those seen during adult healing, but 
also provides a model of increased mechanical strength and function. By comparing and 
contrasting parameters of neonatal development and adult healing differential effects can be 
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Figure 4.12:  
Representative 
micrographs for 
each age 
throughout 
neonatal 
development. 
Fibril diameters 
were circular 
throughout 
neonatal 
development 
and an obvious 
increase in fibril 
diameter size 
occurred 
throughout 
development. 
ascertained.  Parameters that show a differential effect during development can be implemented 
in new tissue engineered constructs.  For instance, adding an element to a construct that 
decreases the amount of biglycan present may improve healing.  A treatment that promotes the 
lateral fusion of the collagen fibrils during healing may help reestablish mechanical strength in the 
healing process; thereby improving the functional outcome of adult tendon healing. 
  
4.4.2 Limitations  
 The current study is not without limitations.  For instance, the increase in collagen content 
observed during healing and development usually has a larger percentage of type III collagen 
than is observed in normal mature tendon.  A relationship between type III collagen and small 
diameter fibrils has previously been reported in the literature[3].  Type III collagen is present 
during early development but disappears from the mid-substance of the tendon when the fibril 
diameters start to increase; however, these changes occur before the youngest age examined in 
this study [42].  Therefore, it can be assumed that the contribution of type III collagen to the total 
collagen content measured in this study is insignificant.   
 The relative expression of biglycan and decorin were measured through mRNA 
expression in this study.  It would have been advantageous to measure the 
actual protein content of these proteoglycans during development.  The ability to collect 
quantitative measures from individual tendons is necessary for rigorous statistical regression 
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models.  Therefore, this goal was used when selecting compositional and structural parameters 
to measure.  Unfortunately, protein measures could not be obtained for individual tendons due to 
the small size of neonatal AT and limited quantity of biglycan and decorin in an individual tendon.  
Specifically, a commercial biglycan ELISA kit is not currently available.  While an ELISA for 
human biglycan was developed by collaborators in our laboratory, it was not sensitive enough to 
detect the small amount of biglycan present in neonatal tendons.  An alternate approach would 
have been to detect biglycan and decorin through western blot analysis.  However, western blot 
analysis is even less sensitive than ELISAs.  Previous studies that detected these proteins 
through western blot have pooled 6-12 neonatal tendons to obtain enough protein.  In the current 
study, a pilot study was conducted with pooled comparisons of mRNA and protein.  Unfortunately, 
the results of this study were inconclusive.  Despite this, previous work in mouse neonatal tendon 
development showed some similarities between mRNA and protein expression in the FDL [10].  
In addition, a study in rabbit ligament demonstrated similar expression between decorin protein 
and mRNA expression after injury [43].Therefore, given the restraints of the study design, tissue 
size and data from previous studies, the relative expression of mRNA is likely a reasonable 
predictor of the actual protein present and supports its use in this study.   
 While it is currently 
unknown if there are sex 
differences at the ages examined, 
previous studies showed little to no 
effect of sex on tendon mechanics 
and composition in one month old 
mice or rats[4, 28, 44].  It is 
important to note that effects due 
to sex were seen at older ages, after the onset of puberty in some studies.  While there is still a 
possibility of sex differences even in pre-pubescent mice, we were unable to demonstrate any in 
the mechanical parameters in the current study.  Compositional and structural parameters were 
Age (days)
4 41.3 ± 5.9abc 9.87 ± 0.17abc
7 50.1 ± 3.9ab 13.80 ± 1.90ab
10 54.3 ± 2.4ab 15.43 ± 0.54ab
14 70.5 ± 14.3a 22.15 ± 6.77a
21 83.1 ± 14.0a 25.99 ± 6.42a
28 107.9 ± 8.8 36.26 ± 6.08
 a: significantly different from 28 days; b: signif icantly different 
from 21 days; c: signi ficantly different than 14 days
Average (nm) StDev (nm)
Table 4.4: Average and standard deviation of fibril diameters
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not evaluated for sex differences due to the low number of total specimens per group; however, 
based on previous studies it is assumed that there is no effect due to sex. 
  
4.4.3 Summary  
 In summary, quantitative compositional, structural and mechanical changes during 
neonatal development of the mouse AT were demonstrated.  Through this mouse model, the 
mechanisms governing the development of mechanical strength can be rigorously studied with 
genetically modified mice and commercially available assays.  In addition, by comparing and 
contrasting development and healing new therapies for adult tendon healing can be ascertained.   
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Chapter 5: Recapitulation of the Achilles tendon mechanical properties during neonatal 
development: a study of differential healing during two stages of development in a mouse 
model 
 
5.1 Introduction 
5.1.1 Significance 
 Tendon injuries are a common occurrence and of particular concern because of scar 
formation.  Scar is created when adult tendons undergo a reparative process [1, 2] after injury 
that includes inflammation, extracellular matrix production and remodeling of the tissue. During 
these processes, extracellular matrix components are quickly deposited by fibroblasts to fill the 
defect and restore function. The composition and the structure of the scar tissue are 
consequently altered from normal tendon resulting in inferior mechanical properties.  While in 
some cases scar returns some function to the tendon over time, the tendon rarely regains its 
original functionality or mechanical properties [3, 4].  Two common problems from this scar 
include adhesion formation between the tendon and tendon sheath preventing normal sliding and 
reduced mechanical properties that can result in reruptures.  
 Clinical advances have been made in tendon repair over the last two decades through 
improved surgical techniques and postoperative rehabilitative protocols [5, 6].  Even with these 
improvements, scarring and reruptures still remain a frequent occurrence.  Alternatively, 
knowledge of the biological processes during tendon repair has also significantly advanced.  
From this knowledge, attempts have been made to improve tendon healing through cytokine 
application, gene therapy, cell based therapies, and tendon grafts.  While some of these studies 
have been successful in animal models, a significant improvement in clinical tendon healing is still 
needed.  Most of the previous studies used normal, adult healing as a model because a thorough 
understanding of the natural processes during scar formation is valuable; however, it may be 
difficult to discover novel treatments when using reparative adult healing as a model.  Therefore, 
new in vivo models of superior tendon healing need to be explored so novel strategies that 
quickly return tendon to normal function post-injury can be developed. 
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5.1.2 Regenerative Healing 
 Unlike adult reparative healing, fetal tissue is well known to heal through a regenerative 
process [7].  While first demonstrated in skin, fetal scarless healing also occurs in tendon and is 
characterized by faster wound healing, lack of an inflammatory response and an absence of scar 
tissue[5, 8, 9].  The mechanism responsible for fetal healing is still unknown, but it is believed that 
the regenerative response is a property of the tissue and not the environment [9].  Extensive 
investigations have been done on fetal healing in the hope of being able to recapitulate scarless 
healing in adults.  However, while fetal healing presents great promise, there are many 
parameters that are different between adult and fetal healing, for instance, the mechanical 
environment during healing and inflammation [9].  These differences can not easily be 
recapitulated in adult tendon healing; therefore, a new model system needs to be developed to 
investigate improved healing parameters. 
  
5.1.3 Tendon Development and Healing 
 Developing tendons undergo a well orchestrated process whereby extensive structural 
and compositional changes occur in synchrony to produce a functional tissue [10, 11]. 
Interestingly, many of these changes parallel structural and compositional changes that occur 
during the repair response to injury. For instance, collagen content and the average fibril 
diameters increase throughout both development and healing.  In addition, biglycan is present 
during early stages of development and healing but is very sparse in mature tendon [12]. 
However, there are also differences in development and healing.  While biglycan is elevated in 
early development and healing, expression rapidly decreases as development progresses but 
remains elevated for an extended period during healing [13, 14].  In addition, during development, 
the diameters of the collagen fibrils begin to spread out and have a large distribution while during 
healing the diameters remain fairly uniform.  The most striking difference, despite the numerous 
similarities, is that during development, a mechanically functional tendon is formed whereas 
during healing, a tendon with inferior mechanics results; therefore, it has been postulated that 
development could serve as a paradigm through which improved adult healing may occur [15].   
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 It has been hypothesized that healing parameters change from the fetal stage, through 
development and into adulthood [11].  For example, neonatal developing tendons may heal 
through scar formation but regain normal structure and function faster than during adult healing.  
Therefore, a neonatal development model of tendon healing may be beneficial to improve adult 
healing.  Few studies have been able to test this hypothesis due to the small size and fragile 
nature of developing tendons. One study, on the healing of subfailure ligament injury in immature 
and mature rat, showed that a 21 day old rat regained 95% of its strength by 7 days post injury 
whereas an 8 month old rat only regained 81% at 14 weeks [16].  Therefore, greater 
understanding of healing at different stages of neonatal development can provide guidance in the 
development of new therapeutic strategies to improve the outcome of adult tendon healing.  
 
5.1.4 Objective and Hypotheses 
 The objective of this study is to develop and quantitatively characterize a model of 
neonatal healing at two stages of development in the mouse Achilles tendon (AT).  A surgical 
model will be developed and utilized to injure AT in neonatal mice at 7 and 21 days old.  Mice will 
be sacrificed at two time points post injury and collagen content, biglycan and decorin mRNA 
expression, collagen fibril parameters, collagen organization, cell shape, cell number and elastic 
and viscoelastic mechanical properties will be quantified.  It is hypothesized that maximum stress, 
modulus and decorin levels will be significantly higher in early developmental injury when 
compared to late developmental injury (injured tendon normalized by contralateral uninjured 
tendon).  Collagen content, fibril diameter spread and percent relaxation will be significantly 
higher at late stages of healing in early developmental injury when compared to late 
developmental injury (injured tendon normalized by contralateral uninjured tendon).  Collagen 
content, collagen organization and biglycan levels will significantly increase over time in late 
developmental injury (injured tendon normalized by contralateral uninjured tendon).  Lastly, when 
normalized, maximum stress, modulus and percent relaxation will significantly increase over time 
in early development injury but will remain low in late development injury. 
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5.2 Methods 
5.2.1 Animals 
 This study was approved by the University of Pennsylvania IACUC. Neonatal mice in a 
C57BL/6 background were bred in house.  All litters were weaned at birth to 6 pups to reduce 
variance from litter size [17].  Mice were weaned at 21 days old and sexes were separated at this 
time.  Both males and females were used in this study.  Care was taken to ensure that mice from 
the same litter were not used in the same assay. 
 
5.2.2 Surgical Model 
 In preparation for the surgical procedure, 288 neonatal mice at 7 and 21 days old (144 
mice /age) were anesthetized with a mixture of isofluorane (5%) and oxygen (0.6%).  For the 21 
days old mice, one hindlimb, chosen randomly, was shaved. During the surgical procedure, 
anesthesia was delivered via a nose cone with a reduced level of isofluorane (1-2.5%) and 0.6% 
oxygen. The neonatal mice were placed ventral side down and the foot of the randomly chosen 
limb was dorsal flexed. A skin incision was made lateral to the AT to ensure the AT was not 
accidentally injured.  A plastic coated blade was then placed underneath the AT tendon and the 
end was gripped with hemostats for additional support (Figure 5.1) With the coated blade serving 
as support, a 0.3mm diameter biopsy punch (Shoney Scientific, Waukesha, WI) was used to 
create a central full thickness, partial width (~50%), excisional injury in the AT, approximately 
2mm proximal from the calcaneous.  While no suture repair was performed on the AT, the skin 
wound was closed with a single suture. The contralateral AT remained uninjured to serve as an 
internal control of developmental changes.  Mice were allowed to resume normal cage activity 
until euthanized at 3 or 10 days post injury. Mice were euthanized by CO2 inhalation and cervical 
dislocation to confirm death.  
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5.2.3 Mechanical Analysis 
 To determine the mechanical properties of the developing neonatal mouse AT, both the 
injured and uninjured controlateral AT from each of forty-eight mice (12 mice/group) were 
carefully dissected out under a dissection scope.  The tendons were cleaned of excess tissue 
leaving only the calcaneous.  Tendon width and thickness were then quantified, and cross-
sectional area was measured using a custom built device consisting of LVDTs, a CCD laser, and 
translation stages[18].  Each tendon was dumbbell stamped to 0.3mm width of the central portion 
with a custom built device to remove the uninjured fibers on either side of the central injury 
(Figure 5.2). The cross-sectional area was measured again for material property calculations. 
Figure 5.1: Unilateral injuries were performed on neonatal mice.  A rubber backing was 
used for support as the biopsy punch created a partial width, full thickness injury in the 
Achilles tendon.  
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Stain lines were placed to measure strain optically, 1.5 mm apart for 7 days old AT sacrificed at 3 
and 10 days post injury and 2 mm apart for 21 days old AT sacrificed at 3 and 10 days post 
injury.  Sandpaper was then glued to the calcaneous and myotendinous end of the AT, 3 mm 
apart for 7 days old AT sacrificed at 3 and 10 days post injury and 4 mm apart for 21 days old AT 
sacrificed at 3 and 10 days post injury (Figure 5.3).   While gauge lengths varied with age due to 
increased AT size, the ratio of grip to stain line gauge length remained constant.  Due to the 
fragile nature of neonatal mouse AT, custom fixtures were designed to ensure the AT was 
unharmed during test preparation, as shown in Chapter 4.  Custom designed grips were placed in 
a grip-boat to eliminate unwanted motion of the grips while the tendon was being secured in the 
Figure 5.2: Dumbbell stamping device.  The stamp is affixed to the upper fixture and the 
tendon rests on the platform.  Linear bearings maintained constant vertical translation of the 
stamping device to ensure appropriate placement of the stamp in the neonatal tendon. 
.  
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grips.  Once the tendon was secured, a custom grip-holder was attached to both grips.  
Importantly, this fixture ensured that the 
tendons remain unloaded during handling 
and mounting for mechanical testing 
(Instron 5543, Instron Corp., Canton, MA). 
 Each AT underwent the following 
protocol while immersed in a 37oC PBS 
bath—preloaded to a nominal load, 
preconditioned for 10 cycles (0.01N-0.02N 
for AT injured at 7 days old, 0.02N-0.04N 
for AT injured at 21 days old) at a rate of 
0.1%/s, and held for 300s. Immediately 
following, a stress relaxation experiment 
was performed by elongating the tendon 
to a strain of 5% at a rate of 5%/s, 
followed by a relaxation for 600s. The 
tendon was returned to pre-stress relaxation elongation for 60s and finally, a ramp to failure was 
applied at a rate of 0.1%/s. Local tissue strain was measured optically as described 
previously[19]. From these tests, percent relaxation, linear region modulus and maximum stress 
were determined. All parameters were then normalized within an individual mouse by dividing the 
value from the injured AT by the value from the uninjured AT. This normalization was performed 
to isolate changes in healing from changes in development.  A value less than one is indicative of 
a decrease in the mechanical property, a value higher than one is an increase in the mechanical 
property and a value of 1 indicates no difference between injured and uninjured.   
5.2.4 Hydroxyproline Analysis 
 For analysis of total collagen content both the injured and uninjured contralateral AT from 
48 mice (12/group) were cleanly dissected and the length of tendon corresponding, to the grip to 
grip gauge length, was isolated.  Wet weights were obtained and subsequently AT were dried at 
Figure 5.3: Representative sample of a 
developmental Achilles tendon prepared for 
mechanical testing, with the ends glued between 
sandpaper and the stain lines in the midsubstance. 
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65°C for 24 hours. Dry weights were then obtained, followed by tissue digestion in 5mg/mL 
proteinase K solution at 65°C for 18 hours.  For hydrolysis, samples were sealed in glass vials 
with 6N HCL and heated to 110C for 16 hours.  Upon completion of hydrolysis, samples were 
neutralized by evaporating off HCL in a lyophilizer with NaOH and then resuspended in water.  o-
Hydroxy-proline (OHP), a measure of collagen content, was determined colorimetrically by 
reaction of the digest with p-benzaminoaldehyde and chloramine-T. OHP content was converted 
to total collagen content, assuming hydroxyproline content is 14% of total collagen as previously 
reported[20]. Collagen content was normalized to the dry weight of the individual samples.  
Collagen content/dry weight was then normalized within an individual mouse by dividing the value 
from the injured AT by the value from the uninjured AT. 
 
5.2.5 Gene Expression 
 To determine the expression of the proteoglycans biglycan and decorin, both the injured 
and uninjured AT from each of forty-eight mice (12 mice/group) were used.  The AT was cleanly 
dissected and the length of tendon corresponding to the grip to grip gauge length was isolated. 
Individual AT were mechanically homogenized with a mortar and pestle in RNase-free conditions. 
RNA was extracted using the TRIZOL isolation system (Invitrogen, Carlsbad, CA) and RNeasy 
Mini Kit (Qiagene Inc., Valencia, CA) as described by the manufacturers. cDNA was produced by 
reverse transcription-polymerase chain reaction (RT-PCR) from 100ng of total RNA using the 
Superscript first-strand synthesis system for RT-PCR as described by the manufacturer 
(Invitrogen).  1 mL aliquots of the cDNA were amplified by real time quantitative polymerase chain 
reaction (Q-PCR) in a 25 mL reaction volume in a ABI Prism 7300 Sequence Detection System 
(Perkin-Elmer; Applied Biosystems, Warrington, UK) with a SYBR Green PCR Master Mix 
(Applied Biosystems).  Mouse specific primers were used for glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH; F - CTC GTC CCG TAG ACA AAA TGG; R - GTG ACC AGG CGC 
CCA ATA), decorin (DEC; F – GCTGCGGAAATCCGACTTC; R – TTGCCGCCCAGTT 
CTATGAC), biglycan (BIG; F – CCTTCCGCTGCGTTACTGA; R – GCAACCACTGCCTCTAC 
TTCTTATAA).  Each sample was assayed in triplicate. The relative quantity of mRNA for each 
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gene of interest was computed using a six-fold dilution standard curve. Biglycan and decorin were 
normalized by the GAPDH value within the same tendon.  All parameters were then normalized 
within an individual mouse by dividing the value from the injured AT by the value from the 
uninjured AT.  Statistics were performed on the relative quantity as is standard [21]. 
 
5.2.6 Histological Analysis 
 To determine the organization of the AT, both the injured and uninjured contralateral AT 
from each of forty-eight mice (12 mice/group) were evaluated histologically. Briefly, the hind limb 
was disarticulated, the skin dissected off, and processed with standard histological techniques. 
During processing, the foot was secured at a 90 degree angle to the tibia [22].  7 mm sagittal 
sections were cut parallel to the tendon and stained with hematoxylin-eosin.  Sections were then 
graded for cellularity, cell shape, and collagen fiber organization.  This analysis was 
accomplished in a semiquantitative manner by assigning a rank (1-4) to each of the observations  
Table 5.1: Grades and key for each non-paremeteric parameter measured by 3 blinded graders
Grade Cell Shape Cell Number Fiber Organization
1 Spindle Few cells, spread out Well aligned, straight, parallel f ibers
2 Most cells are spindle Few cells, multiple in a line Majority of area is organized
3 Most cells are rounded Many cells, with matrix seperating Disorganized, with areas of aligned fibers
4 Rounded Many cells with litt le matrix between Greatly disorganized, no clear alignement  
where 1 represents low cellularity, spindle cell shape and organized fibers and 4 represents high 
cellularity, rounded cell shape and disorganized collagen fibers (Table 5.1).  The experimental 
tendons were evaluated based on a series of standards with defined ranks for each variable at 
each level to facilitate comparison and reliable grade assignment. This series included of both 
uninjured and injured AT. The histologic analysis was performed independently by 3 graders 
masked to specimen group on representative sections from each tendon. For each variable 
examined, the median of the measures from the 3 graders for each sample was determined.   
The overall median and interquartile range for both the injured and uninjured AT within each 
group were then determined.  Histologic parameters were not normalized due to the non-
parametric nature of the measurements obtained.  Statistical analysis was also not performed on 
these parameters due to a non-normal distribution and non-parametric nature of the 
measurements. 
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5.2.7 Transmission Electron Microscopy 
 AT samples from both legs of forty-eight mice (12 mice/group) were analyzed by 
transmission electron microscopy as previously described [23]. Briefly, the AT was dissected out 
with the calcaneous and muscle intact and fixed in 4% paraformaldehyde, 2.5% glutaraldehyde, 
0.1 M sodium cacodylate, pH 7.4, with 8.0 mM CaCl2, post-fixed with 1% osmium tetroxide. They 
were dehydrated in an ethanol series, followed by propylene oxide. The tissue samples were 
infiltrated and embedded in a mixture of EMbed 812, nadic methyl anhydride, dodecenyl succinic 
anhydride, and DMP-30 (Electron Microscopy 
Sciences, Hatfield, PA). Thin sections (80 nm) 
were cut using a Leica ultramicrotome and post-
stained with 2% aqueous uranyl acetate and 1% 
phosphotungstic acid, pH 3.2. The AT were 
examined at 80 kV using a JEOL 1400 
transmission electron microscope equipped with 
an Orius widefield side mount CCD camera. 
  
5.2.8 Fibril Diameter Distribution  
 For each of the 4 groups, 12 injured and 
12 uninjured contralateral AT were analyzed. 
Micrographs from non-overlapping regions of the 
central portion of the tendon were taken at 
60,000x.  The injury was visually located in the micrograph and micrographs were obtained from 
predetermined locations (Figure 5.4).  Specifically, the central line of the injury was identified 
then, within the injury, the predetermined grid was used as a guideline for sampling locations.  
This configuration ensured that sampling was taken in the region of interest and that possible 
variability within the injury would not bias the data.  Four unique micrographs were sampled for 
uninjured AT, six unique micrographs were sampled for injured samples.  Fibril diameters were 
Figure 5.4: Schematic of the 
predetermined grid for TEM sampling. 
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measured using a RM Biometrics-Bioquant Image Analysis System (Nashville, TN). All fibrils 
within a region of interest in each micrograph were measured; multiple regions of interest were 
used if necessary to collect at least 80 fibril diameter measurements per micrograph.  For each 
group, the total number of regions of interest and minimum and maximum fibril measurements 
per region are as follows [age at injury/days post injury/(I)njured or (U)ninjured/# ROI (min-max)]:  
7/3/U/40 (82-200), 7/3/I/65 (45-238), 7/10/U/85 (44-96), 7/10/I/79 (46-204), 21/3/U/100 (29-74), 
21/3/I/152 (23-129), 21/10/U/110 (28-60), 21/10/I/148(15-98).  For each AT the average and 
standard deviation were determined and analyzed statistically.  The standard deviation is used 
here to represent the spread of the fibril diameter sizes.  All parameters were then normalized 
within an individual mouse by dividing the value from the injured AT by the value from the 
uninjured AT.   
  
5.2.9 Statistical Analysis  
 Each quantitative parameter was measured and normalized within each mouse by the 
contralateral AT (injured/uninjured) as described.  The mean +/- the standard deviation was 
reported unless otherwise stated.  A two-way ANOVA with Fisher’s LSD hoc was performed 
across age at injury and days post injury for each quantitative parameter measured.  Additionally, 
3 and 10 days post injury data were paired at both 7 and 21 days old through a bootstrapping 
technique to compare changes across post injury time. For both AT injured at 7 and 21 days old, 
multiple (between 9 and 13, depending on sample size) random pairings were made between the 
3 and 10 days post injury time points for all parameters (i.e., cross-sectional area, maximum 
stress, modulus, percent relaxation, collagen content, decorin and biglycan content, fibril diameter 
average, fibril diameter coefficient of variation, fibril diameter median and fibril diameter 
interquartile range). The standard deviations for the resulting normalized data (3 days post injury 
was subtracted from 10 days post injury) were calculated.  The pairing that produced the median 
result was chosen for comparison to provide the best pairing. Paired, normalized data was 
analyzed using a one-tailed t-test. For all statistical tests, significance was set at p ≤ 0.05 and a 
trend at p ≤ 0.1. 
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5.3 Results 
5.3.1 Pilot Studies 
5.3.1a Ex vivo surgery pilot 
 A pilot study was conducted in 8 days old neonatal Achilles mice to confirm that collagen 
fibers were being consistently severed during injury.  Figure 5.5 demonstrates the tendon before 
and after a biopsy punch was used to create a full thickness, 50% width injury in the middle of the 
Achilles tendon.  A distinct injury can be seen post-injury.  In addition, when viewed under 
polarized light, cut fibers are distinct and can be clearly seen providing support for the injury 
method. 
 
5.3.1b “Normal” contralateral pilot 
 A pilot study was conducted to determine if the uninjured contralateral tendon was altered 
due to potential compensation due to the injured tendon’s limb after injury.  To conduct this study, 
0.3mm 
biopsy 
punch
Tendon Pre-injury Creating injury Injury
AT under polarized light
Cut Fibers
Rubber 
backing
Figure 5.5: A pilot study was conducted in 8 
days old AT to ensure the tendon fibers were 
being cut.  The top panels clearly show the 
mode of injury with a rubber backing placed 
under the tendon and a 0.3mm biopsy punch 
utilized to create the injury.  The panel at 
right clearly shows cut fibers when the AT is 
viewed under polarized light.  
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eight 7 days old tendons underwent unilateral injury (as described above) while four 7 days old 
mice underwent no injury to either tendon.  All mice were sacrificed at 17 days of age (10 days 
post injury).  All uninjured tendons were then mechanically tested (as described above).  
Mechanical parameters from uninjured contralateral tendons in injured mice were compared to 
both AT in uninjured mice through a one-tailed t-test.  No differences were seen between the two 
groups in any of the mechanical parameters.  Therefore, the uninjured contralateral tendon in this 
model can be considered normal. 
 
5.3.1c Pilot to determine “ruptured” 
parameters 
 A pilot study was conducted to 
ensure that if a neonatal AT ruptured after 
injury, in vivo, it could be easily identifiable 
as if this was not possible, it would be 
difficult to consistently address our study 
goals.  Three mice at 7 days old under 
went surgery.  Achilles tendons were 
randomly assigned to undergo normal 
surgery (as described above) followed by 
both struts ruptured, one strut ruptured or 
no struts ruptured.  Two AT were included in each group.  Mice were sacrificed at 10 days post 
injury.  Differences between fully ruptured AT were clear and distinct (Figure 5.6).  Therefore, AT 
ruptured in vivo in experimental mice would also be easily identifiable.  
 
5.3.1 Animals  
 Extensive body weight growth was observed in neonatal mice between the ages of 10 and 31 
days old (Figure 5.7).  The surgical procedure did not appear to have a negative effect on normal 
neonatal growth as determined by normal body weight increases in experimental mice.  Upon 
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Figure 5.6: An example of a neonatal limb with 
a normal AT injury (left) and a fully ruptured AT 
(right).  The rough, “sunken in” appearance of 
the area where the AT should be is indicative of 
a fully ruptured AT. (The black near the AT in the 
photos is India ink used to help identify the AT). 
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dissection, AT injured at 7 
days old and euthanized at 3 
days post injury had large 
areas of scared tendon with 
translucent tissue and non-
uniform cross-sectional areas.  
By 10 days post injury, the 
healing area had remodeled 
and regained a uniform cross-
sectional area but still 
maintained a translucent 
appearance that was 
distinctly different than that of the uninjured contralateral AT (Figure 5.8).  AT injured at 21 days 
old and sacrificed at 3 days post injury had the white glistening appearance of an uninjured 
tendon except for a very small area directly around the injury.  This area had a distinct injury still 
present and sometimes contained small amounts of scar tissue.  By 10 days post injury, the area 
around the injury had become translucent and increased in size.   
 
 
5.3.2 Mechanical Properties 
Figure 5.8: Representative samples of AT after gross dissection for each age and time 
point post injury. One unit = 1 mm. 
 
Figure 5.7: Comparison of body weights between normal 
development and injury during development demonstrating no 
detrimental effects of the surgical method on developmental 
growth. 
Figure 5.7: Comparison of body weights between normal 
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 In AT that were injured at 7 days old, the normalized cross-sectional area was 
significantly decreased at 10 days post injury when compared to 3 days post injury (Figure 5.9).  
Alternatively, AT injured at 21 days old showed a trend towards increased normalized cross-
sectional area at 10 days post injury when compared to 3 days post injury.   When comparing 
across days post injury, specifically 3 days post injury, the normalized AT injured at 7 days were 
significantly larger compared to those injured at 21 days post injury.   
 For viscoelasticity, the only difference observed is a trend towards increased normalized 
percent relaxation inthe AT injured at 21 days at 3 days post injury when compared to those 
injured at 7 days post injury (Figure 5.10).  When comparing across age at injury, the normalized 
maximum stress and modulus 
were significantly greater in 
AT injured at 21 days old 
when compared to those 
injured at 7 days old at 3 days 
post injury.  However, at 10 
days post injury, the AT 
injured at 21 days old were 
significantly weaker than 
those injured at 7 days old.  
When comparing across days 
post injury, in the AT injured at 
7 days old, the normalized 
maximum stress and modulus 
were significantly increased at 10 days post injury when compared to 3 days post injury.  A 
significant decrease in normalized modulus was observed in AT injured at 21 days old between 3 
and 10 days post injury and a trend toward decreased maximum stress was observed. 
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Figure 5.9: The cross-sectional area was increased during 
early development but decreased by 10 days post injury.  
During late developmental injury, little change was observed 
at 3 days injury and an increase in cross-sectional area was 
seen at 10 days post injury. The horizontal line at 1 indicates 
no change from normal development. Error bars represent 
standard deviation. 
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 Bootstrapping techniques were utilized to pair 3 and 10 days post injury time points to 
determine differences between time post injury in 7 days old animals and 21 days old mice.  Mice 
injured at 7 days old had a larger difference, between 3 and 10 days post injury than those at 21 
days old.  For the mechanical parameters percent relaxation, maximum stress and modulus, 
there was a significant difference between mice injured at 7 days old then at 21 days old when 
examining the differences between 3 and 10 days post injury.  Mice injured at 7 days old 
demonstrated a change toward improved mechanical parameters while mice injured at 21 days 
old demonstrated a change toward decreased mechanical parameters.   
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5.3.3 Collagen Content 
 Collagen content, as measure by hydroxyproline content, showed no significant 
differences across age at injury or time post injury (Figure 5.11). 
Figure 5.10: Differential responses 
between early and late development 
were observed in mechanical 
parameters.  Specifically, a return to 
normal mechanics was observed in early 
developmental injury (7 days old), not 
mechanics are still decreased in late 
developmental injury (21 days old).  The 
horizontal line at 1 indicates no change 
from normal development. Error bars 
represent standard deviation. 
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 When examining the difference between 3 and 10 days post injury, in mice injured at 7 
days old compared to those injured at 21 days old, there were no significant differences in 
collagen content.  
 
5.3.4 Proteoglycan Expression 
 Normalized biglycan and decorin contents were significantly increased in AT injured at 21 
days old between 3 and 10 days post injury.  When comparing across age at injury, at 10 days 
post injury, there was a significant increase in normalized biglycan and decorin contents between 
AT injured at 7 and 21 days old (Figure 5.12).   
 When examining the difference between 3 and 10 days post injury, mice injured at 21 
days old had a significant increase in both 
biglycan and decorin expression when 
compared to those injured at 7 days old. 
 
5.3.5 Histological Analysis 
 There was a marked increase in 
disorganization, rounded cell shape and cell 
number from 3 days to 10 days post injury in 
AT injured at 21 days (Figure 5.11; Figure 
5.12).  No appreciable differences were 
observed at 3 days post injury or in AT 
injured at 7 days old. 
 
5.3.6 Fibril Diameter Parameters 
 Ultrastructural observations demonstrated circular fibril profiles in all groups (Figure 
5.15).  For uninjured AT, fibril diameters were initially small and uniform as demonstrated during 
early development (Figure 5.16) and the distribution spread throughout growth to include larger 
fibrils as expected.  When examining the contralateral injured AT, a shift towards smaller fibrils 
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Figure 5.11: Collagen content showed no 
significant changes across any group. The 
horizontal line at 1 indicates no change from 
normal development. Error bars represent 
standard deviation. 
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was observed, particularly in fibrils approximately 40-60nm in diameter.  This shift is most evident 
in both ages at 10 days post injury, but prominent in AT injured at 7 days old.  These changes 
were demonstrated quantitatively by examining the average and standard deviation (Table 5.1).  
Specifically, both parameters were significantly decreased at 10 days post injury when compared 
to 3 days post injury in AT injured at 7 days old.  In AT injured at 21 days old, fibril diameter 
average  was significantly decreased between 3 and 10 days post injury whereas the standard 
deviation trended towards a decrease.  When comparing across age at injury, the average 
trended towards a decrease at 3 days post injury between AT injured at 7 and 21 days old. 
Alternatively, both parameters were significantly increased at 10 days post injury in AT injured at 
21 days old when compared to those at 7 days old. 
When examining the difference between 3 and 10 days post injury, mice injured at 7 days 
old had a significant decrease in both fibril diameter average and standard deviation when 
compared to those injured at 21 days old.  
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5.4 Discussion 
5.4.1. Interpretation of Results 
 The goal of this study was to characterize healing during two distinct stages of neonatal 
tendon development in a mouse Achilles tendon (AT).  Overall, it was demonstrated that AT 
Figure 5.12: Proteoglycan mRNA expression.  Increased expression was observed in late 
developmental injury, particularly at 10 days post injury. The horizontal line at 1 indicates no 
change from normal development. Error bars represent standard deviation. 
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injured at 7 days old had an accelerated healing response when compared to those injured at 21 
days old. 
 When evaluating tendons that were injured during early development (7 days old), there 
was an initial decrease (3 days post injury) in mechanical properties which was followed by a 
quick return to function after only 10 days.  This change in mechanics was accompanied by an 
initial increase in cross-sectional area which decreased back to uninjured values during the same 
period of time.  This is counter to previous studies done in adult tendons that demonstrate little to 
no improvement of the impaired mechanics post injury, particularly not during such a short time 
post injury [24, 25].  It has previously been shown that during development, the mouse AT 
showed an increase in mechanical properties, collagen content, and express biglycan and 
decorin[26].  After normalizing for these developmental changes in the current study, no further  
changes in any of these parameters were observed at 10 days post injury in early developmental 
healing.  Tendons during early development already have high cellularity, rounded cell shape and 
  
are in the process of producing collagen and proteoglycans in an organized fashion, all of which 
are common observations post injury. Therefore, it is possible that during early development, AT 
simply continue these processes after injury until the tendon has regained its age appropriate 
Figure 5.13: Representative histological images from each experimental group at 20x 
magnification. A marked increase in disorganization, rounded cell shape and cell number from 
3 days to 10 days post injury in AT injured at 21 days can be seen. 
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mechanical properties. The only parameters that remained altered at 10 days post injury were 
fibril diameter average and standard deviation, both of which were decreased.  It is possible that 
the AT recapitulated the mechanical properties quickly at this stage by increasing the number of 
small diameter fibrils.  All together, this data indicates that AT injured during early development 
may follow an accelerated healing process.   
 Conversely, when examining AT injured late during development (21 days old) it was 
initially observed  (3 days post injury) that little to no change from uninjured tendons had 
occurred, including cross-sectional area, mechanics, collagen content, collagen organization, fibril 
diameter parameters, cellularity, or cell shape.  However, when AT injured at 21 days old were 
examined at 10 days post injury, they had an increased cross-sectional area, decreased 
mechanical properties, increased proteoglycan expression, decreased collagen organization, 
decreased fibril diameter size and spread, increased cellularity and an increase in rounded cell 
shape.  These parameters combined are indicative of a normal adult reparative healing response 
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where cellular proliferation and extracellular matrix production are delayed for the initial 3 days 
post injury[27].   
 When examining across days post injury, it was observed that AT injured at 7 days old 
were significantly larger at 3 days post injury than those injured at 21 days old.  Mechanical 
properties on the other hand were significantly decreased in 7 days old mice.  While there were 
Figure 5.14: Median and interquartile range of histological parameters.  AT injured at 21 days 
old show marked increase in disorganization, rounded cell shape and cell number whereas 
AT injured at 7 days do not. Inj = Injured; Un = Uninjured 
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Figure 5.15: Representative micrographs for each experimental group. Fibril diameters were 
circular throughout developmental healing. 
no differences between injured and uninjured AT histologically, AT injured at 7 days old showed 
more disorganized collagen, increased cellularity and a more rounded cell shape than those 
injured at 21 days old.  No changes were seen in collagen content and proteoglycan expression.  
Conversely, when examining healing at 10 days post injury, it was observed that no change in 
cross-sectional area had occurred between injury at 7 and 21 days old and a decrease in the 
mechanical properties of AT injured at 21 days old compared to 7 days old was seen.  There was 
a significant increase in proteoglycan expression and no change in collagen content, collagen 
organization, cellularity or cell shape.  While the AT injured at 7 days old were almost back to 
normal uninjured values in all parameters measured, the AT injured at 21 days old were in the 
middle of the remodeling process.   
 When examining changes across time post injury through bootstrapping techniques, 
larger differences were shown between 3 and 10 days post injury in 7 days old mice than in 21 
days old mice, not to mention there were beneficial changes in 7 days old mice.  Alternatively, 
changes in 21 days old AT showed detrimental effects and were characteristic of the early stages 
of remodeling[27]. These results again demonstrate an accelerated healing process in AT injured  
at 7 days old while injury at 21 days old is more indicative of a classic healing response.  
 
116 
 In the current study, a return to normal tendon mechanics after only 10 days post injury 
without treatment, in a neonatal mouse AT was demonstrated for the first time. Previous studies 
have investigated changes in composition[28], gene expression[13], cell type[29, 30], 
structure[31] and mechanical parameters [25] during healing in adult tendons to better 
understand the healing process.  It is important to understand the natural mechanisms governing 
adult healing, because without this understanding, improvements upon normal adult healing 
cannot be effectively implemented.  However, injured adult tendons do not return to normal 
mechanics and therefore, discovering new strategies to improve mechanical properties may be 
difficult in an adult healing model.    Alternatively, during fetal healing, tendons heal scarlessly 
which is beneficial but are drastically different than adult tendons making application of fetal 
processes to an adult environment difficult [9].  Interestingly, in the current study, a fast return to 
normal mechanics is present during early neonatal development that is not demonstrated in either 
fetal or adult healing.  Not only has the current study demonstrated accelerated healing in early 
development, but it has also presented these findings in a mouse model.  The availability of 
genetically modified mice and commercially available assays makes the mouse an ideal model to 
study the mechanisms that govern recapitulation of mechanical properties.  A greater 
understanding of these mechanisms will lead to new techniques to improve adult healing.   
One possible mechanism for the return of mechanical parameters after only 10 days 
during early neonatal development is that the early neonatal tendon is able to continue normal 
developmental processes until the mechanical parameters return to normal. Prior to injury, cells 
during early neonatal development are already rounded, in high numbers and producing 
appropriate extracellular matrix. Therefore, this natural process may be the dominating 
mechanism during early developmental healing that is not present during either fetal development 
or maturity. 
 During normal tendon development, cell number decreases [32], extracellular matrix 
production increases and cells become more spindle shaped.   The cells are well aligned within 
collagen fibers, and cellular processes extend out from the main cell body that are thought to 
allow communication between cells.  The increased number of cells during development 
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compared to mature tendon indicates this communication is probably vital to the development of 
a normal tendon. While not examined in this study, it is hypothesized that strain experienced in 
one cell could be sensed at the cell junctions and initiate signaling cascades in response to 
mechanical stimuli.   In the current study, similar cellular changes continue during early 
developmental injury with only slight alterations.  During early development, the cells are already 
producing matrix, in an organized fashion, to increase mechanical parameters.  Injury during this 
period may cause a decrease in the stress and strain the cells experience locally, causing them 
to produce more matrix until an appropriate mechanical environment is reestablished. However, 
in late developmental injury, an increase in cellular number and a return to rounded cell shape 
was observed.  In this case, it appears the injury may have first initiated a cellular cascade of 
factors from broken cellular junctions, which led to cellular proliferation and migration.  Once 
enough cells were present then extracellular matrix production was resumed.  This response is 
indicative of a normal adult healing response. 
Figure 5.16: Histogram of uninjured and injured AT during neonatal development.  A shift towards 
small diameter fibrils and decreased spread can be seen in AT injured at 10 days post injury in 
both ages.   
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Age at 
Injury
Days post 
Injury
7 3 1.01 ±0.14ad 1.04 ±0.13a
7 10 0.52 ±0.13c 0.41 ±0.14c
21 3 0.91 ±0.09a 0.97 ±0.12b
21 10 0.83 ±0.10 0.88 ±0.13
a: significantly different than 10 days post injury; b: trend 
showing differences from 10 days post injury; c: significnatly 
different than injury at 21 days old (at same time point post 
injury); d: trend showing differences from injury at 21 days 
old (at same time point post injury).
Average     
(nm/nm)
Standard 
Deviation (nm/nm)
 One of the main differential responses between early and late developmental healing is 
the fibril diameter parameters.  Normally, fibrils are formed through fibrillogenesis which is a multi-
step process and each step is independently regulated during tendon development.  Collagen 
fibrils are initially assembled as immature fibril intermediates.  This is followed by linear and 
lateral growth of mature fibrils from the preformed intermediates, which initiates around 10 days 
old in weight bearing tendons in mice [33, 34].  Proteoglycans have been implicated as important 
regulators in this process. Structure function studies indicate complementary roles for decorin and 
biglycan in tendons and demonstrate that these fibrillar changes lead to altered mechanics[35].  
In the current study, little changes were seen in proteoglycan expression in early developmental 
healing and a large, significant increase was seen in late developmental healing.  Interestingly,   
                 a shift to smaller diameter fibrils in 
both early and late developmental 
healing was observed, although it 
is more pronounced during early 
development when the mechanics 
had been restored. It is possible 
that early developmental injury is 
simply accelerated (proteoglycan 
expression has already decreased 
and more small fibrils have already accumulated) than late injury (still see elevated proteoglycans 
and small fibrils are only starting to accumulate).  Alternatively, other mechanisms, not examined 
in this study, could be affecting fibrillogenesis, mechanics, or their interaction, thereby explaining 
the differential effect of small diameter fibrils being associated with both a decrease and increase 
in mechanics.   
 Differences between early and late neonatal healing, in particular fibril diameter 
parameters, could also be attributed to differences in collagen degradation and synthesis.  
Collagen, in general, has a slow turnover rate but this is altered during injury when 
Table 5.1: Normalized fibril diameter parameters, average 
and standard deviation.   
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metalloproteinases are activated.  It is unclear if MMP activation is beneficial or detrimental to the 
healing process or to what extent.  One possibility, in the current study, is that during early 
healing, the fibroblasts may continue to produce new collagen and lay it down in an organized 
fashion amongst the injured fibers.  This could account for the increase in small diameter fibrils 
present during early developmental healing; however, these fibrils could also be from MMP 
degradation.  On the other hand, late developmental healing may require more activation of 
MMPs to clear the injured area prior to scar formation.  Further studies need to be conducted to 
examine the role of MMPs during neonatal healing and whether the presence of small fibrils is 
due to de novo collagen synthesis or degraded collagen 
 Previous studies examining fibril diameter after injury have demonstrated a reduction in 
fibril average diameter and spread that does not return to normal even after extended time post 
injury [15, 36].  In a sheep model of posterior cruciate ligament auto graft reconstruction, even 
after 2 years, there was no evidence of the reestablishment of large diameter fibrils.  One 
explanation for all these previous studies could simply be that adult fibroblasts are not able to 
recapitulate neonatal fibrillogenesis.  However, a recent study was able to demonstrate the 
initiation of developmental fibrillogensis by adult human tendon fibroblasts when they were 
cultured under tension [37].  It was demonstrated that mature tendon fibroblasts have the intrinsic 
capacity to behave like cells in the developing tendon and suggests that the environment in 
developing and mature tendon determines mechanisms of fibril synthesis, deposition and 
alignment [38].  In the current study, a return to normal fibril parameters was not seen.  Future 
studies that examine longer time points post injury would be beneficial to see if fibril parameters 
do indeed return to normal after early developmental injury or whether these are permanently 
altered.  These observations in conjunction with the current study are promising because they 
indicate that if an early developmental neonatal environment is recreated in an adult injury, that 
the healing process can be accelerated. 
 Proteoglycan expression has been associated with many processes including normal 
tendon development and fibrosis.  During normal adult healing, biglycan levels are elevated and 
remain so[13] but decorin expression either does not change [14] or decreases [13]. Interestingly, 
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in the current study, differential expression of biglycan and decorin during either early or late 
developmental healing was not observed.  It appears that during early development, the 
proteoglycan expression does not change drastically from what is observed during normal 
development.  Therefore, it’s possible that despite the presence of an injury the tendon 
progresses through normal developmental stages of extracellular matrix deposition.  During late 
development however, there is an increased expression of both decorin and biglycan.  It has 
been proposed that an elevated level of biglycan could be attributed to the small fibril diameters 
and decreased mechanics post injury.  Decorin expression has been associated with scar 
formation and fibrosis [39, 40] but alternatively, there is also data suggesting that decorin 
decreases scar formation [41]. A previous study that examined proteoglycan expression in adult 
mouse patellar tendon showed an increase in only biglycan at 7 days post injury and not 
decorin[26]. Therefore, even though the same accelerated healing in late development was not 
seen, there are still mechanisms at play in late developmental healing that are different than 
those in adult injury.  It is possible that if a later time point post injury was investigated a full return 
of mechanical parameters may have been demonstrated.  Lastly, decorin and biglycan have been 
hypothesized to have a role in sequestering and storing growth factors.  An increased presence 
of proteoglycans may therefore store more cytokines, making them less available to the 
fibroblasts.  However, current laboratory techniques make differentiating between stored and 
active growth factors difficult to determine. 
 While the role of proteoglycans in fibrillogenesis is well defined, the direct role of 
proteoglycans in tensile and viscoelastic mechanical properties is relatively unknown.  It has been 
hypothesized that proteoglycans have a structure-function role through interconnecting 
neighboring fibrils [42-44], transferring forces between them [45, 46].  However, when comparing 
two inbred strains of mice, C57Bl/6 mice had a higher chondroitin sulfate/dermatan sulfate 
content but also had a lower elastic modulus, indicating that proteoglycans may negatively affect 
tendon strength.   In addition, two previous studies, one that examined tendons from a decorin 
knock out mouse [35] and one that blocked decorin during ligament healing [47], both 
demonstrated increased mechanical properties.  These results are consistent with those found in 
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the current study.  On the other hand flexor digitorum longus biglycan knockout tendons had a 
significantly lower modulus and maximum stress[35], contrary to results in this study.  However, 
the overall quantity of biglycan in tendons older than 7 days old is much less than that of decorin; 
therefore, the effect of increased decorin may overshadow the effect of biglycan.   
 
5.4.2 Limitation 
 Type I collagen is the major matrix component in tendon during development and 
healing, but type III collagen is also abundant in both of these processes [13]. Since type III 
collagen is a major component in scar it has been implicated in playing a role in reduced 
mechanics.  In the current study, differentiation between type I and type III collagen was not 
conducted.  It was initially hypothesized that overall collagen content would be increased in early 
developmental healing over late developmental healing and would also increase with days post 
injury in late developmental healing.  However, no changes in collagen content were shown with 
any comparison.  Since there were no observed changes in overall collagen content it would be 
interesting to determine if a differential expression in type I and III collagen occurs.  In addition, 
changes were not seen in collagen content, but there was a significant increase in cross-sectional 
area in AT injured at 7 days old at 3 days post injury. It is however important to note that the area 
of tendon analyzed for collagen content corresponded to the grip to grip mechanical testing 
without the uninjured struts being removed.  It is possible that the presence of this uninjured 
tissue may have hidden changes in hydroxyproline content in the injured region.  While collagen 
was not significant across groups, there was an increase in proteoglycans content above normal 
development in these groups.  Proteoglycan are negatively charged and therefore thought to bind 
water within tendon.  Therefore, collagen content was normalized by the dry weight of the tissue 
and changes in cross-sectional area were most likely due to the compositional changes 
mentioned. Future studies in this injury model will investigate the differential and temporal 
expression of types I and III collagen.   
  Data in the current study was presented as normalized data (injured/uninjured) to 
account for changes during development and isolate healing changes.  It is possible that the 
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decrease in mechanics seen at 10 days post injury during late development could have been 
caused by a natural increase in the mechanical properties in the uninjured contralateral tendons.  
However, an examination of the raw uninjured data showed only slight changes between 3 and 
10 days post injury that would not account for the decreases in mechanical parameters 
demonstrated in the injured tendons.  Therefore, the decrease in normalized mechanical 
parameters demonstrated at 10 days post injury in late development is an actual phenomenon 
and not a result of the normalization process.  It is also important to note that all standard 
deviations in the current study are from the normalized data.  Through examination of the raw 
mechanical data for uninjured and injured tendons, it was observed that there is larger variation 
within the injured groups as would be expected.  The standard deviation of the normalized 
parameters was subjectively similar to those seen in the injured parameters and therefore, the 
standard deviation was most likely not artificially reduced when data was normalized. 
  In the current study, no analysis of the integration of de novo tendon was conducted.  It is 
possible that differences in mechanical parameters between early and late developmental healing 
were due to the ability of the early developmental tendons to integrate newly produced matrix with 
preexisting extracellular matrix.  If this were true, the incidence of failure at the wound boundary 
in late developmental tendons would be higher; however, failure locations were evenly distributed 
across groups and included mainly midsubstance and stain line failure locations with fewer grip 
failures. 
  Previous in vivo studies have provided evidence that the inflammatory response to injury 
is altered with age.  Most notably, during scarless fetal healing these is a lack of inflammatory 
response that many have hypothesized could explain scarless healing [7, 48].  In neonates, the 
immune system is not fully mature which leads to differences in the cell subsets in the immune 
response between neonatal and adult [49].  This environment may provide an innocuous 
environment for the growth and development of neonates.  Therefore, one possible explanation 
for the results in this study could be due to differences in immune response and inflammation.  In 
fact, previous work has shown that although healing follows the same trajectory, wounds in 
neonates heal faster than those of adults.  Fibroblasts are present in greater numbers, collagen 
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and elastin are more rapidly produced, and granulation tissue forms more quickly compared to 
adults [50]. Future work in this model will include an investigation into the influx of inflammatory 
cells and the expression of pro-inflammatory and anti-inflammatory cytokines.  This will provide 
further insight into the mechanisms behind the accelerated healing observed in early 
development. 
 Another important aspect of healing is nutrient supply or vascularity.  Tendons are 
hypothesized to have poor healing parameters due to a lack of vascularity. Therefore, increased 
vascularity during early developmental healing could have contributed to improved healing.  While 
histological slides are available to examine vascularity, AT were sectioned through the sagittal 
plain which made identification of vasculature difficult and inconsistent across slides.  Future 
studies could also examine transverse sections for easy identification of vascularture during early 
and late developmental healing. 
 Tendon healing has been studied in many animal models, of which overuse and acute 
injuries are the most common.  Acute models create a complete or partial transection in the 
tendon.  While complete transections are more clinically relevant, the need for suture repair 
complicates the healing environment.  Specifically, when several external factors of surgery were 
studied, suture alone reduced viability, extended the zone of regeneration and had the most 
adverse effect on tendon [51].  In addition, reruptures from suture pull out are common.  Partial 
transections in the middle or along the side of the tendon circumvent the need for repair by 
leaving intact marginal fibers[52].  The injury used in this study is a central, full thickness, partial 
width injury that leaves the lateral struts intact.  This is of particular importance in neonatal mice 
since the small size and fragile nature of the tendon would likely not hold a suture.  A 50% width 
injury was used because previous work in a similar injury model in the adult mouse patellar 
tendon showed only 8% rupture rate in 50% width injuries and a 50% in vivo rupture rate in large 
injuries. In addition, the partial width full thickness injury ensures that differences observed in the 
model are due to differences in innate healing of the tendon and not inflammation from the suture. 
 Despite the advantages in this injury model, there are some disadvantages.  Most 
notably, the uninjured lateral struts on either side of the injury could stress shield the injured 
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tissue in the middle.  If tensile stress is experienced uniformly across the tendon, the injured area 
will be stress protected.  Thus, in vivo stress levels experienced by the injured part of the tendon 
could be substantially less than the uninjured portion.  This could explain the inability of the 
collagen fibrils to regain normal average diameter and spread.  However, the inability of fibrils to 
regain a large distribution and bimodality [25] is well documented in numerous injury models and 
therefore it is unlikely that stress shielding was the main factor in the current study.  In addition, 
the full thickness, partial width injury necessitated the removal of the uninjured struts on either 
side of the injury prior to mechanical testing to ensure only healing tendon was mechanically 
tested. While this procedure ensured the mechanical parameters measured were only healing 
tissue, it did not allow the measurement of structural mechanical parameters, only material.     
 In the current study, comparisons were subjectively made to adult tendon healing but no 
adult tendons were included in the study design.  The objective of the current study was to 
examine healing during development and already required 288 mice.  The addition of a third age, 
which was not part of the study hypotheses, would have added an additional 144 mice to the 
experimental design, substantially increasing the size of the experiment and associated costs. 
Previous studies have already examined most of the parameters examined in this study in adult 
healing, and a current study in our laboratory is currently examining injury in adult mouse AT.  
Therefore, based on previous knowledge available, adult mice were not included in the current 
study. 
 Each litter in the current study was initially weaned to 6 pups and care was taken that no 
more than one pup from each litter was placed in the same experimental group.  By designing the 
study in this fashion, a single litter could be considered a specimen where each assay was 
represented by one pup in that litter [17].  The main advantage to this approach is that it allows 
analysis by multiple regression and decreases variance within a specimen since pups in the 
same litter will tend to be more similar than those in different litters (Harlan Sprague Dawley, Inc.; 
Indianapolis, Indiana).  However, it is possible that differences amongst pups within a litter are 
large enough to mask correlations between structure, composition and biomechanics.  Despite 
this, there is confidence that the changes in development will not be masked by a litter effect.  In 
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addition, both male and female mice were used in this study.  While there is little information on 
sex differences at the ages studied, work presented in Chapter 4 and a previous study[53] 
demonstrate that there are no sex differences in mechanics, composition and structure at the 
ages examined.   
 In this study changes in collagen organization were demonstrated through three blinded 
graders instead of measuring angular deviation through polarized light microscopy.  Polarized 
light microscopy was attempted in these experimental mice; however, within the wound site of the 
AT injured at 7 days old, there was not enough mature collagen for birefringence.  Evaluation at 
longer time points post injury can be used in future studies to determine quantitative differences 
in collagen organization. 
 When obtaining fibril diameter parameters, spatial variability is always a concern and 
therefore sampling presents inherent problems.  This is the precise reason why in this study each 
AT was sampled not only in the midsubstance of the injury but also along the width.  The 
sampling pattern utilized in this study was chosen to ensure an objective measure of the fibril 
diameters within the wound area of the AT.   
 
5.4.3. Summary 
 In summary, two different models of healing during neonatal development, early and late, 
in a mouse model were characterized.  Overall, it was demonstrated that AT injured at 7 days old 
(early) had an accelerated healing response when compared to those injured at 21 days old 
(late).  In particular, during early development, a significant decrease in mechanical parameters 
was observed at 3 days post injury along with increased cross-sectional area, no change in 
proteoglycans or collagen content or cell shape, number or fiber organization.  By 10 days post 
injury, the mechanical properties has returned to almost normal levels and the only parameter 
that  demonstrated a difference from normal were fibril diameter parameters which have become 
smaller with a decreased spread.  On the other hand, in AT injured at 21 days old (late), little to 
no changes were seen at 3 days post injury including mechanical parameters, cross-sectional 
area, collagen content, fibril diameter average and cell shape, number and fiber organization.  At 
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10 days post injury however, a reduction in mechanical properties was observed along with a 
significant increase in cross-sectional area, proteoglycans expression, fibril diameter average, cell 
number and an increase in rounded cells and disorganized collagen fibers.  All together these 
observations indicate that healing during development either has unique mechanisms or has an 
accelerated healing process.  Either way, early developmental healing provides a model system 
where mechanical properties were quickly recapitulated and can therefore be used to investigate 
new methods for improved adult healing. 
Another important aspect of this study is the use of a mouse model.  The mouse model 
has historically presented logistical complications due to the small size and fragile nature of the 
neonatal mouse tendons; however, this study utilizes consistent, reproducible methods to study 
neonatal healing in a mouse.  A mouse model can be used further to investigate the differential 
mechanisms in these processes through genetically modified mice and commercially available 
assays.   
Lastly, the model presented here was specifically developed to obtain quantitative 
measures when possible.  Quantitative measures can then be input into rigorous statistical 
models to objectively determine which structural and compositional parameters have a significant 
effect on the mechanical parameters.  This information can then be used to develop new 
treatments and strategies for improved adult tendon healing.   
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Chapter 6:  Investigating structure-function relationships in neonatal Achilles tendon 
development and healing in a mouse model using multiple regression models. 
 
6.1 Introduction 
6.1.1 Significance 
 Tendon injuries are a common problem due to their inability to regenerate and the 
prolonged presence of scar tissue.  While there have been significant advances in surgical 
techniques and post operative protocols [1, 2], there is also the potential for biological advances. 
Current strategies for identifying areas for improved tendon healing include using scarless fetal 
healing as a paradigm and gaining in depth knowledge of the reparative healing process during 
adult healing [3, 4].  During fetal healing, tendons are capable of returning to histologically 
uninjured states; however, many differences exist between fetal and adult healing, mechanical 
load environment and inflammation, which can not be easily altered in the adult injury [4].  
Gaining insight into adult healing is important to understand the mechanisms at play during the 
reparative process; however, studying adult healing only shows what is presently occurring, not 
what needs to occur for improved tendon healing.  Chapter 5 in this dissertation characterized 
healing during two stages of neonatal development.  Interestingly, a return to mechanical 
properties only 10 days post injury was observed during early neonatal development.  Therefore, 
healing during early neonatal development is a new model system through which to study 
improved healing in adult tendons and the recapitulation of mechanical properties. 
 
6.1.2 Correlating compositional and structural parameters to mechanics 
Tendons are complex tissues whose mechanical behavior depends on their structural 
organization and biochemical composition, as well as on their location and function within the 
body.  It has long been hypothesized that the structure and composition of tendons are a result of 
the specific function tendons perform [5].  Tendon is composed mainly of type I collagen which 
organizes into aligned fibrils and fibers.  It is believed that these aligned fibers bear the main 
tensile loads that tendons experience in vivo.  Proteoglycans are also present in tendon and, 
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while they are a minor constituent, it has been hypothesized that they also play a significant role 
in mechanics [6, 7].  Specifically, it is has been documented that proteoglycans play a role in 
resisting compression [8] but it has also been hypothesized that they bridge the gap between 
neighboring fibers, providing shear resistance within the tendon. Based on these facts and 
assumptions, previous studies have used numerous methods to measure compositional and 
structural parameters and correlate them to mechanical behavior.  
Previous studies have provided insight into the complex interplay of a tendon’s 
constituents, which is critical to formalizing structure-function relationships [9-12]. For example, 
collagen fibril cross-sectional area fraction explained more than half of the changes in mechanical 
properties of mature to aged tendons through linear regression [10].   Interestingly, the addition of 
data from younger tendons to this study improved the regression model, thereby supporting the 
need for further structure-function analyses of younger, developing tendons.  In addition, 
chondroitin sulfate and dermatan sulfate, main components of proteoglycans, were significant 
predictors of mechanical parameters in a mouse model [11]. While these studies have made 
significant contributions to understanding the structure-function relationships in tendon, there are 
still areas that should be further investigated. For example, one previous study found significant 
correlations between compositional and structural parameters with mechanics, however, the 
models only accounted for approximately 50-70% of the variance[11].  Studies using new 
experimental techniques or different independent parameters may better predict mechanical 
parameters. 
 While many studies have demonstrated that fibril diameter size is correlated with tendon 
mechanics in normal tendons, similar relationships have not been shown in healing tendons. A 
study in the healing MCL of rabbits demonstrated that while the injured ligament increased in 
mechanical strength to 2/3 the control tendon at 40 weeks, the mean fibril diameter remained 
smaller than controls and did not increase over the same time period [13].  An extended study in 
the same model showed that the mean fibril diameter did not change up to 104 weeks post injury; 
however, it was noted that there was an increased proportion of very small fibrils along with large 
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fibrils, creating an increased spread in fibril diameter size [14].  This finding indicates that fibril 
diameter spread may be as important as the average to correlate with mechanics.    
 
6.1.3 Multiple regression models 
Regression models provide a statistical relationship between a dependent (response) 
variable and an independent (predictor) variable. Such a model describes the tendency of the 
dependent variable to vary with the independent variable. A multiple regression model allows 
evaluation of the relationship between a dependent variable and several independent variables 
simultaneously. By regressing independent compositional and structural parameters against 
dependent mechanical parameters, the level of contribution of each of the compositional and 
structural parameters on mechanical properties can be determined while simultaneously 
incorporating the effect of the presence of all the independent parameters. This data will aid in 
determining the importance of each of the independent compositional and structural parameters 
in the development and recapitulation of mechanical properties in tendon. Therefore, the 
objective of this study is to use rigorous statistical models to objectively and quantitatively 
compare and contrast not only early and late healing with each other but also with normal 
development to determine which parameters are beneficial or detrimental to the development of 
mechanical properties.  This will be conducted by regressing the independent parameters 
collagen, biglycan and decorin content and fibril diameter average and standard deviation against 
the dependent mechanical parameters percent relaxation, stress and modulus.  It was first 
hypothesized that that collagen content would be a significant predictor in all groups.  Second, it 
was hypothesized that fibril diameter spread will be a significant predictor for maximum stress 
and modulus in late development and late stages of healing; however, it will be a stronger 
predictor in injury during early development than in injury during late development. Lastly, it was 
hypothesized that biglycan and decorin will both be significant predictors of maximum stress and 
modulus; however biglycan will predict decreased mechanics and decorin will predict increased 
mechanics. 
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6.2 Methods and Materials 
6.2.1 Data collection 
 Data collected in Chapter 5 of this dissertation will be used in the regression analysis 
presented here. An a priori power analysis to determine the sample size for multiple regression 
analysis was calculated based on 5 predictors (total collagen content, fibril diameter mean and 
standard deviation, biglycan and decorin content), an alpha set at 0.05, an anticipated R-squared 
of 0.8 and a desired statistical power of 0.8. Therefore, calculating the sample size for multiple 
regression based on these expectations[15] an n of eleven is needed for each group in this study.   
Multiple regression analysis assumes that each dependent variable and the independent 
variables are obtained from a single specimen.  Therefore, in this study, five distinct and 
reproducible injuries are needed, one for each of the following assays: biomechanics (maximum 
stress, modulus, and percent relaxation), histology (angular deviation), transmission electron 
microscopy (fibril diameter size distribution), biochemistry (total collagen content) and QPCR 
(biglycan and decorin mRNA expression).  For this study design, it was assumed that a litter of 
pups was a single specimen [16].  All litters were weaned to 6 pups to account for experimental 
error.  Not only does this approach allow analysis by multiple regression, but it also decreases 
variance within a specimen since pups in the same litter will tend to be more similar than those in 
different litters (Harlan Sprague Dawley, Inc.; Indianapolis, Indiana).       
 The experimental methods used for this study have been discussed in detail in Chapter 
5. Briefly, neonatal mice were unilaterally injured at both 7 and 21 days old and allowed to heal 
for 3 or 10 days post injury.  Chapter 5 details the methods used to quantify collagen content 
through hydroxyproline analysis, biglycan and decorin through mRNA analysis, fibril diameter 
mean and standard deviation through TEM analysis and mechanical parameters percent 
relaxation, stress and modulus through uniaxial mechanical testing.  These measurements were 
taken for both the injured and contralateral uninjured Achilles tendon for each mouse.  In the 
cases where missing values were observed in a specimen, imputation was conducted using the 
regression method[17].  Lastly, the data was examined for outliers and each group was found to 
have one specimen as an outlier; therefore, each group had a total of 11 specimen. 
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6.2.2 Statistical Models 
 When dealing with large data sets, several experimental groups, multiple variables, and 
interactions, it is important to obtain a thorough understanding of how all these parameters relate 
to and interact with each other.  There are numerous statistical methods that can be employed to 
answer specific questions about the interactions and relationships within the data.  Pearsons 
correlations are an effective statistical test to determine if dependent parameters are linearly 
correlated.  This is important because one of the underlying assumptions of statistical analyses in 
general, is that independent parameters are linearly independent of each other.  When dealing 
with biologic parameters it is often impossible to obtain independent parameters with no 
collinearlity; however, it is still important to understand this correlation when analyzing the data. 
A general linear model (GLM) can estimate and test any univariate or multivariate model, 
including those for analysis of variance and multiple regression.  A GLM is useful because it can 
also handle continuous and categorical parameters and complex model designs.  A GLM can be 
used to determine what significant relationships exist between independent parameters and 
experimental groups with the dependent parameters through an analysis of variance. If there are 
significant relationships, further analysis can be conducted. 
Regression models provide a statistical relationship between a response (dependent) 
variable and a predictor (independent) variable. In a study with multiple groups and several 
independent variables, multiple different regression models could be analyzed.  It is important to 
use information obtained from analysis of the entire data set, along with scientific knowledge of 
the experimental design and hypotheses, to determine the most appropriate final regression 
models.  Initially in this study, a multiple linear regression was used to create a model of the 
entire data set.  However, when the number of independent variables in the regression model is 
large, the potential number of interaction terms becomes very large.  It is therefore appropriate to 
identify, in advance, which independent parameters are more likely to predict the dependent 
variables [18]. Upon obtaining which main effects and interactions should be included, the overall 
model can be examined.  While it is important to understand how the experimental groups affect 
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the dependent parameters, the presence of many highly intercorrelated variables may 
substantially increase the sampling variation of the regression coefficients, detract from the 
model’s descriptive abilities, and not improve, or even worsen the model’s predictive ability [19].   
Therefore, these effects, along with the stated hypotheses, need to be taken  into account when 
formulating the final regression equations. 
 By analyzing a data set through multiple statistical methods, a clear understanding of the 
relationships and interactions between the variables is obtained.  In addition, starting a regression 
analysis with the entire data set and systematically delineating it into appropriate groups clarifies 
the relationships that are present within the data.  Below is a detailed summary of the statistical 
analyses conducted in this study. 
   
6.2.3 General Linear Model 
 Summary statistics of all variables were examined and described by mean, median, 
standard deviation, minimum and maximum to ensure that assumptions necessary for linear 
analysis were met.    A GLM was run to determine if the dependant variables (percent relaxation, 
stress and modulus) were significantly related to the independent parameters: continuous 
(collagen content (Col), biglycan (Big) and decorin (Dec) content, fibril diameter average (Ave) 
and standard deviation (StDev)) and categorical parameters and interactions (age at injury (Age), 
days post injury (Days), injured or uninjured (Injury)).  For all specimens, the percent relaxation, 
stress and modulus was calculated for the injured and uninjured tendon. This resulted in a total of 
96 y-values inputted in the GLM for Equation 6.1, where Y1-Y3 were percent relaxation, stress 
and modulus respectively. 
Equation 6.1: 
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Upon determining that there are significant effects from the continuous and categorical 
parameters on the mechanical properties, an analysis of how the dependent parameters vary with 
the independent parameters can be conducted. 
 
6.2.5 Model Refinement  
To identify important interactions, the mechanical parameters were regressed against the 
continuous and categorical independent parameters, along with the interactions between the 
categorical parameters (Equation 6.2).  In a regression model, the slope and intercept of the 
equation are influenced by the independent parameters by adding interaction terms.  For 
instance, by including the interaction term age at injury*days post injury (Age*Days) the effect of 
days post injury may present different responses in mice injured at 7 days verses those injured at 
21.  Information obtained in Chapter 5, namely significant difference between groups, provides 
support for including these interaction terms in this first regression model.   
A backward stepwise regression was used to find the independent parameters that “best” 
predicted the dependent parameters.  For this method, a simple linear regression model is first fit 
for each of the potential independent variables.  For each simple linear regression model, a p-
value of 0.1 was used to determine whether or not an independent variable was removed from 
the regression equation. A p value of 0.10 was used for this model due to the larger number of 
independent variables being regressed against the dependent variables.  The X variable with the 
largest p-value (p*) is identified and compared to a predetermined value of p to enter. If p* is less 
than p then the variable is added to the regression model, and the analysis is repeated for the 
additional independent variables. If p* exceeds the p to enter, the stepwise analysis terminates. 
After each independent variable is added, the analysis is repeated for all variables with revised 
model. p* is calculated for the previously included variables, and compared to a predetermined 
value of p to leave. If p* falls above this predetermined value of p, the variable is removed from 
the model. The tolerance level was set at 0.01. This regression model was used to determine if 
some of the main effects or interactions could be excluded from the regression equation for the 
entire model.  The reasoning for this is that the equation for the entire model will have very low 
  
139 
power due to the number of interaction terms.  By determining which main effects and 
interactions are not significant in this model, the overall model can exclude these effects, thereby 
increasing power. 
Equation 6.2: 
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Upon determining which main categorical effects and interactions were significant, a 
regression analysis for the entire model was performed including only those categorical 
parameters.  Similar steps were taken as described above.  Due to the number of independent 
terms in the model, which decreases the power, the p value was set to 0.1 and the tolerance level 
was reduced to 0.001. Backwards stepwise linear regression was performed on Equation 6.3.  
This analysis gives an overall understanding of how the mechanical parameters vary within the 
frame work of the entire study. If there are significant effects of the categorical parameters, then 
the data can be broken down into experimental groups for further analysis by multiple 
regression[20]. 
 
6.2.6 Final Multiple Regression Models 
After running the entire model, many significant predictors were found including main categorical 
effects and categorical interactions.  Since the hypotheses of this study are to analyze how the 
mechanical parameters vary with the structural and compositional parameters within each 
experimental group, and due to the high number of categorical interaction terms, the data will be 
split into experimental groups. Therefore, the final multiple linear regression models will quantify 
the relationship between the dependent variables (percent relaxation, stress and modulus) and 
the continuous independent variables (collagen content, fibril diameter mean and standard 
deviation, biglycan and decorin content) (Equation 6.4) within each experimental group [19].  The 
data was delineated into 8 categories based on age at injury (7 and 21 days old), days post injury 
(3 and10 days post injury) and injured or uninjured (I, U). This resulted in a total of 11 y-values 
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Equation 6.3:  
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inputted in the linear regression for equations 6.4, where Y1-Y3 were percent relaxation, stress 
and modulus respectively.  In this method, a simple linear regression model is first fit for each of 
the potential independent variables. For each simple linear regression model, that partial F 
statistic (F*) is calculated to determine whether or not the slope is zero. The X variable with the 
largest F* is identified and compared to a predetermined value of F to enter. If F* exceeds F then 
the variable is added to the regression model, and the analysis is repeated for the additional 
independent variables. If F* does not exceed the F to enter, the stepwise analysis terminates. 
After each independent variable is added, the analysis is repeated for all variables with revised 
model. F* is calculated for the previously included variables, and compared to a predetermined 
value of F to leave. If F* falls below this predetermined value of F, the variable is removed from 
the model. The tolerance level was set at 0.01. The F to enter was set at 3.3 and F to be removed 
was set at 3.2. The criteria for choosing the appropriate range of F to enter and F to remove is 
based on the degrees of freedom in the model. For this model, this range for F corresponds to a 
significance level of 0.1 for a single test. Tolerance is defined as 1-R
2
k  
is the coefficient of 
multiple determination the X
k 
is regressed over the other included x variables in the model. A 
tolerance of 0.01 would mean that a variable is excluded if its coefficient of multiple determination 
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when it is regressed over the other x-variables exceeds 0.99. Typical values for tolerance level 
range between 0.01 and 0.001. This is one measure to prevent entry of variables that are highly 
correlated with other x-variables included in the model. Significance was again set at p < 0.1, this 
time due to the small sample size (n=11) per regression model and variances within the data.  
Equations 6.4       StDevAveDecBigColYi 543210 bbbbbb +++++=  
 
 Durbin Watson (DW) statistic was calculated to identify the existence of correlations 
between independent variables. For each equation 6.4 (n=11/group), based on established 
guidelines for interpretation of DW statistic , a DW value lower than 1.08 indicated correlation 
between the independent variables[21]. 
 
6.3 Results 
6.3.1 Correlations between the independent parameters 
 The Pearson correlation coefficients (r) showed some relationships between the 
independent variables.  Correlations were determined between independent variables within each 
group.  Correlations were considered strong for r<0.7, moderate for 0.5<r<0.7 and weak for r<0.5 
[22].  In the 8 experimental groups examined fibril diameter average was correlated to fibril 
diameter standard deviation moderately in 2 groups and strongly in 3 groups.  Similarly, decorin 
and biglycan were moderately correlated in 3 groups and strongly correlated in 3 groups.  Finally, 
collagen content and fibril diameter average were moderately correlated in 3 groups (see 
Appendix 6.1 for all Pearson correlations). 
   
6.3.2 General Linear Model 
 A general linear model was conducted on the data for this study to determine how the 
dependant variables were related to all the independent variables including the continuous 
structural and compositional parameters and the categorical parameters (age at injury, days post 
injury and injury).  Importantly, this model showed that the interaction terms Days*Age and 
Days*Age*Injury both had a significant effect on all the mechanical parameters.  In addition, injury 
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had a significant effect on stress and modulus.  Therefore, this analysis states that the 
mechanical parameters are highly dependent on the all three categorical parameters, age at 
injury, days post injury and injury.  This provides support to further analyze this data through 
regression analysis. 
 
6.3.3 Whole Model Analysis - Backward Stepwise Linear Regression Model 
 To further understand the relationships present in the entire data set, two sets of linear 
regression models were developed that included all the data.  First, the continuous independent 
parameters and categorical main effects and interactions were examined against the dependant 
parameters.   Equations 6.5-6.7 below show the results of this analysis: 
Equation 6.5: 
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Equation 6.6: 
)**(*75.2
)*(*27.1)*(*5.4*44.2*44.0Re
InjuryDaysAge
InjuryDaysDaysAgeInjuryStDevlaxPerc
+
+-+=
 
Equation 6.7:  
)**(*78.8
)*(*71.16*22.27*87.22*00.1
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 From this analysis it can see that days post injury (Days) and the interaction term 
Injury*Age do not contribute to the overall prediction of the mechanical parameters.  Therefore, 
when developing a linear regression model that includes all the interactions, these parameters 
can be excluded.  This method helps to increase the overall power of the entire regression 
analysis. 
 Now that a clearer idea of which parameters are predictive has been determined, a full 
model with all the interactions was conducted (Equation 6.3) where Y1-Y3 are percent relaxation, 
stress and modulus respectively. 
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 Results of this analysis showed not only predictive effects from the main parameters but 
also from many of the interactions, including interactions with Age, Days and Injury (See 
Appendix 6.2).  Due to the complexity of interpreting these equations and the stated hypotheses 
of the study, the data will be separated into experimental groups (age, days, injury).   A clearer 
understanding of how the structural and compositional parameters affect the mechanics, without 
the confounding effects of the age, days and injury, will therefore be obtained. 
 
6.3.4 Grouped Analysis – Backward Stepwise Linear Regression Analysis 
 For this analysis, data was grouped according to age at injury (7, 10 days old), days post 
injury (3, 10 days post injury) and whether or not the tendon was injured or uninjured.  This 
resulted in 8 categories with 3 regression equations for each (percent relaxation, stress and 
modulus) for a total of 24 equations (Figure 6.1).  See Appendix 6.3 for a summary of the 
complete results of all 24 equations.  Presented here are the results of the significant models. 
(Equations 6.8-6.20).  None of the models presented below had a Durban-Watson score lower 
than 1.08. 
  
6.4 Discussion 
6.4.1 Interpretation of Results 
 This study employed a neonatal healing model in a mouse to study the structure-function 
relationships in tendon development and healing.  A unilateral injury was created in developing 
neonatal Achilles tendons at two ages (7 and 21 days old) and held out to two time points post 
injury (3 and 10 days post injury).  The uninjured and injured Achilles tendons were then assayed 
for mechanical parameters (percent relaxation, stress and modulus), compositional parameters 
(collagen, biglycan and decorin content) and structural parameters (fibril diameter average and 
standard deviation).  The compositional and structural parameters measured were then used as 
independent variables in multiple regression models to predict mechanical properties, the 
dependent variables.  Briefly, proteoglycans were shown to be significant predictors of modulus 
during early developmental healing but not during late developmental healing or normal 
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Eq. # Linear Regression Equation Model p Model R2
8 0.04 0.57
9 0.07 0.30
10 0.01 0.50
11 0.01 0.50
12 0.08 0.60
13 0.05 0.65
14 0.03 0.59
15 0.05 0.50
16 0.06 0.50
17 0.01 0.57
18 0.00 0.77
19 0.06 0.34
20 0.04 0.39
AveCollaxPerc U *77.0*12.04.18Re ,3,7 +-=
DeclaxPerc U *14.2880.70Re ,10,7 -=
CollaxPerc U *06.000.78Re ,3,21 -=
AveStress U *38.081.47,3,21 -=
StDevAveBigModulus U *62.16*76.8*52.25526.478 4,3,21 +--=
AveBigCollaxPerc U *57.0*84.60*03.014.136Re ,10,21 ---=
StDevAveModulus U *75.6*66.394.39 4,10,21 -+-=
StDevAvelaxPerc I *75.2*05.114.54Re ,3,7 +-=
DecBigModulus I *00.3*62.465.14,3,7 +-=
StDevlaxPerc I *25.154.40Re ,10,7 +=
DecBigMod I *35.66*2.1027.31,10,7 -+=
AveStress I *23.010.29,3,21 -=
AveModulus I *19.35.370,3,21 -=
development.  Multiple independent parameters predicted percent relaxation during normal 
development, however, only biglycan and fibril diameter parameters predicted percent relaxation 
during early developmental healing.  Last, multiple differential predictors were observed between 
early development and early developmental healing, however, no differential predictors were 
observed between late development and late developmental healing.    
To date, the viscoelastic parameter stress relaxation has not been regressed against 
compositional and structural parameters in tendon.  Proteoglycans and water, along with the 
inherent viscoelasticity of the collagen itself, are thought to be primarily responsible for 
viscoelastic behavior [23, 24]. In the current study, collagen content is a predictor of percent 
relaxation in three of the four uninjured developmental equations.  In addition, both proteoglycans 
are predictors in one equation each while fibril diameter average is a predictor in two.  
Throughout development collagen content increases and small, discontinuous fibril intermediates 
are longitudinally fused to form continuous fibrils and laterally fused to produce larger diameter 
fibrils [25].  It has been proposed that small, uniform fibrils contribute to viscoelastic parameters 
due to possible discontinuity thereby allowing sliding between the fibrils.  The presence of 
collagen and fibril diameter average as predictors for percent relaxation throughout development 
supports this hypothesis.  Proteoglycans are negatively charged, hold water in the tendon and 
therefore, are hypothesized to have an effect on viscoelastic parameters [26], which is also 
supported in this study.  Surprisingly, only fibril diameter average and standard deviation are 
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significant predictor of percent relaxation during healing.  This may be due to increased 
discontinuity of fibrils in the injured tendon.   Future studies will further investigate the differential 
mechanisms behind viscoelastic parameters during normal development and developmental 
healing.   
When examining the elastic parameter modulus during early develop and healing, 
significant predictors, decorin and biglycan, were demonstrated only in healing tendon, with no 
significant predictors for uninjured development.  It has been previously hypothesized that 
collagen bears the main load in elastic tensile mechanics; however, these results are not 
surprising as chondroitin sulfate and dermatan sulfate have previously been demonstrated to 
significantly predict elastic mechanical parameters in a mouse model[11].  It is important to point 
out that in Chapter 5 the same experimental group demonstrated an accelerated healing 
response with a return of mechanical function.  This could therefore indicate that increased 
proteoglycan expression is beneficial during healing.  Further investigation into the role of the 
proteoglycans in this model could lead to new treatments for improved healing in adult injury.   
Interestingly, no changes were seen in any group for maximum stress.  During 
development, tendon fibroblasts must ensure that the tendon is growing and functionally strong 
enough to accommodate an increasing body size.  It is hypothesized that the mechanical 
parameters most important for function are toe region and linear region parameter, for example, 
modulus.  In particular, during development, tendons rarely experience stresses that would cause 
tendon rupture (maximum stress). Therefore, it is possible that in the healing tendon, resources 
were allocated to regaining function (modulus) over failure properties (maximum stress).   
In Chapter 5, an accelerated healing response was observed during early development 
that was not seen in late developmental.  Interestingly, 4 out of the 6 possible early 
developmental healing equations had significant predictors and only 2 out of the 6 had significant 
predictors during late developmental healing.  In addition, the predictors in late developmental 
healing were also present in normal development in comparable groups, indicating that these 
predictors may simply be an effect of developmental growth and not healing.  One possible 
explanation for these observations is that the healing response during late development is slower; 
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therefore, the parameters that were measured may not have had enough time to affect the 
mechanics.  In addition, there may be other factors, not measured in the current study, that better 
predict healing during late development. 
In this study, specific compositional and structural parameters were chosen that were 
hypothesized to predict mechanical parameters during development.  Collagen content was 
chosen as it is the main constituent of tendon; however, it may have been more beneficial to 
analyze type I, III, V, XII and XIV collagens throughout development and healing as they each are 
shown to have an effect on fibril growth.  In particular, type III and type V collagen are associated 
with early stages of tendon development and injury [27, 28]. On the other hand, as stated in 
Chapter 3, type XII and XIV collagens play a role in fibrillogenesis during development and type 
XIV collagen has a differential effect on mechanical parameters during development and maturity.  
It was important in this study to obtain quantitative information on each compositional measure 
from an individual neonatal tendon; therefore, it was unfortunately technically not possible to 
separate each collagen type in this study.  Elastin is also a major component of tendon which is 
believed to affect mechanical parameters and increases during development.  It also however is 
present in relatively small quantities and would have been difficult to measure quantitatively in 
individual tendons.  In addition to collagen, the proteoglycans decorin and biglycan were 
examined in the current study.  Decorin and biglycan were chosen because they are the most 
abundant proteoglycans in tendon and are thought to be differentially regulated.  In addition, they 
play a role in fibrillogenesis and possibly mechanical development.  Other proteoglycans are 
thought to have similar roles including lumican and fibromodulin.  Knockout mice studies have 
shown altered fibrillogenesis in these mice which also led to altered mechanics during 
development.  While each proteoglycan present in tendon may play a role in mechanical 
development and injury, decorin and biglycan were chosen based on abundance and the 
possibility of obtaining protein content (mRNA content was obtained in this study, this limitation 
was discussed in Chapter 4).  Lastly, collagen cross-links have been extensively studied in soft-
tissue development and are thought to prevent fiber sliding.  A previous study correlated an 
increase in collage cross-links with tensile mechanical strength in cartilage [29].  However, 
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current methods for measuring cross-links can depend on the concentration of the cross-links and 
may therefore be inaccurate.  
Tendon is a hierarchical structure and there is much debate as to which hierarchical level 
contributes the most to tendon mechanics.  At the smallest structural level, bonds which are 
reversible between fibrils and fibril associated molecules, are thought to be integral in the 
mechanical integrity of a tissue.  Some of these fibril associated molecules include decorin and 
biglycan, which lends further support to including them in this study.  It has long been 
hypothesized that fibril diameter is an important mechanical predictor since fibril diameter 
increases throughout development concurrently with mechanics.  Some studies have shown 
correlations between fibril diameter parameters and mechanics, but fibril diameter average was 
not able to account for most changes in mechanics post injury in the current study.  At the next 
level, some studies have suggested that fiber sliding is one of the main causes of stress-
relaxation in tendon [30].  Lastly, others have argued that examining a whole fascicle provides a 
“homogonous” section of tendons to be studied.  In the current study, fibril diameter parameters 
were chosen based on past correlations during development and the hypothesis that fibril 
diameter spread would be an important predictor during healing.  Fiber organization was 
examined during normal development but could not be examined during healing due to lack of 
mature fibers.  It would have been advantageous to examine fiber sliding during stress-relaxation 
and ramp to failure in the current study, but extensive preparation and manipulation for this 
measurement may have altered the mechanical parameters of the neonatal Achilles tendon.  
Lastly, in order to maintain appropriate power for the regression analysis, the number of 
independent parameters had to remain low (5).  Therefore, for the reasons stated above, total 
collagen content, biglycan and decorin expression, and fibril diameter average and standard 
deviation were chosen for this study. 
Multiple statistical analyses were conducted in this study to gain a thorough 
understanding of the data and to determine the appropriate final linear regression model to 
analyze.  Before a multiple linear regression could be conducted, it had to first be determined if 
the categorical experimental parameters (age at injury, days post injury and injured or uninjured) 
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were related to the dependent mechanical parameters.  A GLM was run to determine this 
relationship.  It was demonstrated that interactions between the categorical parameters were 
indeed significantly related to the mechanical parameters.  Second, with this knowledge, a 
backward stepwise linear regression was conducted on the entire data set to help refine the 
model.  A reduced form of the model was run to determine which categorical parameters were 
significant predictors of the mechanical parameters without the confounding effects of every 
possible interaction.  The reduced regression model of all the data demonstrated that the 
categorical parameters days post injury (Days) and the interaction term (age at injury)*(injury) 
(Age*Injury) were not significant predictors.  Third, a backward stepwise regression model was 
run which included all continuous parameters, all categorical and all interactions (excluding Days 
and Age*Injury).  This analysis demonstrated multiple, significant predictor variables, many of 
which included categorical parameters.  Along with the hypotheses of the study, this analysis 
provided support for running individual regression analyses based on experimental groups.   
An analysis of the compositional and structural independent variables measured in this 
study revealed some multicollinearity between independent parameters.  In particular, fibril 
diameter average and standard deviation, decorin and biglycan, and collagen content and fibril 
diameter all showed correlations in some of the groups analyzed. These correlations are 
observationally supported by previous studies that have examined compositional and structural 
properties of tendon.  For instance, as tendons develop, both the fibril diameter average and 
standard deviation (spread) increase with age [25].  In addition, biglycan and decorin are thought 
to have differential effects on collagen fibrillogenesis and be differentially regulated with respect 
to each other [6, 7, 26].  Lastly, it is not surprising that collagen content and fibril diameter 
average showed correlations in some groups because increased collagen production and 
increased fibril diameter average occur during similar stages of development [25, 31, 32].  When 
predictor variables are highly correlated, the regression coefficients tend to have large sampling 
variability.  Imprecise information may be presented about the true regression coefficients in 
these models; however, definite statistical relations may still exist between the independent and 
dependent parameters. The Durbin–Watson statistic is a test statistic used to detect the presence 
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of autocorrelation in the residuals from a regression analysis.  In other words, it tests for the lack 
of randomness in least squares residuals.  No correlations were seen between the independent 
variables for any of the significant models, therefore the error terms were indeed random.   
 
6.4.2 Limitations 
Stepwise linear regressions are used to automatically determine the “best” subset of 
independent variables that would significantly predict the dependent variables.  The forward 
stepwise regression procedure is probably the most widely used of the automatic search 
methods.  However, in the current study, the backwards stepwise regression was employed.  The 
main difference between the two procedures is that in a forward regression, parameters that have 
a significant effect are added to the model.  In backwards regression, all the parameters are 
initially in the model and subsequently removed if they do not have a significant effect.  For small 
and moderate numbers of variables in the pool of potential independent variables, some 
statisticians argue for backward stepwise search over forward.  This argument is based primarily 
on situations where it is a first step to look at each X variable in the regression function adjusted 
for all the other X variables in the pool [19].  While no significant differences should be observed 
between the two methods, the backward stepwise was used in the current study based on the 
argument above. 
The coefficient of determination (R2) for the significant equations ranged from 0.3 to 0.77.  
A low R2
 
indicates that a very small portion of the variability in the mechanical parameter is 
attributable to these independent parameters. It is likely that the inclusion of factors not 
considered in this model would result in an improvement in some of the R2 values. Such 
additional factors could include additional compositional parameters such as type XII and XIV 
collagens, additional structural parameters, such as fibril area fraction, or biologic parameters 
such as the number of inflammatory cells present.  In addition, a nested study design may have 
been possible based on the fact that each individual mouse is only present within each 
“specimen.”  However, based on the study design and hypotheses, a specimen was defined as 5 
individual mice (from the same litter).  Therefore, the factors for this study were age at injury and 
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days post injury with individual “specimen” randomly assigned to each group.  This study design 
dictated that a crossed design across factors, and not nested within specimen, was most 
appropriate for the hypotheses.    
The existence of correlations between independent variables causes complexities in 
interpreting the results. For instance, the effect of individual factors cannot be separated out. 
However, since this correlation is not an experimental artifact, but rather the result of the complex 
environment experienced by the tendon, manual removal of any factor was not conducted. In 
addition, the regression analysis manages such correlations by removing strongly correlated 
variables in the backward elimination step, leaving only the strongest predictor variables in the 
model. However, it should be noted that correlations between the dependent variables potentially 
allows one variable to mask the contribution of another. The hypotheses of this study were to 
determine which independent parameters had a significant effect on the dependent parameters; 
therefore, despite collinearity, the conclusions presented here remain valid. 
In this study, 13 out of the potential 24 equations were found to have significant 
predictors.  Most of the regression equations that did not demonstrate any significant predictors 
were due to high influence in the data set.  A specimen is considered to be influential if its 
exclusion causes major changes in the fitted regression function.  One possible explanation for 
the high incident of influence could be the small sample size used in the final grouped analyses.  
While an a prior power analysis test was conducted, a general rule of thumb for sample size in 
regression analysis is an n of 10 per independent parameter.  Therefore, the current study could 
have consisted of 50 specimens per group.  As a reminder, one specimen actually consisted of 6 
neonatal mice, with 4 experimental groups (uninjured and injured samples came from the same 
specimen); therefore, 1,200 neonatal mice would have been required under these criteria.  
Interestingly, 13 out of 24 equations were still found to have significant predictors.  However, an 
increase in sample size would likely produce more significant results and should be taken into 
consideration in future studies.  
 
6.4.3 Summary 
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 In summary, 8 different experimental groups (age at injury, days post injury and injured or 
uninjured) were analyzed in backward stepwise linear regression to determine how the 
independent parameters (collagen, biglycan and decorin content, and fibril diameter average and 
standard deviation) predicted the dependent parameters (percent relaxation, stress and 
modulus).  13 out of the 24 possible equations were demonstrated to have significant predictors.  
Specifically, percent relaxation was found to have collagen content, fibril diameter average and 
decorin content as significant predictors during normal development; whereas, only fibril diameter 
average and standard deviation predicted percent relaxation during healing.  In addition, during 
early development, biglycan and decorin are significant predictors of modulus during healing but 
no significant predictors for modulus were demonstrated during normal development.  The 
differences between early normal development and developmental healing should be further 
examined due to the fact that early developmental healing demonstrated an accelerated healing 
response with a recapitulation of normal mechanical properties. Understanding the exact 
mechanisms of action behind these predictor variables could provide new therapeutic treatments 
for the improvement of mechanical properties during adult healing. 
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Chapter 7: Summary, Limitations and Future Directions 
 
7.1 Overall Conclusions 
 The previous chapters describe different methods in which development can be used as 
a new paradigm through which to improve adult healing.  Through the course of the work, factors 
that were differentially regulated during development and healing were more closely examined in 
knock-out mouse models, a new model of neonatal tendon development in a mouse Achilles 
tendon was established as well as a new model of healing during two stages of neonatal 
development in a mouse Achilles tendon.  A brief summary of the background and significance 
motivating this work, a brief summary of the findings, as well as limitations and future directions 
are provided below. 
 
7.1.1 Background and Significance 
 Tendon injuries are a large problem clinically due to their inability to regain normal 
function.  During the repair response to injury, structural and compositional changes occur, but a 
mechanically inferior tendon is produced.   An injured tendon which is mechanically inferior, has 
compromised function and reruptures after treatment is commonly observed clinically.  
Conversely, during neonatal development, tendons undergo a well orchestrated process whereby 
extensive structural and compositional changes occur in synchrony to produce a normal 
tendon[1, 2].  As a result, the process of development has been postulated as a potential 
paradigm through which improved adult tendon healing may occur. 
Chapter 1 outlined general knowledge of tendon composition, structure, mechanical 
properties, healing process and the current issues still plaguing tendon healing clinically.  
Tendons are composed mainly of aligned, type I collagen and transfer tensile stress from the 
muscle to the bone.  Minor constituents are also present (minor collagens and proteoglycans) that 
are thought to play a role in fibrillogenesis during development and possibly mechanics. Some of 
the new treatments to help tendons heal include new surgical and rehabilitation protocols, growth 
factor and cytokine application, gene therapy, and tendon grafts with cells. Interestingly, fetal 
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tendons have the ability to heal without scar, but have fundamentally differences from adult 
healing that are difficult to alter in the adult wound [3]. Due to the differential healing response 
between fetal and adult tendons, it has been proposed that healing parameters may change 
throughout fetal and neonatal development into adulthood.  During neonatal development, 
tendons have significant compositional and structural changes including an increase in collagen 
content, temporal expression of minor constituents and an increase in both the fibril diameter 
average and spread.  However, little information is available on the mechanical development and 
healing parameters during neonatal development.  With this in mind, it is the goal of this 
dissertation to characterize neonatal development and healing, identify parameters that are 
important to mechanical properties during development and healing and see how these 
parameters affect healing.   
 
7.1.2 CD44 Deficiency Improves Healing Tendon Mechanics and Increases Matrix and Cytokine 
Expression in a Mouse Patellar Tendon Injury Model 
 In Chapter 2, the role of CD44 in adult healing was investigated.  CD44 is a cellular 
receptor for hyaluronic acid (HA).  During fetal healing CD44 expression is depressed and HA 
has a prolonged expression; however, during adult healing CD44 is highly expressed and HA is 
also expressed but for only a short period of time.  Due to this differential response between fetal 
and adult healing, it was hypothesized that a lack of CD44 would have an effect on adult healing.  
Based on previous studies that investigated a decrease in CD44 during healing, it was 
hypothesized that a lack of CD44 would have a detrimental effect on adult healing.  To test this 
hypothesis, a CD44 knockout (KO) mouse model was used in conjunction with a patellar tendon 
injury model.  In general, the cross-sectional areas of the KO tendons were reduced at 3 and 6 
weeks post injury when compared to wild type (WT) controls.  In contrast to the hypothesis, 
mechanical stress, strain energy density and failure strain were increased when compared to WT.  
Histologically, when comparing across time post injury, the KO tendons approached uninjured 
fiber organization whereas WT did not at 6 weeks post injury.  Lastly, gene expression data 
indicated that matrix components and cytokines that are beneficial to superior healing were up 
157 
regulated in KO tendons.  This study indicates that limiting the role of CD44 may improve healing 
parameters in adult tendon injury.   
 
7.1.3. Temporal and Tissue Specific Dysfunction in the Absence of Type XIV Collagen in a 
Mouse Model 
  In Chapter 3, the role of type XIV collagen in tendon mechanics was evaluated during 
both development and maturity in soft tissues, specifically tendon and skin.  Type XIV collagen is 
a fibril associated collagen that is present during development in tendon and throughout life in 
skin.  It is a minor constituent that has a role in the lateral fusion phase of fibrillogenesis.  It was 
hypothesized that the significant role type XIV collagen plays in the regulation of fibrillogenesis 
would lead to alterations in the mechanics of developing soft tissues. To test this hypothesis, a 
new method to mechanically test small, fragile neonatal tendons was developed.   As 
hypothesized, skin in the mature KO mice had a reduced stress and modulus.  A decrease was 
also seen in almost all mechanical parameters of neonatal flexor digitorum longus tendons with 
no change in cross-sectional area; however, there was no change in mechanics in the mature 
tendons.  In addition, heterozygous tendons (Col14-/+) had mechanical properties intermediate to 
those of the WT and KO tendons, implying that type XIV collagen has a dose dependent effect on 
the mechanics of neonatal developing tendon.  Changes in collagen structure from altered 
fibrillogenesis during development may account for the changes seen in tendon neonatal 
development but not maturity.  Overall, the data suggested a tissue-specific and age specific role 
of type XIV collagen in the structure-function relationships of connective tissues.   
  
7.1.4 Mechanical, Compositional and Structural Properties of the Neonatal Mouse Achilles 
Tendon 
It has been proposed that understanding the similarities and differences between 
neonatal development and healing could lead to new treatments in adult healing; however, a 
greater understanding of neonatal development must first be obtained.  In Chapter 4, a mouse 
model of neonatal development was created to investigate compositional, structural and 
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mechanical changes throughout development.  Achilles tendons from mice at 4, 7, 10, 14, 21 and 
28 days old were examined.  In general, it was found that collagen content increased, biglycan 
expression decreased, decorin content was unaltered, fibril diameter mean and spread increased, 
cross-sectional area and mechanical parameters increased.  Not only does this chapter provide 
fundamental knowledge about neonatal development, but it provides that information using a 
mouse model.  A mouse model is important because of the potential use of genetically altered 
mice and commercially available assays that will help answer more mechanistic questions in 
future studies 
 
7.1.5 Recapitulation of the Achilles Tendon Mechanical Strength during Neonatal Development:  
A Study of Differential Healing During Two Stages of Development in a Mouse Model 
 As previously stated, understanding the differences between development and healing 
could lead to improved healing in adults.  In addition, it has been proposed that healing 
parameters change throughout development.  A thorough understanding of healing during 
development could lead to new models for improved tendon function during healing.  In Chapter 
5, two different stages of healing during neonatal development were investigated.  Data from 
Chapter 4 demonstrated that at 7 and 21 days old neonatal Achilles tendons were distinctly 
different in their composition, structure and mechanics; therefore, these two stages were chosen 
to study healing. An in vivo surgical model of neonatal healing was created by introduction of a 
full thickness, partial width (~50%) biopsy injury in the Achilles tendon.  Healing parameters were 
then observed at 3 and 10 days post injury.  In general, it was observed that during early 
development (7 days old) compositional and mechanical parameters had returned to normal 
values although the fibril diameter mean and spread remained lower (small fibrils, narrow spread) 
than normal.  During late development (21 days old), there was little to no change in most 
parameters at 3 days post injury and then drastic changes at 10 days post injury, most of which 
were associated with adult reparative healing (increased collagen and proteoglycans content, 
increased cross-sectional area, decreased mechanical properties).  In addition, mechanical 
properties were higher in early development when compared to late (when comparing parameters 
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normalized for development) and during early development, mechanical properties improved over 
time but not during late development (when comparing parameters normalized for development). 
Overall, Chapter 5 demonstrated an accelerated healing response during early development that 
was not present during late development.   
 
7.1.6  Investigating Structure-Function Relationships in Achilles Tendon Neonatal Development 
and Healing during Neonatal Development in a Mouse Model using Multiple Regression Models 
 In Chapter 6 a linear regression statistical model was utilized to quantitatively and 
objectively compare and contrast normal developmental tendons with healing developmental 
tendons.  In Chapter 5, compositional, structural and mechanical changes were quantified for 
both uninjured and injured tendons through a unilateral injury in the mouse Achilles tendon.  This 
data was then used in statistical analyses.  First, a general linear model was used to determine 
how the compositional, structural and experimental groups (age at injury, days post injury and 
injured or uninjured) related to the mechanical parameters.  Second, a backward, stepwise linear 
regression model was examined for the entire data set.   A model regressing the compositional, 
structural, and experimental groups and only the interactions between the experimental groups 
was initially conducted.  After excluding non-significant experimental groups a backward, 
stepwise linear regression model of the entire data set, including all other main effects and 
interactions, was run for each mechanical parameter. This analysis provided statistical support to 
regress the mechanical parameters against only the compositional and structural parameters 
within experimental groups.  Out of 24 possible equations (3 mechanical parameters for each of 8 
groups), 13 were found to have significant predictors.  In general, proteoglycans were shown to 
be significant predictors of modulus during early developmental healing but not during late 
developmental healing or normal development.  Multiple independent parameters predicted 
percent relaxation during normal development, however, only biglycan and fibril diameter 
parameters predicted percent relaxation during early developmental healing.  Last, multiple 
differential predictors were observed between early development and early developmental 
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healing, however, no differential predictors were observed between late development and late 
developmental healing. 
 
7.2 Limitations and Future Directions 
 The body of work described in this dissertation has expanded our knowledge of neonatal 
tendon development and healing through a greater understanding of the specific roles of CD44 in 
healing and type XIV collagen in development, a characterization of neonatal development and 
healing during development and a structure-function analysis of development and healing during 
development.  Within this work, a new mouse model of neonatal tendon development and healing 
during neonatal development was created.  In addition, a new method to mechanically test small, 
fragile tendons and a new surgical model were developed.  This dissertation has uncovered 
fundamental knowledge on neonatal development and healing and answered questions regarding 
the role of different tendon parameters during development and healing.  In addition, it has 
provided new model systems through which additional questions can be proposed and answered.  
The following sections describe limitations in the current studies and potential avenues for future 
work loosely organized around the previous Chapters 2-6. 
 
7.2.1 CD44 in Adult Healing 
 As with all studies, the study of the role of CD44 during healing had its limitations.  First, 
mRNA expression may not completely mirror the protein levels since there is post-transcriptional 
regulation of protein synthesis.  However, these findings are consistent with those reported by 
other investigators [4].  Second, only male mice were examined.  It was recently demonstrated 
that collagen synthesis in human females is significantly less than in males [5]; therefore, the 
results of this study may not be translatable to female mice.  However, since a change in type I 
collagen expression was not shown, the overall conclusions are likely still applicable to both 
sexes.  Third, all the uninjured control tendons were harvested at 12 weeks of age, even though 
they were compared to injured mice as up to 18 weeks of age.  Somerville et al [6] demonstrated 
that most material and mechanical properties of cortical bone had reached their maximum value 
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around 3 months of age.  Therefore, it is unlikely that an additional 6 weeks would have 
significantly affected results on the material properties of the tendons due to growth. Fourth, as 
with all knockout studies, there is a possibility of compensation by other molecules.  The most 
likely candidate is RHAMM, another HA receptor.  While RHAMM expression was not examined 
directly, signaling or the inflammatory response, which is connected to RHAMM expression.  
Nevertheless, expression of IL1b, a main down stream effecter of RHAMM, was not increased in 
this study; therefore, it is unlikely that RHAMM signaling increased in this study.       
 The present study was a good first step in determining CD44’s role in tendon healing and 
mechanical properties; however, the mechanism of action was not uncovered in this study.  If the 
mechanisms are determined, then clinical applications involving CD44 could be undertaken to 
help improve adult tendon healing.  Outlined below are steps that could be taken in future studies 
to meet these objectives. 
 First, a better understanding of possible compensatory mechanisms would provide 
further insight into this model system.  While the gene analysis conducted in this study pin 
pointed the cytokines and matrix molecules that were deemed important from previous research, 
other components of normal and healing tendon may also be altered.  Previous studies have 
examined the phenotypes of CD44 KO mice and found some differences in inflammatory cell 
recruitment [7, 8].  However, an overall view of the differential expression of mRNA has not been 
conducted.  Microarray provides a broad understanding of the changes in mRNA expression, 
thereby providing more complete knowledge of possible altered mechanisms.  Therefore, an 
analysis of mRNA expression in WT and CD44 KO adult mice should be conducted.  Upon 
obtaining baseline expression values and differences, an additional microarray study examining 
differences in expression shortly after injury (1, 3 and 7 days post injury) would help explain the 
differential healing response demonstrated in the current study.  The value of a microarray study 
is that a broad range of targets were examined; therefore, molecules that were not initially 
hypothesized to play a role in healing in the absence of CD44 can be identified for further study.  
After determining overall expression in the normal KO and the KO during healing, further 
investigation into differentially regulated molecules can be conducted.  First, altered expression 
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needs to be confirmed by PCR and second, if possible, protein levels should be determined. 
Upon determining that these molecules are indeed differentially regulated, a greater 
understanding of the mechanisms can be determined. 
The present study demonstrated a beneficial effect of limiting the expression of CD44, 
but, as stated, it did not provide the mechanism behind this effect.  When CD44 and HA interact 
on the cell surface, a cascade of events is initiated intracellularly.  The work in this study could 
indicate that these intracellular events are detrimental to healing; however, it is possible that there 
are still beneficial mechanisms from the interactions of CD44 and HA.  Support for this hypothesis 
is based on the fact that high molecular weight HA has been shown to have beneficial effects on 
tendon healing (fetal healing) whereas low molecular weight HA has detrimental effects (adult 
healing) [9].  The differential response between these two interactions is still not well understood.  
Therefore, a closer examination of the intracellular signaling processes that occur during fetal 
healing and normal adult healing may help elucidate and differentiate these mechanisms. CD44 
has been implicated to in the initiation of the ERK [10], Rac [11] and p38 [12] intracellular 
pathways.  Specific cell signaling differences have already been observed in vitro with age [13] 
and between high and low molecular weight HA [11].  One method to determine how different 
intracellular signaling pathways are mediating the healing process is through inhibition of an 
upstream target.  Specifically, the inhibitors SB 203580 (p38) and U0126 (ERK) can be applied to 
an injury in vivo.  In addition, these inhibitors can be applied singularly and in combination.  These 
inhibitors act by preventing the phosphorylation of p38 and ERK which occurs after injury.  One 
complication of this method is that phosphorylated and unphosphorylated p38 and ERK need to 
be detected in injury, without inhibitors and with inhibitors, respectively.  Unfortunately, due to the 
p38/ERK’s intracellular location and the small number of cells present in tendon, this is a 
technically difficult assay, particularly in a mouse model where the tendons provide limited 
starting material.  Therefore, future studies should examine these mechanisms in a larger animal 
model, either a rat or potentially even a rabbit.   Lastly, a thorough investigation into which form of 
HA is present in each of the age groups examined is necessary to elucidate the differential effect 
of HA on the intracellular processes in vivo.  With information obtained from this experiment, a 
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deeper understanding of the exact mechanisms behind improved healing in the absence of CD44 
and its intracellular signals will be obtained and may therefore be applied clinically. 
The present work is very encouraging because it demonstrates the ability to alter the 
mechanical, organizational and genetic response to injury through the removal of a single 
molecule.  This is particularly important clinically because synergistic effects with other treatments 
can be avoided.  One method that could potentially block CD44’s actions clinically that is showing 
promise is the application of siRNA and shRNA (small interfering plasmid and lentiviral RNA) [14].  
These small RNA molecules are targeted to knock down expression of a specific gene of interest 
and have been used extensively in vitro [4], in animal models [15] and even clinically [16].  The 
main advantage of this research tool is that the possibility of developmental compensation is 
circumvented by applying the siRNA locally and only after injury. Multiple methods for delivery are 
being investigated including nanoparticles, viral and extracellular matrix.  In addition, this 
technology is already in clinical trials and has shown efficient targeting and internalization.  Of all 
the potential delivery methods, the most promising for the field of tendon regeneration is the 
ability to deliver siRNA through matrix components [17]; therefore, CD44 siRNA could be added 
to a tendon graft to improve tendon healing.   
Before siRNA can be applied clinically, an in vivo animal model must first be conducted in 
a clinically relevant model.  Therefore, a first step would be to augment a rotator cuff tear in a rat 
supraspinatus model with an siRNA treated tendon graft and observe the mechanical parameters 
at 4 and 8 weeks post injury compared to repair without augmentation.  In addition to mechanical 
parameters, fibril organization and mRNA expression of IL-1b, TGFb, decorin, biglycan, types I 
and III collagen should all be examined so the results can be comparable to those found in the 
CD44 KO study.  In addition, assays to confirm uptake of the siRNA into tendon fibroblasts need 
to be conducted prior to the start of this study to ensure transfection efficiency.  Upon completion 
of this study, assuming beneficial healing parameters were observed, future studies in a larger 
animal and then clinical trials can be undertaken.   
  
7.2.2 The Role of Type XIV Collagen in Development 
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  To investigate the role of type XIV collagen during development a Col14a1 knockout (KO) 
mouse was utilized.  As mentioned above in the CD44 study, compensatory mechanisms may 
have accounted for the discrepancy between neonatal and mature tendons.  Other molecules in 
the KO tendon may have compensated by maturity or the discrepancy could simply mean type 
XIV collagen plays a more significant role in mechanical development.  The main candidates for 
compensation were the four proteoglycans, decorin, biglycan, lumican, fibromodulin, and type XII 
collagen. Type XII collagen is also a FACIT collagen and is more widely expressed throughout 
development, maturation and aging than type XIV collagen in most connective tissues [18-20]. 
The four proteoglycans have previously been shown to play multiple roles during fibrillogenesis, 
making them candidates for compensation.  Neither type XII collagen or the four proteoglycans 
were shown to be upregulated in the current study; therefore, it can be hypothesized that the 
discrepancy seen between neonatal development and maturity in the Col14a1-/- tendon is due to 
type XIV collagen.  
  A greater understanding of how type XII and XIV collagen affect fibrillogenesis and 
mechanical properties is needed.  The current study indicates that the absence of type XIV 
collagen decreases the mechanical parameters during development of tendon; therefore, type 
XIV collagen’s presence may be beneficial during development and healing.  If subsequent 
studies find data to support this hypothesis, type XIV collagen can be incorporated into tendon 
grafts for clinical applications. However, numerous studies need to be conducted before tissue 
engineering work can begin.  First, a study parallel to the one conducted in this dissertation needs 
to be conducted on the type XII and compound type XII/XIV KO mice.  Specifically, the 
mechanical properties, fibril diameter average and spread, along with the expression of biglycan, 
decorin, fibromodulin and lumican should be studies in developing, juvenile and mature Achilles 
tendons (7, 21 and 42 days old).  The study should incorporate a multiple regression statistical 
analysis that will systematically demonstrate which compositional and structural parameters affect 
the mechanics and whether the FACIT collagens have a differential effect.  Therefore, the 
statistical model should regress the mechanical parameters against the presence of the FACIT 
collagens, compositional and structural parameters.  This design will demonstrate how the FACIT 
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collagens are affecting mechanics in three stages of development, whether the change in fibril 
properties are a main effect and whether there are significant compensations by  the 
proteoglycans in the knockout mice. 
  Type XIV collagen plays a role in the lateral fusion of fibrils during fibrillogenesis.  In 
particular, in the absence of type XIV collagen, an increase in fibril diameter was observed along 
with a decrease in mechanical parameters.  In a pilot study presented in Chapter 3, type XIV 
collagen expression was present in elevated levels one week post injury in adult tendon and adult 
healing tendon has been shown to have decreased fibril diameters.  Similarly, in Chapter 5 of this 
dissertation, during early neonatal development, a decrease in fibril diameter average was 
observed along with a return of mechanical properties.  These three observations lead to the 
hypothesis that the presence of type XIV collagen, post injury could be preventing the lateral 
fusion of fibrils; however, small diameter fibrils may be beneficial to the recapitulation of 
mechanical strength during development but detrimental during adult healing. This differential 
response could be due to the presence or absence of type XIV collagen or other minor 
constituents during development or healing.  Therefore, gaining an understanding of how the 
FACIT collagens affect both fibril diameter and the mechanical parameters would give invaluable 
information considering the apparently contrasting observations.  Specifically, the unilateral injury 
model presented in Chapter 5 should be implemented in mice at 7, 21 and 60 days old and 
examined at 7, 14 and 28 days post injury.  Fibril diameter average, spread and modality, 
collagen content (both type I and III) measured by either ELISA or western blot, decorin and 
biglycan protein expression by western blot, fiber organization measured through polarized light 
microscopy, type XII and XIV collagen content measure by western blot and mechanical 
parameters from stress relaxation and ramp to failure tensile tests should all be investigated.  The 
proposed ages were chosen due to the differential effect of type XIV collagen’s absence between 
7 and 60 days old mice during normal development and due to the differential healing response 
between 7 and 21 days old mice.  The time points post injury were chosen so fiber organization, 
progression of possible fibril diameter growth and accumulation of minor matrix molecules can be 
observed.   Similar to Chapter 5, the uninjured contralateral Achilles tendon should be used to 
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control for developmental changes and comparisons should be made across age at injury and 
days post injury.  Due to the older ages proposed in this study, only male mice will be examined 
so sex is not a confounding factor.  In addition, regression analysis is not being proposed for the 
data in this study due to the large number of independent parameters (and therefore large sample 
size required for regression); therefore, litters do not need to be weaned to 6 pups and Achilles 
tendons can be pooled to obtain measurements of matrix constituents (biglycan, decorin, type I, 
III, XII and XIV collagen).   This study will provide a deeper understanding of how type XII and 
XIV collagen affect fibrillogenesis and the development of mechanical properties at different 
stages of development and healing.  Not only will this study characterize type XII and XIV 
collagen during development, but also will further characterize the developmental healing models 
presented in Chapter 5. 
  While the study presented above is too extensive to incorporate a multiple regression 
model as noted, simple linear regressions can be conducted comparing mechanical parameters 
to compositional and structural parameters in groups that showed improved healing.  If fibril 
diameter parameters are found to correlate with mechanics, the fibril diameter average and 
standard deviation can also be regressed with the matrix components.  This analysis will lend 
insight into which proteoglycans and collagens may play a role in fibrillogenesis. While simple 
linear regression does not determine which parameters are the “best” predictors within the frame 
work of all possible predictors, it does give an objective, quantitative relationship between 
measured parameters. 
 
7.2.3. Neonatal Tendon Development and Developmental Healing 
  In this dissertation, the neonatal Achilles tendon mechanical development and 
healing during development in a mouse model were studied for the first time.  These fundamental 
studies were however, not without limitations.  Both male and female mice were used in this study 
due to study design restraints of needing litters of at least 6 pups.  While it is currently unknown if 
there are sex differences at the ages examined, previous studies showed little to no effect of sex 
on tendon mechanics and composition in one month old mice or rats [21-23].  It is important to 
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note that effects due to sex were seen at older ages, after the onset of puberty, in some studies.  
While there is still a possibility of sex differences even in pre-pubescent mice, Chapter 4 
demonstrated little to no effects of sex on mechanical properties.  Compositional and structural 
parameters were not evaluated for sex differences due to the low number of total specimens per 
group; however, based on previous studies, it is assumed that there is no effect due to sex.   
 In addition, in the current study, comparisons were subjectively made to adult tendon 
healing but no adult tendons were included in the present study design.  The objective of the 
current study was to examine healing during development and already required 288 mice.  The 
addition of a third age, which was not part of the study hypotheses, would have added an 
additional 144 mice to the experimental design, substantially and unnecessarily increasing the 
size of the experiment. Previous studies have already examined most of the parameters 
examined in this study in adult healing, and a current study in our laboratory is examining injury in 
adult mouse AT.  Therefore, based on previous knowledge available, adult mice were not 
included in the current study. 
  In this dissertation, total collagen content was measured even though there was most 
likely a differential response between type I and III collagen during healing.  It is possible that the 
presence of type III collagen during healing prevents the progression of fibril diameter growth. 
Future studies should determine the amount of type III collagen during developmental healing to 
determine its role in scar formation and the recapitulation of mechanical properties.  Specifically, 
the future study detailed in section 7.2.2 includes measuring type I and III collagen by either 
ELISA or western blot analysis.  Examining type III collagen, along with the other matrix 
components during several stages of healing will help to draw conclusions as to which 
parameters are differentially regulated and may be beneficial to mechanical properties. 
  The relative expression of biglycan and decorin were measured through mRNA 
expression in this study.  It would have been advantageous to measure the actual protein content 
of these proteoglycans during development.  The ability to collect quantitative measures from 
individual tendons lends itself towards using experimental parameters in rigorous statistical 
regression models.  Therefore, this criterion was used when selecting compositional and 
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structural parameters to measure.  Unfortunately, protein measures could not be obtained for 
individual tendons due to the size of neonatal Achilles tendon and limited quantity of biglycan and 
decorin in an individual tendon, in addition to a lack of a biglycan ELISA.  Previous studies that 
have detected these proteins through western blot pooled 6-12 neonatal tendons together to 
obtain enough protein.  Therefore, this analysis was not used due the necessity of obtaining 
individual measures for each tendon for the regression analysis.  A pilot study was attempted to 
correlate mRNA expression of decorin and biglycan to protein expression with pooled tendon 
during development; however, as detailed in Chapter 4, the results of this study were 
inconclusive.  Future studies should include quantitative measures of actual protein content when 
the appropriate assays become available or when Achilles tendons can be pooled.  Again, the 
study presented in section 7.2.2 takes these additional assays into account. 
  One advantage to conducting the current study in a mouse model is the availability of 
numerous genetically modified mice and commercially available assays and techniques that are 
not available in other animal models.  The current study provides fundamental knowledge of 
normal tendon development from which other, more elaborate, mechanistic studies can be built.  
For instance, by comparing changes in normal development with those in a knockout mouse, the 
role of that molecule in the development of mechanical strength can be further understood.  An 
example, using type XII and compound type XII/XIV collagen KO mice, was provided in section 
7.2.2. In addition, more in depth biological studies can be conducted to determine what cell 
signaling processes are at play during development and how they affect mechanical strength.  An 
example in the CD44 KO mouse using cell signaling inhibitors was given in section 7.2.1.  With 
the number of genetically modified mice (knockout and conditional knockout) and assays 
available, the number of questions that can now be answered about tendon development are 
abundant.  Understanding, on a deeper level, how tendons naturally develop mechanical strength 
and how healing during early development is accelerated will lead to new strategies to improve 
tendon healing. 
  Previous in vivo studies have provided evidence that the inflammatory response to injury 
is altered with age.  Most notably, during scarless fetal healing, there is a lack of inflammatory 
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response that many have hypothesized could explain scarless healing [26, 27].  In addition, when 
comparing skin wounds in mature (6 months old) to aged (30 months old) mice, an early influx of 
neutrophils was apparent in the wounds of the aged compared to the younger controls [28].  One 
possible explanation for the differences observed in this study could therefore be differences in 
inflammation.  Future work in this model should include an investigation into the influx of 
inflammatory cells and the expression of pro-inflammatory and anti-inflammatory growth factors 
(IL-1B, TGFB1, TGFB3, PDGF, IL-4, IL-6, IL-10) during early and late development by both 
mRNA expression and immunohistochemistry. mRNA expression will help obtain a quantitative 
measure while the immunohistochemistry will confirm the location and protein presence of each 
factor.   In addition, the number of inflammatory cells should be determined.  Flow cytometry is 
the most useful tool to determine cellular markers and therefore different cell types; however, due 
to the small size of mouse tendons and the small number of cells within tendon, this technique is 
most likely not feasible.  Instead, immunological staining of cell markers can be conducted and 
cell types can be visually counted.  Upon determining which inflammatory markers and cell types 
are differentially regulated between early and late developmental healing, a study should be 
conducted to replicate the early developmental healing environment in an adult injury.  This will 
provide further insight into the mechanisms behind the accelerated healing observed in early 
development and attempt to improve adult healing by recapitulating that environment. 
   Despite the advantages in this injury model, there are some disadvantages.  Most 
notably, the uninjured lateral struts on either side of the injury could stress shield the injured 
tissue in the middle.  Thus, in vivo stress levels experienced by the injured part of the tendon 
could be substantially less than the uninjured portion.  This could explain the inability of the 
collagen fibrils to regain normal mean diameter and spread.  However, the inability of fibrils to 
regain a large distribution and bimodality [29] is well documented in numerous injury models and 
therefore it is unlikely that stress shielding was the main factor in the current study.  The current 
study also demonstrated a return of mechanical strength during early development in the middle 
portion of the tendon, indicating that it is indeed responding to mechanical load.   
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The full thickness, partial width injury necessitated the removal of the uninjured struts on 
either side of the injury prior to mechanical testing to ensure only healing tendon was 
mechanically tested. While this procedure ensured the mechanical parameters measured were 
only healing tissue, it did not allow the measurement of structural mechanical parameters, only 
material.  The excisional injury used in this model was chosen based on reproducibility and 
consistency of the injury.  In addition, there was a concern of possibly creating too minimal a 
healing response at younger ages with an incisional injury where changes might not be 
observable. An excisional injury provided a more substantial defect to help ensure an observable 
healing response.  An excisional model is appropriate for this study because this study was not 
intended to have a direct clinical translation, but rather to be a model for studying the basic 
biology during developmental healing.  It would however be beneficial to examine if an incisional 
injury demonstrates the same healing properties as the excisional injury presented in this study.  
Specifically, a small study comparing full thickness, partial width excisional and incisional 
unilateral injuries should be conducted on mice at 7 and 21 days of age.  The parameters 
examined should include mechanical properties, proteoglycans expression and fibril diameter 
average.  These parameters were chosen based on large difference observed in Chapter 5.  This 
study may help develop a more clinically relevant model of tendon injury during development. 
 In this study, changes in collagen organization were demonstrated through three blinded 
graders instead of measuring angular deviation through polarized light microscopy.  Polarized 
light microscopy was attempted in these experimental animals; however, within the wound site of 
the AT injured at 7 days old, there was not enough mature collagen for birefringence.  Evaluation 
at longer time points post injury proposed in the study in section 7.2.2 can be used to determine 
quantitative differences in collagen organization.   
  Little is currently know about the mechanisms behind fibrillogenesis post injury and even 
less is known about it during developmental healing.  When qualitatively examining the entire 
width of the injured tendons in this dissertation under electron microscopy, many cellular 
processes were observed at the borders and within the injury.   Understanding the cellular 
changes within a tendon and across groups may provide substantial knowledge on the 
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recapitulation of mechanical strength, particularly since the current study demonstrated prolonged 
changes in fibril diameter properties in the presence of a return to mechanical strength.  A 
detailed study on these processes and how they change from the periphery of the tendon through 
the center of the injury could help gain insight into fibrillogenesis during developmental healing.  
In addition, comparing and contrasting, not only within a tendon but also across groups, could 
lead to the recognition of unique cellular processes observed during early and late neonatatal 
developmental healing.   
 
7.2.5 Regression Analysis of Healing During Development 
Stepwise linear regressions are used to automatically determine the “best” subset of 
independent variables that would significantly predict the dependent variables.  The forward 
stepwise regression procedure is probably the most widely used of the automatic search 
methods.  However, in the current study, the backwards stepwise regression was employed.  The 
main difference between the two procedures is that in a forward regression, parameters that have 
a significant effect are added to the model.  In backwards regression, all the parameters are 
initially in the model and subsequently removed if they do not have a significant effect.  For small 
and moderate numbers of variables in the pool of potential independent variables, some 
statisticians argue for backward stepwise search over forward.  This argument is based primarily 
on situations where it is a first step to look at each X variable in the regression function adjusted 
for all the other X variables in the pool [30].  While no significant differences should be observed 
between the two methods, the backward stepwise was used in the current study based on the 
argument above. 
The coefficient of determination (R2) for the significant equations ranged from 0.3 to 0.77.  
A low R2
 
indicates that a very small portion of the variability in the mechanical parameter is 
attributable to these independent parameters. It is likely that the inclusion of factors not 
considered in this model would result in an improvement in some of the R2 values. Such 
additional factors could include additional compositional parameters such as type XII and XIV 
collagens, additional structural parameters, such as fibril area fraction, or biologic parameters 
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such as the number of inflammatory cells present.  Section 7.2.2 detailed a study that utilizes the 
collagen XII and compound XII/XIV mouse models to determine how composition, structure and 
the presence of the FACIT collagen affect mechanical parameters.   
The existence of correlations between independent variables causes complexities in 
interpreting the results. For instance, the effect of individual factors cannot be entirely separated 
out. However, since this correlation is not an experimental artifact, but rather the result of the 
complex environment experienced by the tendon, manual removal of any factor was not 
conducted. In addition, the regression analysis manages such correlations by removing strongly 
correlated variables in the backward elimination step, leaving only the strongest predictor 
variables in the model. However, it should be noted that correlations between the dependent 
variables potentially allows one variable to mask the contribution of another. The hypotheses of 
this study were to determine which independent parameters had a significant effect on the 
dependent parameters; therefore, despite collinearity, the conclusions presented here remain 
valid.   
  
7.3 Final Conclusion 
 Development has long been considered a potential paradigm through which the 
improvement of adult healing could be studied.  Through extensive work from other researchers, 
much has been learned about development including the stages of fibrillogenesis, compositional 
changes including proteoglycans and minor collagens, structural changes including fibril diameter 
parameter and a few studies have examined mechanical development.  Most studies that 
examined mechanical development started the study at approximately one month of age in a 
mouse.  One study was able to capture the mechanical development throughout neonatal 
development in a chick model.  While these studies have expanded our knowledge greatly, a 
deeper understanding of the mechanisms behind the development of mechanical strength was 
left unknown due to limitations in the animal models used.   
 Healing has previously been shown to have different parameters at different stages of 
life.  In particular, fetal healing occurs scarlessly whereas adult healing occurs with extensive scar 
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formation and reduced mechanical function.  Extensive work has been done in both these healing 
models in an attempt to understand the normal processes and then improve upon them.  
However, neither of these model systems has demonstrated a return of normal mechanics.  
Healing parameters have been hypothesized to heal throughout development but this hypothesis 
was previously untested.  The dissertation presented here first identified two molecules that had a 
differential expression either during development (type XIV collagen) or healing (CD44) and 
examined their role during development and healing respectively.  Then, a mouse model of 
normal tendon development was created that allowed the quantitative measure of compositional, 
structural and mechanical properties.  Further expansion of that model included the development 
of a tendon injury model at two stages of neonatal development.  Through the injury model, an 
accelerated healing response was observed during early neonatal healing that was not seen 
during late neonatal healing.  Lastly, a statistical regression model was developed to objectively 
and quantitatively determine which structural and compositional parameters were significant 
predictors of both normal development and healing during development.    
 As a result of the research presented here, a mouse model of neonatal development and 
healing during neonatal development are available for future studies into the mechanisms behind 
these processes.  In addition, a model of accelerated healing where mechanical strength is 
recapitulated in a short period of time without treatment is presented for the first time.  Lastly, the 
statistical regression data can be used to obtain parameters that are important for improved adult 
healing and implemented in clinical treatments and tissue engineered grafts.  This work has laid 
the ground work for many future mechanistic studies to be conducted on the development of 
mechanical strength during both development and healing.   
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APPENDIX: RESULTS OF REGRESSION MODEL REFINEMENT 
Group – 7,3,U
Group – 7,10,U
Group – 21,3,U
Group – 21,10,U
Group – 7,3,I
Group – 7,10,I
Group – 21,3,I
Group – 21,10,I
Appendix 6.1: Pearons Correlations for all independent parameters calculated within each experimental 
group.  Group = age at injury, days post injur, (I)njured or (U)ninjured
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Appendix 6.2: Results of significant predictors from the backward, stepwise regression 
analysis of the entire data set for percent relaxation, stress and modulus.
Percent Relaxation
Stress
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Modulus
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